{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.14.10-dev",
    "document_metadata": {
      "name": "Apoptosis-2.0-Hs",
      "authors": "Causal Biological Networks Database",
      "licenses": "\t        Please cite:\t\t        - www.causalbionet.com\t        - https://bionet.sbvimprover.com\t\t        as well as any relevant publications.\t\t        The sbv IMPROVER project, the website and the Symposia are part of a collaborative project\t        designed to enable scientists to learn about and contribute to the development of a new crowd\t        sourcing method for verification of scientific data and results. The current challenges, website\t        and biological network models were developed and are maintained as part of a collaboration among\t        Selventa, OrangeBus and ADS. The project is led and funded by Philip Morris International. For more\t        information on the focus of Philip Morris Internationalâ€™s research, please visit www.pmi.com.\t        ",
      "version": "2.0",
      "contact": "CausalBiologicalNetworks.RD@pmi.com",
      "description": "The Apoptosis network describes causal mechanisms in several different signaling pathways that are involved in the induction of apoptosis in response to environmental cues. The pathways include ER stress signaling, particularly the PERK-eIF2alpha-ATF4-CHOP pathway, MAPK components that regulate the pro-apoptotic proteins (Bad,Bax, Bim) via PI3K/AKT and JNK pathways, NFkB signaling which induces downstream expressions of anti-apoptotic proteins, PKC-mediated apoptosis, and activation of TNFR1 and Fas receptor leading to downstream signaling of caspase-8. The network also characterizes the transcriptional role of TP53 in apoptosis through the presence of its downstream anti-apoptotic and pro-apoptotic targets. \\nReviewed during Jamboree2014"
    },
    "namespace_url": {},
    "namespace_pattern": {
      "go": ".*",
      "fplx": ".*",
      "hgnc": ".*",
      "mesh": ".*"
    },
    "annotation_url": {},
    "annotation_pattern": {
      "doid": ".*",
      "cl": ".*"
    },
    "annotation_list": {}
  },
  "nodes": [
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "response to oxidative stress",
        "identifier": "0006979"
      },
      "id": "93e9cda1ce236d46f9d08ff12a40d02a",
      "bel": "bp(go:0006979 ! \"response to oxidative stress\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "response to unfolded protein",
        "identifier": "0006986"
      },
      "id": "db424e29c9f514095f450a34399b8ebe",
      "bel": "bp(go:0006986 ! \"response to unfolded protein\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "cell death",
        "identifier": "0008219"
      },
      "id": "b39069b99a9400fcf8c070e7c043101e",
      "bel": "bp(go:0008219 ! \"cell death\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "response to endoplasmic reticulum stress",
        "identifier": "0034976"
      },
      "id": "1a1fec7b9a103ddc21379c4d94577065",
      "bel": "bp(go:0034976 ! \"response to endoplasmic reticulum stress\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "mesh",
        "name": "Apoptosis",
        "identifier": "D017209"
      },
      "id": "a92f13ced8b2e7f516c1e9e475e8a14e",
      "bel": "bp(mesh:D017209 ! Apoptosis)"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "mesh",
        "name": "DNA Methylation",
        "identifier": "D019175"
      },
      "id": "a3c55b20b62040e98b33adbda6c34121",
      "bel": "bp(mesh:D019175 ! \"DNA Methylation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "mesh",
        "name": "DNA Fragmentation",
        "identifier": "D053938"
      },
      "id": "3ae11cdd0d6dc1937035d550cb952f0f",
      "bel": "bp(mesh:D053938 ! \"DNA Fragmentation\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "IKK_complex",
        "identifier": "IKK_complex"
      },
      "id": "6e18bd5d8e6b69d668802c71c895ce85",
      "bel": "complex(fplx:\"IKK_complex\" ! \"IKK_complex\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "NFkappaB",
        "identifier": "NFkappaB"
      },
      "id": "a7edecc930194d4eff939b226f91107f",
      "bel": "complex(fplx:NFkappaB ! NFkappaB)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "go",
        "name": "mitochondrial permeability transition pore complex",
        "identifier": "0005757"
      },
      "id": "1c1985d89180740baa499b2721f8bf84",
      "bel": "complex(go:0005757 ! \"mitochondrial permeability transition pore complex\")"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "fplx",
            "name": "p14_3_3",
            "identifier": "p14_3_3"
          },
          "id": "e2155e8a91ca4b2fb107fa13f7418ba2",
          "bel": "p(fplx:\"p14_3_3\" ! \"p14_3_3\")"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "BAD",
            "identifier": "936"
          },
          "id": "71743dff1307a6a57c20ead42098301e",
          "bel": "p(hgnc:936 ! BAD)"
        }
      ],
      "id": "88e1ebb4af75b62f6e632377b28e86b1",
      "bel": "complex(p(fplx:\"p14_3_3\" ! \"p14_3_3\"), p(hgnc:936 ! BAD))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "RIPK1",
            "identifier": "10019"
          },
          "id": "c94ef9553c5a685aeb3bedd1b3fd9a19",
          "bel": "p(hgnc:10019 ! RIPK1)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "TNFRSF10A",
            "identifier": "11904"
          },
          "id": "445fb6861ba9718dacbf8f872daf51a5",
          "bel": "p(hgnc:11904 ! TNFRSF10A)"
        }
      ],
      "id": "29a95663c2e7bf3b74fbd5901a58f74a",
      "bel": "complex(p(hgnc:10019 ! RIPK1), p(hgnc:11904 ! TNFRSF10A))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "BRCA1",
            "identifier": "1100"
          },
          "id": "abd2eef373a2dfb3508ef576238a6289",
          "bel": "p(hgnc:1100 ! BRCA1)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "TP53",
            "identifier": "11998"
          },
          "id": "0a5566d438a3f8236e3a8cfee0f3c79d",
          "bel": "p(hgnc:11998 ! TP53)"
        }
      ],
      "id": "c5949a857861a0096356e8447fca6351",
      "bel": "complex(p(hgnc:1100 ! BRCA1), p(hgnc:11998 ! TP53))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "CASP9",
            "identifier": "1511"
          },
          "id": "67ab07c9ff4a0430e47c7f65f8ec9010",
          "bel": "p(hgnc:1511 ! CASP9)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "CYCS",
            "identifier": "19986"
          },
          "id": "cda92fd525dae870949beff1622b4dea",
          "bel": "p(hgnc:19986 ! CYCS)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "APAF1",
            "identifier": "576"
          },
          "id": "17d777e2d04fb339a75be35a08230ee6",
          "bel": "p(hgnc:576 ! APAF1)"
        }
      ],
      "id": "d82638ff4e7c8cf11772cb9c64d72e13",
      "bel": "complex(p(hgnc:1511 ! CASP9), p(hgnc:19986 ! CYCS), p(hgnc:576 ! APAF1))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "EIF2AK3",
            "identifier": "3255"
          },
          "id": "4836a01b149955d79286f26cdae9b494",
          "bel": "p(hgnc:3255 ! EIF2AK3)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "HSPA5",
            "identifier": "5238"
          },
          "id": "7b452c94dcb49dd5ea49e67d6b82cf2c",
          "bel": "p(hgnc:5238 ! HSPA5)"
        }
      ],
      "id": "86d933ec4243c96e32974e2cda11b4c4",
      "bel": "complex(p(hgnc:3255 ! EIF2AK3), p(hgnc:5238 ! HSPA5))"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "ERN1",
            "identifier": "3449"
          },
          "id": "f0ffb2e61d52c3da290295fddd3ab173",
          "bel": "p(hgnc:3449 ! ERN1)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "HSPA5",
            "identifier": "5238"
          },
          "id": "7b452c94dcb49dd5ea49e67d6b82cf2c",
          "bel": "p(hgnc:5238 ! HSPA5)"
        }
      ],
      "id": "ae3031b99ba18ab2d4f0e666a37d5ced",
      "bel": "complex(p(hgnc:3449 ! ERN1), p(hgnc:5238 ! HSPA5))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K_p110",
        "identifier": "PI3K_p110"
      },
      "id": "8b79e969188c2874eba3fa100a633e65",
      "bel": "p(fplx:\"PI3K_p110\" ! \"PI3K_p110\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "p14_3_3",
        "identifier": "p14_3_3"
      },
      "id": "e2155e8a91ca4b2fb107fa13f7418ba2",
      "bel": "p(fplx:\"p14_3_3\" ! \"p14_3_3\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "AKT",
        "identifier": "AKT"
      },
      "id": "c89a87549439c8dc34a13d9082b33a57",
      "bel": "p(fplx:AKT ! AKT)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "FOXO",
        "identifier": "FOXO"
      },
      "id": "7677a2303256a79bf8d45020c0534405",
      "bel": "p(fplx:FOXO ! FOXO)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "JNK",
        "identifier": "JNK"
      },
      "id": "2f6658f9c547f93c3f37c98276d1a287",
      "bel": "p(fplx:JNK ! JNK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "P90RSK",
        "identifier": "P90RSK"
      },
      "id": "08c790d6d6ec2cfd1959dbe037c07d34",
      "bel": "p(fplx:P90RSK ! P90RSK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PKC",
        "identifier": "PKC"
      },
      "id": "5bd82f8dca4f5ec860178491eafd427c",
      "bel": "p(fplx:PKC ! PKC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PKC",
        "identifier": "PKC"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 660
        }
      ],
      "id": "da6fe1a760a93adbb86fd74ce7eba3a2",
      "bel": "p(fplx:PKC ! PKC, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 660))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PRKAC",
        "identifier": "PRKAC"
      },
      "id": "d7b0a3f9dd7c83574fe44f6e40746cfb",
      "bel": "p(fplx:PRKAC ! PRKAC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RIPK1",
        "identifier": "10019"
      },
      "id": "c94ef9553c5a685aeb3bedd1b3fd9a19",
      "bel": "p(hgnc:10019 ! RIPK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ROCK1",
        "identifier": "10251"
      },
      "id": "964fb60c30fded2508c5e200af812c7d",
      "bel": "p(hgnc:10251 ! ROCK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RPS6KA1",
        "identifier": "10430"
      },
      "id": "1e0382cadd697195074e4ec9cf6e825b",
      "bel": "p(hgnc:10430 ! RPS6KA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BID",
        "identifier": "1050"
      },
      "id": "24d306b0b930e401bc898e128e336ecc",
      "bel": "p(hgnc:1050 ! BID)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BIK",
        "identifier": "1051"
      },
      "id": "55ce64c793637f2cde6511b17956b72e",
      "bel": "p(hgnc:1051 ! BIK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL12",
        "identifier": "10672"
      },
      "id": "d10a14f6842cb2804b69e74540bd8c94",
      "bel": "p(hgnc:10672 ! CXCL12)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BMX",
        "identifier": "1079"
      },
      "id": "5a774abcf63bd245650dd630535d335d",
      "bel": "p(hgnc:1079 ! BMX)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BRCA1",
        "identifier": "1100"
      },
      "id": "abd2eef373a2dfb3508ef576238a6289",
      "bel": "p(hgnc:1100 ! BRCA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "STAT3",
        "identifier": "11364"
      },
      "id": "16cbb4ba8a8e57b2fe2119d9545dd71a",
      "bel": "p(hgnc:11364 ! STAT3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR4",
        "identifier": "11850"
      },
      "id": "3757d476c6399f77b225fb8b1522441c",
      "bel": "p(hgnc:11850 ! TLR4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNF",
        "identifier": "11892"
      },
      "id": "000255f3feb3add4cefe963ffea45204",
      "bel": "p(hgnc:11892 ! TNF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF10A",
        "identifier": "11904"
      },
      "id": "445fb6861ba9718dacbf8f872daf51a5",
      "bel": "p(hgnc:11904 ! TNFRSF10A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF10B",
        "identifier": "11905"
      },
      "id": "9b9947de64978ca6e9bf5c41e2b46ad8",
      "bel": "p(hgnc:11905 ! TNFRSF10B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF10C",
        "identifier": "11906"
      },
      "id": "7aa17a597e659704af46de1adbfead3d",
      "bel": "p(hgnc:11906 ! TNFRSF10C)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF10D",
        "identifier": "11907"
      },
      "id": "6dbca5c436ba97e0bd55d8c989d8a078",
      "bel": "p(hgnc:11907 ! TNFRSF10D)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF1A",
        "identifier": "11916"
      },
      "id": "6c2a897a0fc06fbfd3c3792f72e4a4c9",
      "bel": "p(hgnc:11916 ! TNFRSF1A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF1B",
        "identifier": "11917"
      },
      "id": "68e9694d38d001117759de9925f4ef08",
      "bel": "p(hgnc:11917 ! TNFRSF1B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FAS",
        "identifier": "11920"
      },
      "id": "45b70d86b2e0ff1d89c978d38419c7cb",
      "bel": "p(hgnc:11920 ! FAS)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFSF10",
        "identifier": "11925"
      },
      "id": "c199a1d34ad3a080df5e9f468c6455d7",
      "bel": "p(hgnc:11925 ! TNFSF10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FASLG",
        "identifier": "11936"
      },
      "id": "d19cadcd00d2a7ab7ef29f282f2f241b",
      "bel": "p(hgnc:11936 ! FASLG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TP53",
        "identifier": "11998"
      },
      "id": "0a5566d438a3f8236e3a8cfee0f3c79d",
      "bel": "p(hgnc:11998 ! TP53)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRADD",
        "identifier": "12030"
      },
      "id": "db2dedcc89d5ace41644233286083983",
      "bel": "p(hgnc:12030 ! TRADD)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRAF2",
        "identifier": "12032"
      },
      "id": "03578fc23fc6a2505a4a99f57c0dd1f4",
      "bel": "p(hgnc:12032 ! TRAF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SCGB1A1",
        "identifier": "12523"
      },
      "id": "3c6bf2d6d72030768a7e5a6be62b229d",
      "bel": "p(hgnc:12523 ! SCGB1A1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "XBP1",
        "identifier": "12801"
      },
      "id": "a9d03b241888e792790c9e4e2cc4ad49",
      "bel": "p(hgnc:12801 ! XBP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP1LC3B",
        "identifier": "13352"
      },
      "id": "569b085005181558b9f576e95c6ff493",
      "bel": "p(hgnc:13352 ! MAP1LC3B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CYFIP2",
        "identifier": "13760"
      },
      "id": "a9565225931247b515d87a27142e398e",
      "bel": "p(hgnc:13760 ! CYFIP2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BACH2",
        "identifier": "14078"
      },
      "id": "e95a8b40cf38c9d6deff671b5417f364",
      "bel": "p(hgnc:14078 ! BACH2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HTRA2",
        "identifier": "14348"
      },
      "id": "802953b6ca8cc228faa6d5b9c35992fb",
      "bel": "p(hgnc:14348 ! HTRA2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PPP1R15A",
        "identifier": "14375"
      },
      "id": "b2e8a01eb3bd0303b609e5063fb548e6",
      "bel": "p(hgnc:14375 ! PPP1R15A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKE",
        "identifier": "14552"
      },
      "id": "c0329353de09247a519ba5d21da15273",
      "bel": "p(hgnc:14552 ! IKBKE)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SIRT1",
        "identifier": "14929"
      },
      "id": "ee235c4b7fcc97b9f15cd3eb36039f18",
      "bel": "p(hgnc:14929 ! SIRT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP10",
        "identifier": "1500"
      },
      "id": "c0a16ac8a6ff14dc4e76b62888966a92",
      "bel": "p(hgnc:1500 ! CASP10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP2",
        "identifier": "1503"
      },
      "id": "15af5675e3558b3ac02d83e91a7031ec",
      "bel": "p(hgnc:1503 ! CASP2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP3",
        "identifier": "1504"
      },
      "id": "573a004b2df2894f9eae97d1d2539176",
      "bel": "p(hgnc:1504 ! CASP3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP4",
        "identifier": "1505"
      },
      "id": "ca260c4aa79f8f74475747b1d7bb8f20",
      "bel": "p(hgnc:1505 ! CASP4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP6",
        "identifier": "1507"
      },
      "id": "dcee462f7a6c0bc0864a6affca916e93",
      "bel": "p(hgnc:1507 ! CASP6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP7",
        "identifier": "1508"
      },
      "id": "272ea9703dccaee21dbcf5d147996381",
      "bel": "p(hgnc:1508 ! CASP7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP8",
        "identifier": "1509"
      },
      "id": "a8847922bcdcb76598ea4423bc2fa8ff",
      "bel": "p(hgnc:1509 ! CASP8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP9",
        "identifier": "1511"
      },
      "id": "67ab07c9ff4a0430e47c7f65f8ec9010",
      "bel": "p(hgnc:1511 ! CASP9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP9",
        "identifier": "1511"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 125
        }
      ],
      "id": "9bec311942bf5d756bed51603464d7ba",
      "bel": "p(hgnc:1511 ! CASP9, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 125))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ACIN1",
        "identifier": "17066"
      },
      "id": "232eac7b915fded51503d90f3fff5af0",
      "bel": "p(hgnc:17066 ! ACIN1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PERP",
        "identifier": "17637"
      },
      "id": "4deffa66c9dd3e368fa4546b85f3d7c4",
      "bel": "p(hgnc:17637 ! PERP)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BBC3",
        "identifier": "17868"
      },
      "id": "5dc245bdfb4561ccc1fe2a710cee1d7f",
      "bel": "p(hgnc:17868 ! BBC3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TP53INP1",
        "identifier": "18022"
      },
      "id": "9d2e83e4f9c38375b251850f400cd171",
      "bel": "p(hgnc:18022 ! TP53INP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RPS27L",
        "identifier": "18476"
      },
      "id": "1fa2005e1db134f316fb34f7c7b0f9b1",
      "bel": "p(hgnc:18476 ! RPS27L)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CFLAR",
        "identifier": "1876"
      },
      "id": "8b1b090b368e4d78176a34988615c432",
      "bel": "p(hgnc:1876 ! CFLAR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TP53I3",
        "identifier": "19373"
      },
      "id": "e4c71a2ba160afb17bf879b8a3f461ac",
      "bel": "p(hgnc:19373 ! TP53I3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CHUK",
        "identifier": "1974"
      },
      "id": "db3393599a0e7a8a656b31553362680e",
      "bel": "p(hgnc:1974 ! CHUK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CHUK",
        "identifier": "1974"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 176
        }
      ],
      "id": "61ada1a0d1ed52887dd2747c9626ac86",
      "bel": "p(hgnc:1974 ! CHUK, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 176))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CHUK",
        "identifier": "1974"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 180
        }
      ],
      "id": "0ee03580f63f65c673870545eee35ae5",
      "bel": "p(hgnc:1974 ! CHUK, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 180))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CYCS",
        "identifier": "19986"
      },
      "id": "cda92fd525dae870949beff1622b4dea",
      "bel": "p(hgnc:19986 ! CYCS)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "DIABLO",
        "identifier": "21528"
      },
      "id": "07a1d71af8117b1d9382329cd5afd0b8",
      "bel": "p(hgnc:21528 ! DIABLO)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RNF144B",
        "identifier": "21578"
      },
      "id": "71f10bc58fe9466a3cf633065a0d6faf",
      "bel": "p(hgnc:21578 ! RNF144B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CREB1",
        "identifier": "2345"
      },
      "id": "f5623397316edb3f74ee540482bae375",
      "bel": "p(hgnc:2345 ! CREB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CREB1",
        "identifier": "2345"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 133
        }
      ],
      "id": "27ce85c9e8dd0f2a01e51262c8e05825",
      "bel": "p(hgnc:2345 ! CREB1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 133))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PARP1",
        "identifier": "270"
      },
      "id": "d5344146a265050e52e8de233270a3b2",
      "bel": "p(hgnc:270 ! PARP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "DDIT3",
        "identifier": "2726"
      },
      "id": "0b8327fd482714272e3fd95438448164",
      "bel": "p(hgnc:2726 ! DDIT3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "DFFA",
        "identifier": "2772"
      },
      "id": "d1a1954cfd6fd1629be40656cf2775da",
      "bel": "p(hgnc:2772 ! DFFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "DFFB",
        "identifier": "2773"
      },
      "id": "3ed7a3de4c452d6b801799566675b3fc",
      "bel": "p(hgnc:2773 ! DFFB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EIF2AK3",
        "identifier": "3255"
      },
      "id": "4836a01b149955d79286f26cdae9b494",
      "bel": "p(hgnc:3255 ! EIF2AK3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EIF2S1",
        "identifier": "3265"
      },
      "id": "ab23a324fbb857ab8430a0ebb220a625",
      "bel": "p(hgnc:3265 ! EIF2S1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EIF2S1",
        "identifier": "3265"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 52
        }
      ],
      "id": "0d9d7d6d9a07659e5c11f53d07c83d54",
      "bel": "p(hgnc:3265 ! EIF2S1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 52))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ELK1",
        "identifier": "3321"
      },
      "id": "05018590f0a2224b29b6e0ca63cf8a20",
      "bel": "p(hgnc:3321 ! ELK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ELK1",
        "identifier": "3321"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 383
        }
      ],
      "id": "1bcba91b31acd3fb99c4147325776947",
      "bel": "p(hgnc:3321 ! ELK1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 383))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ENDOG",
        "identifier": "3346"
      },
      "id": "a34b7ce7daa350de36af0ab031c23d6f",
      "bel": "p(hgnc:3346 ! ENDOG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "EP300",
        "identifier": "3373"
      },
      "id": "46e575893877dfd1675f60f34eb83ef2",
      "bel": "p(hgnc:3373 ! EP300)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ERN1",
        "identifier": "3449"
      },
      "id": "f0ffb2e61d52c3da290295fddd3ab173",
      "bel": "p(hgnc:3449 ! ERN1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FADD",
        "identifier": "3573"
      },
      "id": "18401cd8778683c8693966f33c56b748",
      "bel": "p(hgnc:3573 ! FADD)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FLOT2",
        "identifier": "3758"
      },
      "id": "801fbe72e20423115813cb467183f71f",
      "bel": "p(hgnc:3758 ! FLOT2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXO1",
        "identifier": "3819"
      },
      "id": "1992e5ece9571674b23761d92a8ea7fb",
      "bel": "p(hgnc:3819 ! FOXO1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXO1",
        "identifier": "3819"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 256
        }
      ],
      "id": "4aa12dd593dfa81fd37d0406d586a739",
      "bel": "p(hgnc:3819 ! FOXO1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 256))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXO3",
        "identifier": "3821"
      },
      "id": "6b1d99779dedc2bbf2d22f64555d0526",
      "bel": "p(hgnc:3821 ! FOXO3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FOXO3",
        "identifier": "3821"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 253
        }
      ],
      "id": "4d9bb6d867beccd20c157fd4d3a379c5",
      "bel": "p(hgnc:3821 ! FOXO3, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 253))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AKT1",
        "identifier": "391"
      },
      "id": "3adaa3ad564b6e0ae1b7c41879193857",
      "bel": "p(hgnc:391 ! AKT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AKT1",
        "identifier": "391"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 473
        }
      ],
      "id": "fbf7ce86c9f48235df0c0f79724bfbcf",
      "bel": "p(hgnc:391 ! AKT1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 473))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AKT1",
        "identifier": "391"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 308
        }
      ],
      "id": "1318c3e342031929daf0f6b662b38060",
      "bel": "p(hgnc:391 ! AKT1, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 308))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AKT2",
        "identifier": "392"
      },
      "id": "8dc2dc40c0d6010c404db403a3b0c937",
      "bel": "p(hgnc:392 ! AKT2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AKT3",
        "identifier": "393"
      },
      "id": "abff028fb6abf7c48e731b3b79b52c54",
      "bel": "p(hgnc:393 ! AKT3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "XRCC6",
        "identifier": "4055"
      },
      "id": "52eadc0f6bd7e202836609ba6fc44eec",
      "bel": "p(hgnc:4055 ! XRCC6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "GAS2",
        "identifier": "4167"
      },
      "id": "33d5abfe8062669fc5f09ad9eca1456a",
      "bel": "p(hgnc:4167 ! GAS2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "GSTP1",
        "identifier": "4638"
      },
      "id": "ea80feac22caae82f094478326dba18e",
      "bel": "p(hgnc:4638 ! GSTP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HSPA5",
        "identifier": "5238"
      },
      "id": "7b452c94dcb49dd5ea49e67d6b82cf2c",
      "bel": "p(hgnc:5238 ! HSPA5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IGFBP3",
        "identifier": "5472"
      },
      "id": "9424e3e1a1d8d91ab8ce75175631ffab",
      "bel": "p(hgnc:5472 ! IGFBP3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "APAF1",
        "identifier": "576"
      },
      "id": "17d777e2d04fb339a75be35a08230ee6",
      "bel": "p(hgnc:576 ! APAF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BIRC2",
        "identifier": "590"
      },
      "id": "3b542372906c2488756d351a134ae388",
      "bel": "p(hgnc:590 ! BIRC2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BIRC3",
        "identifier": "591"
      },
      "id": "dfc094fe80294db95dd4ba660e20fbb5",
      "bel": "p(hgnc:591 ! BIRC3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "XIAP",
        "identifier": "592"
      },
      "id": "63b297621f14ff916e706e2e4b0fd1fc",
      "bel": "p(hgnc:592 ! XIAP)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BIRC5",
        "identifier": "593"
      },
      "id": "40d88709af65c6baf958feafeec17aa6",
      "bel": "p(hgnc:593 ! BIRC5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "id": "7a4749b50b3cb8b62deb0877730ffbce",
      "bel": "p(hgnc:5960 ! IKBKB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 177
        }
      ],
      "id": "371fe0ff8b204c13fba9d531feea3f69",
      "bel": "p(hgnc:5960 ! IKBKB, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 177))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 181
        }
      ],
      "id": "b62e75d57cea6c2701117373069dcb4c",
      "bel": "p(hgnc:5960 ! IKBKB, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 181))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKG",
        "identifier": "5961"
      },
      "id": "b57d2b2b7d37a0917ab8f7e2986c2a1c",
      "bel": "p(hgnc:5961 ! IKBKG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL6",
        "identifier": "6018"
      },
      "id": "aa9c1c139b580c6add7164eef64ebb80",
      "bel": "p(hgnc:6018 ! IL6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KDR",
        "identifier": "6307"
      },
      "id": "04acdd6fe94a9adc2b80c0d3a611cc56",
      "bel": "p(hgnc:6307 ! KDR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "LMNA",
        "identifier": "6636"
      },
      "id": "24af48994ccdc2a661a2f83c9795fa58",
      "bel": "p(hgnc:6636 ! LMNA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "LMNB1",
        "identifier": "6637"
      },
      "id": "34da23f5933a7630ee4684ddf571836d",
      "bel": "p(hgnc:6637 ! LMNB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "LMNB2",
        "identifier": "6638"
      },
      "id": "56d2e394f8dc5d3f8d79bdee60bafa80",
      "bel": "p(hgnc:6638 ! LMNB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MARCKS",
        "identifier": "6759"
      },
      "id": "e344935282c68216e5c114cc2f9539fb",
      "bel": "p(hgnc:6759 ! MARCKS)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MARCKS",
        "identifier": "6759"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 159
        }
      ],
      "id": "7e7ff01399244fa1d4f587ca4272753d",
      "bel": "p(hgnc:6759 ! MARCKS, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 159))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MARCKS",
        "identifier": "6759"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 163
        }
      ],
      "id": "c2d79aed8e6f9eb080a195af82772c45",
      "bel": "p(hgnc:6759 ! MARCKS, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 163))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP2K7",
        "identifier": "6847"
      },
      "id": "604755e2b38c88d1f248a4db3b368c76",
      "bel": "p(hgnc:6847 ! MAP2K7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K1",
        "identifier": "6848"
      },
      "id": "73718db88f0f895812ef7c36dd9db9af",
      "bel": "p(hgnc:6848 ! MAP3K1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K1",
        "identifier": "6848"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 957
        }
      ],
      "id": "7bab1f4fbb3fed623e249c73d167ca4d",
      "bel": "p(hgnc:6848 ! MAP3K1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 957))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K1",
        "identifier": "6848"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 994
        }
      ],
      "id": "cca87e4d025d977a376b593336eccab6",
      "bel": "p(hgnc:6848 ! MAP3K1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 994))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K14",
        "identifier": "6853"
      },
      "id": "e660a61fedf86c3f4e9cd7b187cc0d78",
      "bel": "p(hgnc:6853 ! MAP3K14)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K5",
        "identifier": "6857"
      },
      "id": "ac337cc01074ce1fd031e2d5b097aa2b",
      "bel": "p(hgnc:6857 ! MAP3K5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K5",
        "identifier": "6857"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 83
        }
      ],
      "id": "561f25f7046d6d0d72b17205c39c68f9",
      "bel": "p(hgnc:6857 ! MAP3K5, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 83))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K7",
        "identifier": "6859"
      },
      "id": "e78712bc62bb428b8e61d97e9c0da6a7",
      "bel": "p(hgnc:6859 ! MAP3K7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K7",
        "identifier": "6859"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein ubiquitination",
            "identifier": "0016567"
          },
          "code": "Lys",
          "pos": 158
        }
      ],
      "id": "e06942aa59e5a7cc2054b4d47598bd1f",
      "bel": "p(hgnc:6859 ! MAP3K7, pmod(go:0016567 ! \"protein ubiquitination\", Lys, 158))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK1",
        "identifier": "6871"
      },
      "id": "e0c0225b558aed46aa00177aa93224b5",
      "bel": "p(hgnc:6871 ! MAPK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK10",
        "identifier": "6872"
      },
      "id": "8387670a9c5fff90b5738feb088acd0d",
      "bel": "p(hgnc:6872 ! MAPK10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK3",
        "identifier": "6877"
      },
      "id": "6dd741794d73ab1e916725d3d79849b7",
      "bel": "p(hgnc:6877 ! MAPK3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK8",
        "identifier": "6881"
      },
      "id": "1c2457d7fbd8166be7dfce2c8907b829",
      "bel": "p(hgnc:6881 ! MAPK8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK9",
        "identifier": "6886"
      },
      "id": "470f26dd6814d4a71633032e78c129b8",
      "bel": "p(hgnc:6886 ! MAPK9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MCL1",
        "identifier": "6943"
      },
      "id": "2cd5e5baddfe2667fcbe6bdb55851fe3",
      "bel": "p(hgnc:6943 ! MCL1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKB1",
        "identifier": "7794"
      },
      "id": "fb631cdd688dc0faeec8f219cae55fb8",
      "bel": "p(hgnc:7794 ! NFKB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKB2",
        "identifier": "7795"
      },
      "id": "74edda87fa21f94aa6594b9bca0dc600",
      "bel": "p(hgnc:7795 ! NFKB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "id": "00d5e69a95ae1215066cce653d9249d5",
      "bel": "p(hgnc:7797 ! NFKBIA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 32
        }
      ],
      "id": "b7a1888e9d86a9e2ea68c2fabdb501bf",
      "bel": "p(hgnc:7797 ! NFKBIA, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 32))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 36
        }
      ],
      "id": "bd2a5debda128ab761b0a6ed3177458a",
      "bel": "p(hgnc:7797 ! NFKBIA, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 36))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIE",
        "identifier": "7799"
      },
      "id": "d6a3e8f0f105ec220ac7ec13f12cf736",
      "bel": "p(hgnc:7799 ! NFKBIE)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ATF4",
        "identifier": "786"
      },
      "id": "3f6bad91bb9860c1d9e46f1723a3de54",
      "bel": "p(hgnc:786 ! ATF4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PAK2",
        "identifier": "8591"
      },
      "id": "59a8d8a525d1dad633cf07840e35088d",
      "bel": "p(hgnc:8591 ! PAK2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PCNA",
        "identifier": "8729"
      },
      "id": "29b339746ca083d095bbeb0759c57e2d",
      "bel": "p(hgnc:8729 ! PCNA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AIFM1",
        "identifier": "8768"
      },
      "id": "8e0398b12abfcc13da558e5902ea2da0",
      "bel": "p(hgnc:8768 ! AIFM1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFA",
        "identifier": "8799"
      },
      "id": "aa494a1240c61645cad1581cbc7788b2",
      "bel": "p(hgnc:8799 ! PDGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDPK1",
        "identifier": "8816"
      },
      "id": "70b01dfba12859aca0731bcc0403a532",
      "bel": "p(hgnc:8816 ! PDPK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDPK1",
        "identifier": "8816"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 241
        }
      ],
      "id": "f5160b902b6b508ef8db775daf131b46",
      "bel": "p(hgnc:8816 ! PDPK1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 241))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PGF",
        "identifier": "8893"
      },
      "id": "57ec5da1e799851453aeba3daad0872a",
      "bel": "p(hgnc:8893 ! PGF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PMAIP1",
        "identifier": "9108"
      },
      "id": "de8d32b5c372b97120d8e80f6157334f",
      "bel": "p(hgnc:9108 ! PMAIP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BAD",
        "identifier": "936"
      },
      "id": "71743dff1307a6a57c20ead42098301e",
      "bel": "p(hgnc:936 ! BAD)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BAD",
        "identifier": "936"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 75
        }
      ],
      "id": "22fcd823677f4be1b017ce6600c57002",
      "bel": "p(hgnc:936 ! BAD, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 75))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BAD",
        "identifier": "936"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 99
        }
      ],
      "id": "1ecee64f5524081a9998213319abdc3f",
      "bel": "p(hgnc:936 ! BAD, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 99))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCA",
        "identifier": "9393"
      },
      "id": "f772b2097edbba1b198b97f08a0a36ca",
      "bel": "p(hgnc:9393 ! PRKCA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCA",
        "identifier": "9393"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 638
        }
      ],
      "id": "8441fdda1d82b92fa9b300e7d038dfc2",
      "bel": "p(hgnc:9393 ! PRKCA, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 638))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCD",
        "identifier": "9399"
      },
      "id": "e5cf559398d8d373e5a9b147f23a0cca",
      "bel": "p(hgnc:9399 ! PRKCD)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCD",
        "identifier": "9399"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 505
        }
      ],
      "id": "de5503f3cab3122fb8da3bea2cf5b194",
      "bel": "p(hgnc:9399 ! PRKCD, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 505))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCE",
        "identifier": "9401"
      },
      "id": "870422b48ea7750a4d6d784e4c76322f",
      "bel": "p(hgnc:9401 ! PRKCE)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKD1",
        "identifier": "9407"
      },
      "id": "21ada06389aab537d99585c7c6653084",
      "bel": "p(hgnc:9407 ! PRKD1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKD1",
        "identifier": "9407"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 738
        }
      ],
      "id": "34d3cb34e1d992652487c4d191a597cb",
      "bel": "p(hgnc:9407 ! PRKD1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 738))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKD1",
        "identifier": "9407"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 742
        }
      ],
      "id": "0bfdf83afa58ed87e9bd1630d303167a",
      "bel": "p(hgnc:9407 ! PRKD1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 742))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCZ",
        "identifier": "9412"
      },
      "id": "0837cdb40569b0c05b9e699b4cc8ddb3",
      "bel": "p(hgnc:9412 ! PRKCZ)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCZ",
        "identifier": "9412"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 410
        }
      ],
      "id": "7c84060633b52bba5a418165695fce9e",
      "bel": "p(hgnc:9412 ! PRKCZ, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 410))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BAK1",
        "identifier": "949"
      },
      "id": "65a8becbeda808b609fb25d56378ca89",
      "bel": "p(hgnc:949 ! BAK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTEN",
        "identifier": "9588"
      },
      "id": "b62e809f9dda5e7940982d283ac79b36",
      "bel": "p(hgnc:9588 ! PTEN)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTEN",
        "identifier": "9588"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 380
        }
      ],
      "id": "637b4648c5d56e4f2bc5582985689c52",
      "bel": "p(hgnc:9588 ! PTEN, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 380))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTEN",
        "identifier": "9588"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 382
        }
      ],
      "id": "6e8e85f12e89b6f896447c943a072890",
      "bel": "p(hgnc:9588 ! PTEN, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 382))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTEN",
        "identifier": "9588"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 383
        }
      ],
      "id": "986ab8bb1332c1e278a48d6455d301e5",
      "bel": "p(hgnc:9588 ! PTEN, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 383))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BAX",
        "identifier": "959"
      },
      "id": "2c92a281f822c55d65fa6ab1f8306587",
      "bel": "p(hgnc:959 ! BAX)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BAX",
        "identifier": "959"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 184
        }
      ],
      "id": "c0105d4fb85ac5bb831d4034efb3b834",
      "bel": "p(hgnc:959 ! BAX, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 184))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTGS2",
        "identifier": "9605"
      },
      "id": "a599840205cea50660db6b94062760db",
      "bel": "p(hgnc:9605 ! PTGS2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAC1",
        "identifier": "9801"
      },
      "id": "1833ca3c80fe75acb1c59c3ffc45f2ec",
      "bel": "p(hgnc:9801 ! RAC1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAC1",
        "identifier": "9801"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 71
        }
      ],
      "id": "7cdf9584ef6b9ef86965dea719858c09",
      "bel": "p(hgnc:9801 ! RAC1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 71))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAF1",
        "identifier": "9829"
      },
      "id": "faf889e46379ebf3f5cb34b8ad27eb64",
      "bel": "p(hgnc:9829 ! RAF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAF1",
        "identifier": "9829"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 259
        }
      ],
      "id": "3f8c6d2e043bf50ea14876ded96eef05",
      "bel": "p(hgnc:9829 ! RAF1, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 259))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL2",
        "identifier": "990"
      },
      "id": "cb462a8c7c889a80e31847d83b3ec212",
      "bel": "p(hgnc:990 ! BCL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL2A1",
        "identifier": "991"
      },
      "id": "1d920acb12b0c8fac7d84f21cff663b2",
      "bel": "p(hgnc:991 ! BCL2A1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL2L1",
        "identifier": "992"
      },
      "id": "8916e45ae7bd90c6326bf69ead30825c",
      "bel": "p(hgnc:992 ! BCL2L1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL2L11",
        "identifier": "994"
      },
      "id": "ff7d20da9fc7c8e84fa86e651639cfec",
      "bel": "p(hgnc:994 ! BCL2L11)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL2L11",
        "identifier": "994"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 69
        }
      ],
      "id": "6f6230075d20aad367997eb3d3f6eee1",
      "bel": "p(hgnc:994 ! BCL2L11, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 69))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "BCL2L11",
        "identifier": "994"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Thr",
          "pos": 116
        }
      ],
      "id": "e415563b386b523359b4931c461957d4",
      "bel": "p(hgnc:994 ! BCL2L11, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 116))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "REL",
        "identifier": "9954"
      },
      "id": "26d182db0899e6bcdbf4bcc98c9908a3",
      "bel": "p(hgnc:9954 ! REL)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELA",
        "identifier": "9955"
      },
      "id": "b21bc29a07e8a2299916f8a95bdd0528",
      "bel": "p(hgnc:9955 ! RELA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELA",
        "identifier": "9955"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein acetylation",
            "identifier": "0006473"
          }
        }
      ],
      "id": "558bca7151d5cdae7dceb8cd2ccf7c36",
      "bel": "p(hgnc:9955 ! RELA, pmod(go:0006473 ! \"protein acetylation\"))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELB",
        "identifier": "9956"
      },
      "id": "5d57a39d82836535cb07ef932751096d",
      "bel": "p(hgnc:9956 ! RELB)"
    },
    {
      "function": "Pathology",
      "concept": {
        "namespace": "mesh",
        "name": "Emphysema",
        "identifier": "D004646"
      },
      "id": "2787c5313f28bbacb96f864555f21cc1",
      "bel": "path(mesh:D004646 ! Emphysema)"
    },
    {
      "function": "Pathology",
      "concept": {
        "namespace": "mesh",
        "name": "Pulmonary Disease, Chronic Obstructive",
        "identifier": "D029424"
      },
      "id": "98cb883d84a9775f973f1e99c68ba3a2",
      "bel": "path(mesh:D029424 ! \"Pulmonary Disease, Chronic Obstructive\")"
    }
  ],
  "links": [
    {
      "line": 101,
      "relation": "increases",
      "evidence": "Inhalation exposure of the mice to environmentally-relevant fine particulate matter (aerodynamic diameter < 2.5 mum, PM(2.5)) induces endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR) in the lung and liver tissues as well as in the mouse macrophage cell line RAW264.7. Ambient PM(2.5) exposure activates double-strand RNA-activated protein kinase-like ER kinase (PERK), leading to phosphorylation of translation initiation factor eIF2alpha and induction of C/EBP homologous transcription factor CHOP/GADD153.",
      "citation": {
        "db": "PubMed",
        "db_id": "20554909"
      },
      "annotations": {},
      "source": 3,
      "target": 1,
      "key": "2a081951d3faa0a97b39d15b40d98e1d"
    },
    {
      "line": 101,
      "relation": "increases",
      "evidence": "Many disturbances, including those of cellular redox regulation, cause accumulation of unfolded proteins in the ER, triggering an evolutionarily conserved response, termed the unfolded protein response (UPR).",
      "citation": {
        "db": "PubMed",
        "db_id": "16200199"
      },
      "annotations": {},
      "source": 3,
      "target": 1,
      "key": "d3e2d3391284f30c8d1ad778c1f42e9e"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "FIG. 7. The signaling arms of the mammalian UPR diverge to regulate some targets and converge to regulate others. The mammalian UPR activates three signal transducers, ATF6, Ire1, and PERK. 1) Activation of ATF6 leads to increased expression of genes regulated by ERSEs in their promoters including ER chaperones like BiP and GRP94, as well as the transcription factor XBP-1. Activation of Ire1 leads to alternative XBP-1 splicing, which in turn up-regulates XBP-1 specific targets like ERdj4, as well as targets with ERSEs in their promoter. A PERK-dependent target other than ATF4 can influence the activation of the ERSE site by an unknown mechanism, which is indicated by a question mark in the schematics. 2) PERK activation leads to eIF-2{alpha} phosphorylation, which allows the expression of the ATF4 transcription factor that in turn induces GADD34 transcription. There is no evidence at this time for members of the ATF6 and Ire1/XBP-1 pathways to impact on the PERK pathway. 3) Finally, the ATF6, Ire1/XBP-1 and PERK pathways converge to optimally induce targets that include CHOP and Herp. Those targets that are downstream of the PERK branch of the UPR are shared with various other cellular stress conditions like heme deficiency, amino acid deprivation, and dsRNA expression. These stresses all activate an eIF-2{alpha} kinase and as a result induce downstream targets like ATF4 and GADD34, as well as those that are dually regulated by both the shared and the ER stress-specific branches of the UPR, which are represented by CHOP and Herp.",
      "citation": {
        "db": "PubMed",
        "db_id": "14742429"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 3,
      "target": 85,
      "key": "8be1b011fe18eb31ed592c05468c7cc4"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "{From full text}  For example, phosphorylation of eIF2{alpha} by GCN2 (EIF2AK4) is enhanced by amino acid limitation, UV irradiation, and proteasome inhibition (13?16). Phosphorylation of eIF2{alpha} inhibits general protein synthesis by reducing the levels of eIF2-GTP that are required for binding of initiator tRNA to the translation apparatus. Concomitant with lowered protein synthesis, eIF2{alpha} phosphorylation leads to preferential translation of ATF4, a basic zipper (bZIP) transcription activator important for directing transcription of stress-related genes (17?20). Reduced protein synthesis conserves energy and provides the cell time for ATF4 and other stress-responsive transcription factors to reconfigure gene expression slated to alleviate damage elicited by the underlying stress. Other members of the eIF2 kinase family include PEK/Perk (EIF2AK3), whose activity is enhanced by endoplasmic reticulum (ER) stress (21, 22); HRI (EIF2AK1), which is regulated by heme deficiency and oxidative stress (23); and PKR (EIF2AK2), which functions in an antiviral pathway (24).{P@S52 is the common phosphorylation site between all 4 kinases and confirmed in Uniprot}",
      "citation": {
        "db": "PubMed",
        "db_id": "17170114"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 3,
      "target": 85,
      "key": "a7c118b4dcc7f703a93b264ab152f5e1"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "ER stress triggers PERK-dependent Nrf2 nuclear import.",
      "citation": {
        "db": "PubMed",
        "db_id": "14517290"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 3,
      "target": 85,
      "key": "5f881ba79e3610c97dd6073835dc804b"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "% The unfolded protein response (UPR) events triggered by the accumulation of unfolded protein in endoplasmic reticulum (ER) activate the three UPR signaling pathways mediated by IRE1, ATF6 and PERK.",
      "citation": {
        "db": "PubMed",
        "db_id": "16772704"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 3,
      "target": 85,
      "key": "dd5aed47e1ab0977931034fe4bd4fbd1"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "We find that expression of activating transcription factor 3 (ATF3), a member of the ATF/CREB subfamily of basic-region leucine zipper (bZIP) proteins, is induced in response to endoplasmic reticulum (ER) stress or amino acid starvation by a mechanism requiring eIF2 kinases PEK (Perk or EIF2AK3) and GCN2 (EIF2AK4), respectively",
      "citation": {
        "db": "PubMed",
        "db_id": "14729979"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 3,
      "target": 85,
      "key": "9bb37dd505b7d022ce1d79ec098bd585"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "Yeast GCN2 and mammalian PKR and PERK have been shown to be required for autophagy induced by starvation, viral infection, and ER stress, respectively (He and Klionsky, 2009).",
      "citation": {
        "db": "PubMed",
        "db_id": "20965422"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 3,
      "target": 85,
      "key": "47249ff3953bfa141db8da0a3cbc9062"
    },
    {
      "line": 222,
      "relation": "increases",
      "evidence": "A549 cells (lung adenocarcinoma cell line) exposed in vitro to oxidative stress (H2O2) and TNF had higher expression of TRAIL-R1, 2, and 3 but also higher levels of p53,74 suggesting that the modulation of the TRAIL system observed in the emphysematous lung may be attributable to oxidative stress and/or infl ammatory cytokines. As TRAIL is released by activated infl ammatory cells, oxidative stress and infl ammation present in the emphysematous lung may sensitize alveolar cells to its apoptotic effects (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19436685"
      },
      "annotations": {},
      "source": 0,
      "target": 37,
      "key": "57381f67ade9fe7fee0ba2ecd87d6d25"
    },
    {
      "line": 223,
      "relation": "increases",
      "evidence": "A549 cells (lung adenocarcinoma cell line) exposed in vitro to oxidative stress (H2O2) and TNF had higher expression of TRAIL-R1, 2, and 3 but also higher levels of p53,74 suggesting that the modulation of the TRAIL system observed in the emphysematous lung may be attributable to oxidative stress and/or infl ammatory cytokines. As TRAIL is released by activated infl ammatory cells, oxidative stress and infl ammation present in the emphysematous lung may sensitize alveolar cells to its apoptotic effects (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19436685"
      },
      "annotations": {},
      "source": 0,
      "target": 36,
      "key": "f4fdb01a0d283e102567345a6a133e5e"
    },
    {
      "line": 224,
      "relation": "increases",
      "evidence": "A549 cells (lung adenocarcinoma cell line) exposed in vitro to oxidative stress (H2O2) and TNF had higher expression of TRAIL-R1, 2, and 3 but also higher levels of p53,74 suggesting that the modulation of the TRAIL system observed in the emphysematous lung may be attributable to oxidative stress and/or infl ammatory cytokines. As TRAIL is released by activated infl ammatory cells, oxidative stress and infl ammation present in the emphysematous lung may sensitize alveolar cells to its apoptotic effects (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19436685"
      },
      "annotations": {},
      "source": 0,
      "target": 38,
      "key": "173cd8b53557c94da0c2d5bcb56e45c4"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "Release of Grp78 from the N-terminus of ATF6 triggers a different mechanism of protein activation, compared with PERK and Ire1. Instead of oligomerizing, release of Grp78 frees ATF6 to translocate to the Golgi apparatus, where resident proteases (site 1 and site 2 protease) cleave ATF6 at a juxtamembrane site, releasing this transcription factor into the cytosol and allowing it to migrate into the nucleus to regulate gene expression (15). ATF6 collaborates with Ire1, where ATF6 induces transcription to increase XBP-1 mRNA, and Ire1's endoribonuclease activity then processes that mRNA so that XBP-1 protein is produced.",
      "citation": {
        "db": "PubMed",
        "db_id": "16200199"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 1,
      "target": 92,
      "key": "64b4ce5586d7de588f2ace521d43c436"
    },
    {
      "line": 109,
      "relation": "directlyDecreases",
      "evidence": "Upon ER stress, unfolded proteins relieve the repression by triggering the release of BiP from the NLDs of IRE1 and PERK",
      "citation": {
        "db": "PubMed",
        "db_id": "11897784"
      },
      "annotations": {},
      "source": 1,
      "target": 15,
      "key": "b65533e5073a1e6942b3e9eabfc35614"
    },
    {
      "line": 110,
      "relation": "directlyDecreases",
      "evidence": "Upon ER stress, unfolded proteins relieve the repression by triggering the release of BiP from the NLDs of IRE1 and PERK",
      "citation": {
        "db": "PubMed",
        "db_id": "11897784"
      },
      "annotations": {},
      "source": 1,
      "target": 14,
      "key": "e2a84d8e2ef4e788b1cf0f3d8dc0ab84"
    },
    {
      "line": 195,
      "relation": "increases",
      "evidence": "SNAP (100 microM) induced 50--60% apoptosis; higher doses did not increase the rate of apoptosis significantly.",
      "citation": {
        "db": "PubMed",
        "db_id": "11435490"
      },
      "annotations": {},
      "source": 6,
      "target": 4,
      "key": "477e2a3d369b1c3f41500e3a7e7e6030"
    },
    {
      "line": 429,
      "relation": "association",
      "evidence": "Besides to inflammation, DNA methylation also\nparticipates in apoptosis in COPD. Recent studies have highlighted the role of apoptosis in\nthe development of COPD (PMID:     22913201,     22073568)",
      "citation": {
        "db": "Other",
        "db_id": "25807439"
      },
      "annotations": {},
      "source": 5,
      "target": 192,
      "key": "872f178ed1a2a2a4bbf47f465d328237"
    },
    {
      "line": 430,
      "relation": "association",
      "evidence": "Besides to inflammation, DNA methylation also participates in apoptosis in COPD",
      "citation": {
        "db": "Other",
        "db_id": "25807439"
      },
      "annotations": {},
      "source": 5,
      "target": 4,
      "key": "1f710909c3bd81bd43241c2b7eda683d"
    },
    {
      "line": 163,
      "relation": "positiveCorrelation",
      "evidence": "Such apoptotic response of LT-2809 cells is characterised by increased expression of Gas2 which becomes proteolytically processed.",
      "citation": {
        "db": "PubMed",
        "db_id": "16465235"
      },
      "annotations": {},
      "source": 4,
      "target": 105,
      "key": "362ab815a980d963dfbb25cf3269bc1b"
    },
    {
      "line": 163,
      "relation": "positiveCorrelation",
      "evidence": "These results indicate that Gas2 is cleaved when apoptosis is prevalent in the autopod.",
      "citation": {
        "db": "PubMed",
        "db_id": "10049561"
      },
      "annotations": {},
      "source": 4,
      "target": 105,
      "key": "394077d36312d94ba84d389fa3e746c1"
    },
    {
      "line": 424,
      "relation": "positiveCorrelation",
      "evidence": "Toll-like receptors 4 (TLR4) is induced in patients with an advanced stage of chronic obstructive lung disease (COPD) in parallel with increases in apoptosis",
      "citation": {
        "db": "Other",
        "db_id": "22983353"
      },
      "annotations": {},
      "source": 4,
      "target": 34,
      "key": "95acceae1480c7a3f97bb176260ff3b1"
    },
    {
      "line": 424,
      "relation": "positiveCorrelation",
      "evidence": "Toll-like receptors 4 (TLR4) is induced in patients with an advanced stage of chronic obstructive lung disease (COPD) in parallel with increases in apoptosis.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 4,
      "target": 34,
      "key": "d15b2cddacda50dddff5baea88b2898f"
    },
    {
      "line": 425,
      "relation": "negativeCorrelation",
      "evidence": "Depletion of GSTP1 by itself could induce cell death, including apoptosis, in human lung fibroblast-derived HFL-1 cells....the authors reported the association between GSTP1 gene polymorphism and susceptibility to chronic obstructive pulmonary disease (COPD).",
      "citation": {
        "db": "Other",
        "db_id": "14710442"
      },
      "annotations": {},
      "source": 4,
      "target": 106,
      "key": "cd6487704ed181598e088945a8c40caf"
    },
    {
      "line": 430,
      "relation": "association",
      "evidence": "Besides to inflammation, DNA methylation also participates in apoptosis in COPD",
      "citation": {
        "db": "Other",
        "db_id": "25807439"
      },
      "annotations": {},
      "source": 4,
      "target": 5,
      "key": "7c8b840b23f24b32b976e15c892101b5"
    },
    {
      "line": 433,
      "relation": "negativeCorrelation",
      "evidence": "The apoptotic index of pulmonary vascular endothelial cells was negatively correlated with COXII expression",
      "citation": {
        "db": "Other",
        "db_id": "21092633"
      },
      "annotations": {},
      "source": 4,
      "target": 176,
      "key": "ca64b598e9a43a7880dcd04863cf6020"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "quotation",
      "citation": {
        "db": "PubMed",
        "db_id": "15205477"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "transporter activity",
          "identifier": "0005215"
        }
      },
      "source": 9,
      "target": 4,
      "key": "5e1d17bcc079f3a61fa420386b9b64cc"
    },
    {
      "line": 272,
      "relation": "directlyIncreases",
      "evidence": "In the classical NF-{kappa}B signaling pathway, IKK{beta} is both necessary and sufficient for phosphorylation of I{kappa}B{alpha} on Ser 32 and Ser 36, and I{kappa}B{beta} on Ser 19 and Ser 23.",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 7,
      "target": 144,
      "key": "17755f2f4da1751cc4f1e32eecaa1b2e"
    },
    {
      "line": 272,
      "relation": "directlyIncreases",
      "evidence": "The IKK immunoprecipitates from thrombin-treated cells showed increased phosphorylation of GST-IkBalpha compared with the immunoprecipitates from control cells (Fig. 6), indicating the activation of IKK by thrombin.",
      "citation": {
        "db": "PubMed",
        "db_id": "15843586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 7,
      "target": 144,
      "key": "29f3ffb3beccf1ae3b6520d6e1d1cb04"
    },
    {
      "line": 273,
      "relation": "directlyIncreases",
      "evidence": "In the classical NF-{kappa}B signaling pathway, IKK{beta} is both necessary and sufficient for phosphorylation of I{kappa}B{alpha} on Ser 32 and Ser 36, and I{kappa}B{beta} on Ser 19 and Ser 23.",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 7,
      "target": 145,
      "key": "d1eac546f6cc0a3d618ea28cf9ae0d15"
    },
    {
      "line": 273,
      "relation": "directlyIncreases",
      "evidence": "The IKK immunoprecipitates from thrombin-treated cells showed increased phosphorylation of GST-IkBalpha compared with the immunoprecipitates from control cells (Fig. 6), indicating the activation of IKK by thrombin.",
      "citation": {
        "db": "PubMed",
        "db_id": "15843586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 7,
      "target": 145,
      "key": "8e0bdc5d22071968c64a82b5003fc6cd"
    },
    {
      "line": 26,
      "relation": "increases",
      "evidence": "NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 8,
      "target": 111,
      "key": "6183d4995c71189b1ff3daa4d7974635"
    },
    {
      "line": 29,
      "relation": "increases",
      "evidence": "NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 8,
      "target": 71,
      "key": "6cfb73b9e67f25122590a0296c33f1d8"
    },
    {
      "line": 30,
      "relation": "increases",
      "evidence": "NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 8,
      "target": 182,
      "key": "7656f34f772f2ce06d304c3df714cb06"
    },
    {
      "relation": "hasComponent",
      "source": 8,
      "target": 188,
      "key": "d7946658060d248bd232e82ba1dce8c5"
    },
    {
      "line": 20,
      "relation": "increases",
      "evidence": "Subsequent binding of cytochrome c to Apaf-1 results in the formation of a complex known as the apoptosome in the presence of ATP/dATP. The apoptosome can recruit procaspase-9 and thereby activate it through oligomerization which then leads to the activation of executioner caspase-3, -6 and -7.(191,192)",
      "citation": {
        "db": "PubMed",
        "db_id": "15725726"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 13,
      "target": 64,
      "key": "fd302059bbd0333caba084ebba3f6e6a"
    },
    {
      "line": 20,
      "relation": "increases",
      "evidence": "Consisting of APAF-1, cytochrome-c, and caspase-9, in the presence of dATP, formation of the apoptosome results in the autoactivation of caspase-9 and again, activation of the effector caspase-3 (17).",
      "citation": {
        "db": "PubMed",
        "db_id": "12748058"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 13,
      "target": 64,
      "key": "4c94d5ee10a788a0f5ab30b88eeae143"
    },
    {
      "relation": "partOf",
      "source": 64,
      "target": 13,
      "key": "e465dfa69579bcb0967bb4ea772a99de"
    },
    {
      "relation": "hasComponent",
      "source": 64,
      "target": 13,
      "key": "bf944b6673f2c95e6733036d26fe7af5"
    },
    {
      "relation": "hasVariant",
      "source": 64,
      "target": 65,
      "key": "1457bc63a706b06929c240482bc82d8a"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "Once activated, caspase-9 cleaves and activates the effector caspases 3 and 7 to bring about apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "19788417"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 59,
      "key": "71d2fae74e5222e6d1d0bd5e2374ba40"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "The death effector domain (DED) of FADD then binds to the DED of procaspase 8, which triggers the formation of activated caspase 8, the activation of caspase 3, and the apoptotic response.",
      "citation": {
        "db": "PubMed",
        "db_id": "16239906"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 59,
      "key": "b9db042492d4efffa19261c0a7a7d661"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 59,
      "key": "4790f52d698858d2e2ba1a774be779b7"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "Moreover, we demonstrate that DCC interacts with both caspase-3 and caspase-9 and drives the activation of caspase-3 through caspase-9 without a requirement for cytochrome c or Apaf-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "11248093"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 59,
      "key": "00a3209887bfb47aa8f3e3d7d4e32c70"
    },
    {
      "line": 137,
      "relation": "directlyIncreases",
      "evidence": "Cytosolic cytochrome c, together with APAF-1, activates caspase-9 and subsequently caspase-3.",
      "citation": {
        "db": "PubMed",
        "db_id": "17610066"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 59,
      "key": "bc4bbf6d70ecb16af1f5b0e35948be03"
    },
    {
      "line": 138,
      "relation": "directlyIncreases",
      "evidence": "when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 62,
      "key": "4cd845fa31f8cd72e71a8faa967b8c70"
    },
    {
      "line": 138,
      "relation": "directlyIncreases",
      "evidence": "Once activated, caspase-9 cleaves and activates the effector caspases 3 and 7 to bring about apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "19788417"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 62,
      "key": "a411241806d02ba5503422f75b575998"
    },
    {
      "line": 139,
      "relation": "directlyIncreases",
      "evidence": "when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 64,
      "target": 61,
      "key": "0617b3b2f17a305ecb297da4a97d6f43"
    },
    {
      "relation": "partOf",
      "source": 76,
      "target": 13,
      "key": "04337e3ecb0d4149d7a697fca269f61a"
    },
    {
      "relation": "hasComponent",
      "source": 76,
      "target": 13,
      "key": "802b24f0f86acb21df7129186242149d"
    },
    {
      "line": 170,
      "relation": "increases",
      "evidence": "the classical induction of AICD is mediated via CD95, ligation of CD95 by CD95L leads to the recruitment of adapter proteins such as FADD, resulting in the activation of caspase 8, which in turn activates downstream caspases, including caspase 3, 6 and 7, and initates apoptosis independently of the apoptosome, although cytochrome C release and apoptosome activation are required for efficient cell death",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "source": 76,
      "target": 4,
      "key": "1e00e9d92b73f3ca5fa860e1fb77df57"
    },
    {
      "line": 170,
      "relation": "increases",
      "evidence": "The \\\"intrinsic\\\" mitochondrial pathway can be activated in response to stimuli such as ultraviolet light and oxidative stress, and results in the release of mitochondrial cytochrome-c, initiating formation of the apoptosome complex (15, 16)",
      "citation": {
        "db": "PubMed",
        "db_id": "12748058"
      },
      "annotations": {},
      "source": 76,
      "target": 4,
      "key": "9889064a3c1a547b0e849a5a54ac14f2"
    },
    {
      "relation": "partOf",
      "source": 109,
      "target": 13,
      "key": "d0d65df709a673554e7af3570df7037c"
    },
    {
      "relation": "hasComponent",
      "source": 109,
      "target": 13,
      "key": "980f16f8afb51065df39fe5d6780ecac"
    },
    {
      "relation": "partOf",
      "source": 17,
      "target": 10,
      "key": "a2ca4425f5cd3fd6fabbdce085546d23"
    },
    {
      "relation": "partOf",
      "source": 156,
      "target": 10,
      "key": "a1d17eb2164c6676984bdfc33c9361c4"
    },
    {
      "relation": "hasVariant",
      "source": 156,
      "target": 157,
      "key": "56de66529943f6b46d959ae8508e7842"
    },
    {
      "relation": "hasVariant",
      "source": 156,
      "target": 158,
      "key": "fd914b6a1e9f39a62c01453f476a193e"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "enforced PTEN expression results in a marked increase in cellular apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "10597304"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "d36a965d691ba1873fcb645c6bc4200b"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "The phosphorylation of BAD at S155 within the BH3 domain inhibits death-promoting activity of BAD (33â€“37) and promotes its interaction with 14-3-3 proteins",
      "citation": {
        "db": "PubMed",
        "db_id": "12754297"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "fbdc5350547933cdb4ae097ac9387864"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "Rsk1 directly phosphorylated the pro-apoptotic protein Bad at the serine %residues that, when phosphorylated, abrogate Bad's pro-apoptotic function.",
      "citation": {
        "db": "PubMed",
        "db_id": "10679322"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "3174e54bc21b483ff6b4c64fd0034a26"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "activated Rac1-induced Bad phosphorylation by a cell-permeable competitive peptide inhibitor representing this Bad phosphorylation site sensitizes lymphoma cells to drug-induced apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "15226424"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "18b1c700f0f2663e2c2f5a73eca8cef2"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "AKT pro-survival pathway may play a role also in the modulation of extrinsic apoptosis. The human gastric carcinoma cell line MKN45, which expresses COX-2, was sensitized to Fas-induced apoptosis by NS-398. The COX-2 inhibitor, indeed, was able to increase the level of PTEN, leading to a decrease of Akt phosphorylation and activation of Bad [114].",
      "citation": {
        "db": "PubMed",
        "db_id": "20339581"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "9886b88982b467df41003c70be85275d"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "Akt phosphorylates BAD in vitro and in vivo, and blocks the BAD-induced death of primary neurons in a site-specific manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "9346240"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "442405ce8dd21c7dc8b8acdb9cc8d6fa"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "Nicotine induces multisite phosphorylation of the proapoptotic protein Bad, thereby causing its inactivation and preventing cell death. Nicotine-induced phosphorylation of Bad (at Ser112, Ser136 and Ser155) is mediated by the PKC, PKA, MEK and PI3K signaling pathways [17].",
      "citation": {
        "db": "PubMed",
        "db_id": "18262664"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "702278551c472a6dd06ffba98d91a92b"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "phosphorylation of BAD protein inhibits the pro-apoptosis function of BAD",
      "citation": {
        "db": "PubMed",
        "db_id": "17393317"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "55f2d5931fe166ce942f68cfffa6f006"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "We report here that the phosphorylation of BAD at Ser-155 within the BH3 domain is a second phosphorylation-dependant mechanism that inhibits the death promoting activity of BAD. Phosphorylation at Ser-155, similar to phosphorylation at SER-112 and Ser-136, inhibits BAD-induced death-promoting activity but does so in a different manner. Phosphorylation at Ser-155 does not induce 14-3-3 binding and ctoplasmic sequestration but instead directly blocks BH3-dependent dimerization with Bcl-XL. The binding of Bcl-XL by the BH3 domain may cause Bcl-XL to release APAF-1 or regulate other Bcl-XL activites resulting in a caspase 9-initiated cascade of proteolysis and induction of apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "10837486"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "7b69a7b02fd03414e7d8eb3b456e6189"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "In its nonphosphorylated state, BAD translocates from the cytosol into mitochondria and promotes apoptotic cell death by inhibiting Bcl-2 or Bcl-xL",
      "citation": {
        "db": "PubMed",
        "db_id": "10409722"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "73ecdd0a5cf4e09aa7f5131c8e939ef9"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 4,
      "key": "916e90fb7ec3aa089e179224a0bf471d"
    },
    {
      "line": 95,
      "relation": "increases",
      "evidence": "BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "17115033"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 174,
      "key": "421bd8ce1ac7643cd6f313c415077d87"
    },
    {
      "line": 96,
      "relation": "increases",
      "evidence": "BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X(L) to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "17115033"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 156,
      "target": 169,
      "key": "fa33a4a54acb2d35263134edefc16b7f"
    },
    {
      "relation": "partOf",
      "source": 32,
      "target": 12,
      "key": "ed8791aaad8ed573eef6e5b7045d75c4"
    },
    {
      "relation": "partOf",
      "source": 45,
      "target": 12,
      "key": "5f08c67bc98bc2617a920e8d020575b0"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 12,
      "key": "6966f2c28e779cb00d9dcf14dff715bf"
    },
    {
      "line": 237,
      "relation": "decreases",
      "evidence": "Endogenous bcl-2 protein level decreased 12 fold and bax increased approximately 4 fold in PC3 vector control cells following Ad-p53 infection.",
      "citation": {
        "db": "PubMed",
        "db_id": "11146439"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 45,
      "target": 181,
      "key": "b71349de7e4ac7ca6e468c90d15ebd7b"
    },
    {
      "line": 237,
      "relation": "decreases",
      "evidence": "NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 45,
      "target": 181,
      "key": "122860889808c2b23b651407478de232"
    },
    {
      "line": 266,
      "relation": "increases",
      "evidence": "The acrolein-induced increase in FasL expression was significantly inhibited by pifithrin-alpha, suggesting that this response was mediated by p53 (Fig. 2E).",
      "citation": {
        "db": "PubMed",
        "db_id": "20393600"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 45,
      "target": 44,
      "key": "9586da33a56ac29870ee37ef2543cc6c"
    },
    {
      "line": 189,
      "relation": "directlyDecreases",
      "evidence": "Upon ER stress, unfolded proteins relieve the repression by triggering the release of BiP from the NLDs of IRE1 and PERK",
      "citation": {
        "db": "PubMed",
        "db_id": "11897784"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 14,
      "target": 85,
      "key": "1a2208de864f4b1dca57ffdf0d95b280"
    },
    {
      "relation": "partOf",
      "source": 85,
      "target": 14,
      "key": "a9bfe43258ab70fd41e25add9dc28f6f"
    },
    {
      "relation": "hasComponent",
      "source": 85,
      "target": 14,
      "key": "f7902b2ab454a6388f8effc8d313b009"
    },
    {
      "line": 172,
      "relation": "directlyIncreases",
      "evidence": "The endoplasmic reticulum (ER)-resident protein kinase PERK attenuates protein synthesis in response to ER stress through the phosphorylation of translation initiation factor eIF2alpha at serine 51.",
      "citation": {
        "db": "PubMed",
        "db_id": "17998206"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 85,
      "target": 87,
      "key": "a12b167193e8f23a1961ef8db676223a"
    },
    {
      "line": 172,
      "relation": "directlyIncreases",
      "evidence": "Activated PERK then phosphorylates the translation-initiation factor eIF2a, reducing the overall frequency of messenger RNA translation initiation. However, selected mRNAs, such as ATF4 mRNA, are preferentially translated in the presence of phosphorylated eIF2a. ATF4 activates the transcription of UPR target genes encoding factors involved in amino-acid biosynthesis, the antioxidative-stress response and apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "18650916"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 85,
      "target": 87,
      "key": "cd289556cb5d68e44a90b415964543fb"
    },
    {
      "line": 437,
      "relation": "decreases",
      "evidence": "The knockdown of PERK suppressed the expression of both PERK and p-eIF2a and caused a great increase in cell apoptosis.",
      "citation": {
        "db": "Other",
        "db_id": "23072721"
      },
      "annotations": {},
      "source": 85,
      "target": 4,
      "key": "e927f73aa9db56493e866e623e4fdd4d"
    },
    {
      "relation": "partOf",
      "source": 107,
      "target": 14,
      "key": "c53d69e17de2b583d60b9fb4f11b5219"
    },
    {
      "relation": "hasComponent",
      "source": 107,
      "target": 14,
      "key": "95b016fe7cf8b3dd1442e7737a596b51"
    },
    {
      "relation": "partOf",
      "source": 107,
      "target": 15,
      "key": "d6875266d6376b856bb68d3b3779de28"
    },
    {
      "relation": "hasComponent",
      "source": 107,
      "target": 15,
      "key": "eb4d97bd32f5908b5fd2900a3835486c"
    },
    {
      "line": 435,
      "relation": "decreases",
      "evidence": "The downregulation of GRP78 expression by GRP78 siRNA also led to the increased expression of caspase-3 and an increased apoptotic index (AI, P<0.05 vs. other groups).",
      "citation": {
        "db": "Other",
        "db_id": "24126384"
      },
      "annotations": {},
      "source": 107,
      "target": 59,
      "key": "0e6429188de37a152ed5f14c5022ddec"
    },
    {
      "line": 351,
      "relation": "directlyDecreases",
      "evidence": "Ire1 similarly oligomerizes in ER membranes when released by Grp78. The Ire1Ãƒ?Ã‚Â± protein is a type I transmembrane protein, which contains both a Ser/Thr kinase domain and an endoribonuclease domain; the latter processes an intron from X box protein-1 (XBP-1) mRNA, rendering it competent for translation to produce the 41-kDa XBP-1 protein, a bZIP-family transcription factor. XBP-1 binds to promoters of several genes involved in retrograde transport of misfolded proteins from ER to cytosol and in ER-induced protein degradation (reviewed in ref. 8).  # Ire1 = ERN1",
      "citation": {
        "db": "PubMed",
        "db_id": "16200199"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 15,
      "target": 92,
      "key": "53df884ec43033542c8d6943ff8d0bee"
    },
    {
      "relation": "partOf",
      "source": 92,
      "target": 15,
      "key": "825a36dfebfe7a08b8afe43511cc29be"
    },
    {
      "relation": "hasComponent",
      "source": 92,
      "target": 15,
      "key": "07c4f29cc1c08fed13bda880f0a99c66"
    },
    {
      "line": 38,
      "relation": "directlyIncreases",
      "evidence": "IRE1 is a bifunctional transmembrane kinase/endoribonuclease that induces the non-conventional splicing of Xbp1 mRNA to produce another b-ZIP transcription activator, XBP1 .",
      "citation": {
        "db": "PubMed",
        "db_id": "19137072"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 92,
      "target": 49,
      "key": "a9ea5afa2b772caa1dcbac7ba64b080b"
    },
    {
      "relation": "partOf",
      "source": 25,
      "target": 11,
      "key": "37ba7833215c09c7bf18af41181d76d5"
    },
    {
      "relation": "hasComponent",
      "source": 25,
      "target": 11,
      "key": "b9c67c45edcee86f9a2c83755fe68fc8"
    },
    {
      "line": 232,
      "relation": "directlyIncreases",
      "evidence": "Figure 6 Phosphorylation of MEKK1 at Ser-957 and Ser-994 is important for RIP-induced MEKK1 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11369754"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 128,
      "key": "576b31bb6e88d23acddb24d7b364d3df"
    },
    {
      "line": 233,
      "relation": "directlyIncreases",
      "evidence": "Figure 6 Phosphorylation of MEKK1 at Ser-957 and Ser-994 is important for RIP-induced MEKK1 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11369754"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 129,
      "key": "6477e2fbc8d7fd967d31e5aa92745b58"
    },
    {
      "relation": "partOf",
      "source": 36,
      "target": 11,
      "key": "7dae0240421d9fe956618bddcfa75e2d"
    },
    {
      "relation": "hasComponent",
      "source": 36,
      "target": 11,
      "key": "420ac42cfc5b17ae377c7ac6308db2af"
    },
    {
      "line": 329,
      "relation": "increases",
      "evidence": "DR4 and DR5 are the genuine death receptors inducing apoptosis whereas DcR1 and DcR2 function as decoy receptors and physiologically block apoptosis, which might thus contribute to the pathogenesis of autoimmunity.",
      "citation": {
        "db": "PubMed",
        "db_id": "20799941"
      },
      "annotations": {},
      "source": 36,
      "target": 4,
      "key": "e912dcd75f5f7b8a198f9f60459eb91f"
    },
    {
      "line": 329,
      "relation": "increases",
      "evidence": "In accordance with increased oxidative markers in the emphysematous lung and as oxidative stress increases TRAIL-R1/2 expression, p53 levels and Bax/Bcl-xL ratio (balance toward apoptosis) in A549 cells , we report that H2O2 and cigarette smoke sensitized A549 cells to TRAIL-mediated apoptosis in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "21824395"
      },
      "annotations": {},
      "source": 36,
      "target": 4,
      "key": "47ab778de73425a1ad25104b1371ceab"
    },
    {
      "line": 409,
      "relation": "increases",
      "evidence": "Here we show that TRAIL-R1-, TRAIL-R2-, and TRAIL-R4-induced NF-kappaB activation are mediated by a TRAF2-NIK-IkappaB kinase alpha/beta signaling cascade but is MEKK1 independent.",
      "citation": {
        "db": "PubMed",
        "db_id": "10521444"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 36,
      "target": 47,
      "key": "68db7dbd61f87cb8993d90206baf2ee3"
    },
    {
      "line": 395,
      "relation": "increases",
      "evidence": "inhibition of acinus-dependent chromatin condensation",
      "citation": {
        "db": "PubMed",
        "db_id": "16177823"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 66,
      "target": 4,
      "key": "3dd6ddd526297a0cb9956c2cfb604377"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "endonuclease G and apoptosis-inducing factor (AIP) might induce cell death independently of caspase activation",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "source": 150,
      "target": 4,
      "key": "e2746ddf1f3153b6bc9f9c2616f87b3e"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "Reduction of AIF expression by RNA interference inhibited large-scale DNA fragmentation and conferred significant protection against MPP+ toxicity.",
      "citation": {
        "db": "PubMed",
        "db_id": "16156740"
      },
      "annotations": {},
      "source": 150,
      "target": 4,
      "key": "1da392cba23c6b12ff373e2d0e894ddc"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "cadmium induces Hep3B cells apoptosis mainly by calcium- and oxidative stress-related impairment of mitochondria, which probably favors release of apoptosis-inducing factor and endonuclease G.",
      "citation": {
        "db": "PubMed",
        "db_id": "15182854"
      },
      "annotations": {},
      "source": 150,
      "target": 4,
      "key": "ac5a51b350579618eeb2d6189c45ff98"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "Heat shock protein 70 (HSP70) can inhibit apoptosis by neutralizing and interacting with apoptosis-inducing factor (AIF), a mitochondrial flavoprotein that translocates upon apoptosis induction to the nucleus, via the cytosol AIF inhibition by HSP70 involves cytosolic retention of AIF.",
      "citation": {
        "db": "PubMed",
        "db_id": "14555980"
      },
      "annotations": {},
      "source": 150,
      "target": 4,
      "key": "1dacf35c99705376a524b191d9693885"
    },
    {
      "relation": "hasVariant",
      "source": 99,
      "target": 100,
      "key": "06f054f1e105f4a485c540faaa41e59c"
    },
    {
      "relation": "hasVariant",
      "source": 99,
      "target": 101,
      "key": "a9389af3a9849e91d28c87dcd365ed55"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Thrombin induces the activation of platelet serine/threonine kinase Akt. Akt activation is dependent on its phosphorylation at threonine 308 and serine 473.",
      "citation": {
        "db": "PubMed",
        "db_id": "17883592"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "43aca050a43ec96138b6d838eccd71dc"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Fig. 1. Insulin-like growth factor 1 (IGF-1)-mediated signaling pathways relevant to hypertrophy. Binding of IGF-1 activates the IGF-1 receptor (purple), which then recruits insulin-receptor substrate (IRS-1). This leads to the activation of two signaling pathways: the Ras-Raf-MEK-ERK pathway and the phosphatidylinositol 3-kinase (PI3K)- Akt pathway. The PI3K-Akt pathway recapitulates hypertrophy caused by IGF-1 stimulation. Akt1 activity can be modulated either by directly controlling its phosphorylation state or by altering the levels of the lipid that it binds at the cell membrane, phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] (orange). Signaling molecules that have been shown to have a negative effect on hypertrophy are colored red, and proteins whose activation induces hypertrophy are shown in green. Proteins that have not been assayed for their role in hypertrophy are shown in blue. Abbreviations: eIF-2B, eukaryotic translation initiation factor 2B; ERK, extracellular-signal-regulated kinase; GSK3b, glycogen-synthase kinase 3b; mTOR, mammalian target of rapamycin; p70S6K, p70 S6 kinase; PDK, phosphoinositide-dependent protein kinase; PtdIns(3,4)P2, phosphatidylinositol (3,4)-bisphosphate; PtdIns(4,5)P2, phosphatidylinositol (4,5)-bisphosphate; PHAS-1, phosphorylated heat- and acid-stable protein 1; PP2A, protein phosphatase 2A; PTEN, phosphatase and tensin homologous on chromosome 10; SHIP2, SH2-domain-containing inositol phosphatase; Tsc1/2, tuberous sclerosis complex 1 and 2. Modified from Ref. [87]. Akt1 activity can be modulated either by directly controlling its phosphorylation state or by altering the levels of the lipid that it binds at the cell membrane, PtdIns(3,4,5)P3 [22] (Fig. 1). Akt1 activity depends on phosphorylation at two sites: Ser473 and Thr309 [29].",
      "citation": {
        "db": "PubMed",
        "db_id": "12928036"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "44ea109a43608710da6b7dac3c810b07"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Activation of PKB alpha and beta is then achieved at the plasma membrane by phosphorylation of Thr308/309 in the A-loop of the kinase domain and Ser473/474 in the carboxy-terminal regulatory region, respectively.  The upstream kinase that phosphorylates PKB on Thr308, termed PI-dependent protein kinase-1, has been identified and extensively characterised. A candidate for the Ser473/474 kinase, termed the integrin-linked kinase, has been identified recently.",
      "citation": {
        "db": "PubMed",
        "db_id": "10454216"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "b985289190d76a94cbb7369b30e25f31"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Upon stimulation with insulin, AKT is recruited to cellular membranes by binding of its amino terminal pleckstrin (PH) domain to membrane bound phosphatidylinositol 3,4,5, trisphosphate (PIP3) [3]. The membrane bound form of AKT then becomes phosphorylated on two regulatory residues, a threonine within the activation loop (Thr308 in AKT1,Thr309 in AKT2, Thr305 in AKT3) and a serine in the C-terminus of the enzyme (Ser473 in AKT1,Ser474 in AKT2, Ser472 in AKT3), and both phosphorylations are considered to be required for AKT to reach maximum kinase activity [1]. The kinase responsible for phosphorylation of Thr308/309/305 has been identified as phosphoinositide-dependent kinase 1 (PDK1) [3].",
      "citation": {
        "db": "PubMed",
        "db_id": "15890450"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "1a01cedfffdd9b7563e9a11134b0b8ad"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "The impact of IL-8 binding to AAT or HSA on its ability to stimulate Akt Ser473 phosphorylation, a key step in IL-8? mediated neutrophil chemotaxis (27), was explored. Figure 7D shows that IL-8 (1 ng) stimulated adequate Akt phosphorylation after just 10 minutes and that this effect was unaffected by prebinding of IL-8 to HSA (27.5 uM).",
      "citation": {
        "db": "PubMed",
        "db_id": "21060150"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "5c2e3b4c59d9b197846bd7e961fb5888"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "In vivo 32P labeling and mutagenesis demonstrated that m/p-PKBalpha activity was due to phosphorylation on Thr308 and Ser473, that are normally induced on PKB following stimulation of the cells with insulin or insulin-like growth factor-1 (IGF-1).... Following activation the kinase detached from the membrane and translocated to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "9395488"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "551a54c27ce142b118d4ec05b4b1882c"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Akt becomes activated upon phosphorylation of Ser473 and Thr308. In the absence of insulin, dexamethasone reduced Ser473 phosphorylation by 33% (P <\t 0.05 vs. no treatment, n =  3).",
      "citation": {
        "db": "PubMed",
        "db_id": "17229808"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "5d79290ae36bf40352e0c10bcf7dfd94"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "three isoforms, AKT1 (PKBalpha), AKT2 (PKBbeta) and AKT3 (PKBgamma) they all contain a central kinase domain with an activation-loop phosphorylation site, Thr308, and a conserved, regulatory C-terminal phosphorylation site, Ser473",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "d426a514a8c2a1d15870123d01e3a3fc"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Furthermore, we show that inhibition of mTOR by rapamycin induces the activation of Akt as shown by increased Akt phosphorylation at Ser(473) and the inhibition of 6-TG-induced apoptosis and cell death.  Activated Akt is a well-known inhibitor of autophagy.",
      "citation": {
        "db": "PubMed",
        "db_id": "18381446"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "abf6af361f847bae562f8f5e2362f8f0"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Stimulation of platelets with a PAR1-activating peptide (SFLLRN), PAR4-activating peptide (AYPGKF), and thrombin resulted in Thr308 and Ser473 phosphorylation of Akt, which results in its activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "14623889"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "aa51f8bb3020107043155eb17106f44e"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "After PIP3 binding, Akt1 is activated by phosphorylation on two critical residues, namely threonine %308 (T308) and serine 473 (S473); similar activation residues (S472 and S474, %respectively) are highly conserved in Akt2 and Akt3 Phosphoinositol-3-phosphate (PIP3) is a product of phosphoinositol 3-kinase enzymatic activity and has been shown to be a prerequisite lipid modulator of Akt activity Akt activity can be regulated by the PTEN tumour suppressor gene, which negatively regulates PIP3 levels PIP3 has been described as a downstream component of a wide range of receptors, including the c-Met receptor [5], the epidermal growth factor receptor family [6], fibroblast growth factor receptor [7], insulin growth factor receptor [8] and platelet-derived growth factor receptor",
      "citation": {
        "db": "PubMed",
        "db_id": "15987444"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "e7e25927f683dbc1d3e760ca7fa3f512"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "mTORC2 can be activated by PI3K directly and phosphorylates Akt at S473, which together with phosphorylation at T308 results in the full activation of Akt [12,13].",
      "citation": {
        "db": "PubMed",
        "db_id": "17200144"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "286d83479bf7ac3a97943a0825adc822"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation at Ser473 in the hydrophobic motif, along with Thr308 in its activation loop, is considered necessary for Akt function.",
      "citation": {
        "db": "PubMed",
        "db_id": "20691662"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "d79d4480a1c540f39a56e96a42f70d0f"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Furthermore, serum starvation-induced apoptosis caused a twofold increase in caspase 3 activity in C1-TEN-overexpressing cells vs. mock cells. In addition, C1-TEN-overexpressing cells showed a markedly reduced phosphorylation of Akt/PKB kinase and its substrate GSK3, as well as reduced Akt enzymatic activity.  Equal amounts of total cell lysates were subjected to 10% SDSPAGE. The membrane was then probed with polyclonal antibody against GSK3 specifically phosphorylated at Ser21/9 (pGSK3?/?, CST), after which the membrane was stripped (stripping buffer, Pierce) and reprobed with polyclonal anti-total Akt antibody (CST). and Western blotting for detection of either Akt kinase specifically phosphorylated at Ser473 (pAkt) or both 42 and 44 kDa isoforms of phosphorylated ERK (pERK) using specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).",
      "citation": {
        "db": "PubMed",
        "db_id": "15817639"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "bdd4e32853004009dc76eb1e613a9e08"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "Overexpressed IRS-3 as well as IRS-1 enhanced phosphoinositide (PI) 3-kinase activity in response to insulin and increased phosphorylation of protein kinase B (PKB) at S473 and phosphorylation of one of the members of the forkhead transcription factor FKHRL1 on T32 in both insulin-untreated and -treated states.",
      "citation": {
        "db": "PubMed",
        "db_id": "12504093"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "1e1d7953228f3d5c6a8259eab38be14c"
    },
    {
      "line": 354,
      "relation": "directlyIncreases",
      "evidence": "As shown in Fig. 2 B, subconfluent HeLa cultures have relatively low levels of active PKB, as detected by antibodies specifically recognizing PKB phosphorylated on serine 473. Phosphorylation of PKB is fully inhibitable by treatment with the specific PI 3-kinase inhibitor LY294002. Sparse cultures have barely detectable levels of phosphorylated PKB; however, dense cultures have much more activated PKB, whereas the total levels of PKB protein remain constant under all conditions examined.",
      "citation": {
        "db": "PubMed",
        "db_id": "11535620"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 100,
      "target": 99,
      "key": "691133c6500a8c9c9c9d2b4cfe8af4bf"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "mTORC2 can be activated by PI3K directly and phosphorylates Akt at S473, which together with phosphorylation at T308 results in the full activation of Akt [12,13].",
      "citation": {
        "db": "PubMed",
        "db_id": "17200144"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "b6d8e50e5ca80e7a134182620082d487"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Fig. 1. Insulin-like growth factor 1 (IGF-1)-mediated signaling pathways relevant to hypertrophy. Binding of IGF-1 activates the IGF-1 receptor (purple), which then recruits insulin-receptor substrate (IRS-1). This leads to the activation of two signaling pathways: the Ras-Raf-MEK-ERK pathway and the phosphatidylinositol 3-kinase (PI3K)- Akt pathway. The PI3K-Akt pathway recapitulates hypertrophy caused by IGF-1 stimulation. Akt1 activity can be modulated either by directly controlling its phosphorylation state or by altering the levels of the lipid that it binds at the cell membrane, phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] (orange). Signaling molecules that have been shown to have a negative effect on hypertrophy are colored red, and proteins whose activation induces hypertrophy are shown in green. Proteins that have not been assayed for their role in hypertrophy are shown in blue. Abbreviations: eIF-2B, eukaryotic translation initiation factor 2B; ERK, extracellular-signal-regulated kinase; GSK3b, glycogen-synthase kinase 3b; mTOR, mammalian target of rapamycin; p70S6K, p70 S6 kinase; PDK, phosphoinositide-dependent protein kinase; PtdIns(3,4)P2, phosphatidylinositol (3,4)-bisphosphate; PtdIns(4,5)P2, phosphatidylinositol (4,5)-bisphosphate; PHAS-1, phosphorylated heat- and acid-stable protein 1; PP2A, protein phosphatase 2A; PTEN, phosphatase and tensin homologous on chromosome 10; SHIP2, SH2-domain-containing inositol phosphatase; Tsc1/2, tuberous sclerosis complex 1 and 2. Modified from Ref. [87]. Akt1 activity can be modulated either by directly controlling its phosphorylation state or by altering the levels of the lipid that it binds at the cell membrane, PtdIns(3,4,5)P3 [22] (Fig. 1). Akt1 activity depends on phosphorylation at two sites: Ser473 and Thr309 [29].",
      "citation": {
        "db": "PubMed",
        "db_id": "12928036"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "37579b9659842230a7e308e67ce93752"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Upon stimulation with insulin, AKT is recruited to cellular membranes by binding of its amino terminal pleckstrin (PH) domain to membrane bound phosphatidylinositol 3,4,5, trisphosphate (PIP3) [3]. The membrane bound form of AKT then becomes phosphorylated on two regulatory residues, a threonine within the activation loop (Thr308 in AKT1,Thr309 in AKT2, Thr305 in AKT3) and a serine in the C-terminus of the enzyme (Ser473 in AKT1,Ser474 in AKT2, Ser472 in AKT3), and both phosphorylations are considered to be required for AKT to reach maximum kinase activity [1]. The kinase responsible for phosphorylation of Thr308/309/305 has been identified as phosphoinositide-dependent kinase 1 (PDK1) [3].",
      "citation": {
        "db": "PubMed",
        "db_id": "15890450"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "e9c77b7a5e94fcea23286873ee77ec43"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Conversely, the H157 cells, which showed decreased T308 phosphorylation with serum deprivation, exhibited less kinase activity in low serum.",
      "citation": {
        "db": "PubMed",
        "db_id": "11358816"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "a85d86ee277169c801dfccfad06ac780"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Thrombin induces the activation of platelet serine/threonine kinase Akt. Akt activation is dependent on its phosphorylation at threonine 308 and serine 473.",
      "citation": {
        "db": "PubMed",
        "db_id": "17883592"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "e147fc532d33aa57c5c2b03de46fbdb9"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "three isoforms, AKT1 (PKBalpha), AKT2 (PKBbeta) and AKT3 (PKBgamma) they all contain a central kinase domain with an activation-loop phosphorylation site, Thr308, and a conserved, regulatory C-terminal phosphorylation site, Ser473",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "3855a3ea42d00f5afb74345df22b59cf"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "In vivo 32P labeling and mutagenesis demonstrated that m/p-PKBalpha activity was due to phosphorylation on Thr308 and Ser473, that are normally induced on PKB following stimulation of the cells with insulin or insulin-like growth factor-1 (IGF-1).... Following activation the kinase detached from the membrane and translocated to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "9395488"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "97959fdf8021ea00a4d2106305e146e7"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Akt becomes activated upon phosphorylation of Ser473 and Thr308. In the absence of insulin, dexamethasone reduced Ser473 phosphorylation by 33% (P <\t 0.05 vs. no treatment, n =  3).",
      "citation": {
        "db": "PubMed",
        "db_id": "17229808"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "42e93107bb49d5b0861dddc817af1eb9"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Stimulation of platelets with a PAR1-activating peptide (SFLLRN), PAR4-activating peptide (AYPGKF), and thrombin resulted in Thr308 and Ser473 phosphorylation of Akt, which results in its activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "14623889"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "dc79e82e6d41f18d05c101d43b9b8d4a"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation at Ser473 in the hydrophobic motif, along with Thr308 in its activation loop, is considered necessary for Akt function.",
      "citation": {
        "db": "PubMed",
        "db_id": "20691662"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "8bffc6f498665fc2dc221e232fbaee7b"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "identified four sites (Ser-124, Thr-308, Thr-450, and Ser-473) on Akt1 that are phosphorylated in vivo. Thr-308 and Ser-473 are inducibly phosphorylated after treatment of cells with extracellular stimuli, whereas Ser-124 and Thr-450 appear to be basally phosphorylated The third mechanism by which 3'-phosphorylated phosphoinositides regulate Akt activity is by controlling the accessibility of Akt as a substrate for PDKs. In in vitro reconstitution assays, the binding of PI3,4,5P to the Akt PH domain is required for PDK-1 to phosphorylate Akt In addition, PDK-1 complexed with either a fragment of PRK2, PRK2, or a PRK2-related peptide may be regulated by increased phospholipid concentrations",
      "citation": {
        "db": "PubMed",
        "db_id": "10579998"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "b76d3b6706380b7e6e27e83f88faf007"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "Activation of PKB alpha and beta is then achieved at the plasma membrane by phosphorylation of Thr308/309 in the A-loop of the kinase domain and Ser473/474 in the carboxy-terminal regulatory region, respectively.  The upstream kinase that phosphorylates PKB on Thr308, termed PI-dependent protein kinase-1, has been identified and extensively characterised. A candidate for the Ser473/474 kinase, termed the integrin-linked kinase, has been identified recently.",
      "citation": {
        "db": "PubMed",
        "db_id": "10454216"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "e6e7324b6b8d1abecddc69c79cc29c03"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "All three isoforms (PKBalpha, PKBbeta and PKBgamma) were phosphorylated at similar rates and activated to similar extents by 3-phosphoinositide-dependent protein kinase-1 (PDK1)",
      "citation": {
        "db": "PubMed",
        "db_id": "9512493"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "555d440df47005093363138d6f59036a"
    },
    {
      "line": 327,
      "relation": "directlyIncreases",
      "evidence": "After PIP3 binding, Akt1 is activated by phosphorylation on two critical residues, namely threonine %308 (T308) and serine 473 (S473); similar activation residues (S472 and S474, %respectively) are highly conserved in Akt2 and Akt3 Phosphoinositol-3-phosphate (PIP3) is a product of phosphoinositol 3-kinase enzymatic activity and has been shown to be a prerequisite lipid modulator of Akt activity Akt activity can be regulated by the PTEN tumour suppressor gene, which negatively regulates PIP3 levels PIP3 has been described as a downstream component of a wide range of receptors, including the c-Met receptor [5], the epidermal growth factor receptor family [6], fibroblast growth factor receptor [7], insulin growth factor receptor [8] and platelet-derived growth factor receptor",
      "citation": {
        "db": "PubMed",
        "db_id": "15987444"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 101,
      "target": 99,
      "key": "6a38cb4e50d39bc6cb7b83f141ec0f62"
    },
    {
      "line": 152,
      "relation": "directlyDecreases",
      "evidence": "AKT2 interacts with and phosphorylates ASK1 at Ser-83 resulting in inhibition of its kinase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12697749"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 102,
      "target": 131,
      "key": "e1c39c004a96768eb8b3fbbc05b78585"
    },
    {
      "line": 442,
      "relation": "increases",
      "evidence": "The present findings suggest that the type 1 diabetes candidate gene BACH2 regulates proinflammatory cytokine-induced apoptotic pathways in pancreatic Î²-cells by crosstalk with another candidate gene, PTPN2, and activation of JNK1 and BIM.",
      "citation": {
        "db": "Other",
        "db_id": "24608439"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 52,
      "target": 20,
      "key": "daac1fcec31e01822e77f54a7a92d683"
    },
    {
      "line": 153,
      "relation": "directlyDecreases",
      "evidence": "NNK enhanced the levels of phospho-Bad (Ser112, Ser136 and Ser155; fig. 3c and d), which indicates that Bad was inactivated by NNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "18508827"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 157,
      "target": 156,
      "key": "3a963bbb03f2dd47f9afff2c1da80722"
    },
    {
      "line": 153,
      "relation": "directlyDecreases",
      "evidence": "activated Rac1-induced Bad phosphorylation by a cell-permeable competitive peptide inhibitor representing this Bad phosphorylation site sensitizes lymphoma cells to drug-induced apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "15226424"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 157,
      "target": 156,
      "key": "c0a4c468823edea6b00607b052610654"
    },
    {
      "line": 283,
      "relation": "directlyDecreases",
      "evidence": "NNK enhanced the levels of phospho-Bad (Ser112, Ser136 and Ser155; fig. 3c and d), which indicates that Bad was inactivated by NNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "18508827"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 158,
      "target": 156,
      "key": "5365d5d725dd0fe64ab9b33827ccfa02"
    },
    {
      "relation": "hasVariant",
      "source": 174,
      "target": 175,
      "key": "08c1e560283ae910d822725226687a31"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "JNK is essential for UV-stimulated apoptosis mediated by the mitochondrial pathway by a Bax/Bak-dependent mechanism",
      "citation": {
        "db": "PubMed",
        "db_id": "12591950"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "ea03a996d2bb144a87519fa6cf8a4385"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "[vBCL2] also partially reverses cell death induced by Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "12794189"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "46ae10c4f1796ebca7175b0597da63ee"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "either Bax or Bak is required for ER stress-induced apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "90c0d0f38447208245db075e415455f8"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "BID induces oligomerization of proapoptotic members BAX and BAK, resulting in release of cytochrome c from mitochondria and subsequent induction of apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "15353788"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "ff2a6eea1ed19ff634f1e1cec0ffeb9d"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "Moreover, activated K-Ras, RASSF1A, and MOAP-1 synergize to induce Bax activation and cell death.",
      "citation": {
        "db": "PubMed",
        "db_id": "16344548"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "039dd162aa0766b0afa785028709ffb4"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "In response to stress, Atr participates in the down-regulation of FRAG1 expression, leading to the induction of apoptosis through the release of Rad9 from damaged chromatin during the S phase of the cell cycle, allowing Rad9-Bcl2 association and induction of proapoptotic Bax protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "15983387"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "0dcafda7aca0f991213717aecca356e7"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "# sentences for pubmedID=12782632: # GeneRif: Cat D triggers Bax activation, Bax induces the selective release of mitochondrial AIF, and the latter is responsible for the early apoptotic phenotype in T-cells # Pubmed:gene: Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12782632"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "3d65ba5f14223ea4b8fe57b8d9907d40"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": "MAP-1 is a mitochondria-enriched protein that associates with Bax only upon apoptotic induction, which coincides with the release of cytochrome c from mitochondria. Small interfering RNAs that diminish MAP-1 levels in mammalian cell lines confer selective inhibition of Bax-mediated apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16199525"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 174,
      "target": 4,
      "key": "6ed981065d613ad26ec129c1edfcdda1"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "SIRT1 sequesters the proapoptotic factor Bax, prevents stress-induced apoptosis of cells, and thus, prolongs survival.",
      "citation": {
        "db": "PubMed",
        "db_id": "15850715"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "e8a5241ee20b2ee0ae0f938369242813"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "Co-immunoprecipitation analysis confirmed that Bis interacted with Bcl-2 in vivo. DNA transfection experiments indicated that Bis itself exerted only weak anti-apoptotic activity, but was synergistic with Bcl-2 in preventing Bax-induced and Fas-mediated apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "10597216"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "146015ec3dcef7cbbf7bd68f4856d989"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "PKB/ Akt-dependent signaling controls many essential cellular processes such as cellular metabolism, transcription, cell proliferation, migration and survival [37,73,74]. PKB/Akt is believed to promote endothelial cell survival and angiogenesis via the phosphorylation and inactivation of the pro-apoptotic molecules Bad, Bax, caspase 9, and the Forkhead (FRKH) transcription factor [75], the stimulation of nitric oxide (NO) production [76,77], and the inhibition of the stressactivated kinases p38 and JNK [78].",
      "citation": {
        "db": "PubMed",
        "db_id": "14984767"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "33471221b2a3d48d2504c16fc7555fd6"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "Further support for the importance of Bax, but not Bak, inMYC-mediated apoptosis was obtained using a switchable mouse model of MYC-induced apoptosis in pancreatic beta cells, where it was shown that c-MYC induces apoptosis in vivo exclusively through Bax (Dansen et al., 2006).",
      "citation": {
        "db": "PubMed",
        "db_id": "18955973"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "056693c0936d8e0a3a9986e9386e5859"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "if Bak or Bax is present, Bid then triggers cytochrome c release and apoptosis, apparently by inducing Bax and Bak to oligomerize and breach membrane integrity",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "3ce890d957b8fb6fd83666334e5a2c37"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "SIRT1 deacetylates the DNA repair factor Ku70, causing it to sequester the proapoptotic factor Bax away from mitochondria, thereby inhibiting stress-induced apoptotic cell death.",
      "citation": {
        "db": "PubMed",
        "db_id": "15205477"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "27fade2b1ac86fff008b939fe78ce4cc"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "These genes can be divided in three classes: one that controls cell-cycle arrest and senescence, one that controls apoptosis and one that regulates glucose metabolism and autophagy [42]. p53 is essentially known as a pro-apoptotic transcription factor that upregulates the expression of proteins such as BCL2-associated X protein (BAX), p53 upregulated modulator of apoptosis (PUMA) or NOXA.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "30e0484ce5c0f53b6d5ec7106e0c20e6"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "We identified down-regulation of Thsp1- and Bax-regulated apoptotic response in those tumors with Sept9 overexpression, an effect that could be reversed by inhibiting Sept9 expression using transfection with small interference RNA.",
      "citation": {
        "db": "PubMed",
        "db_id": "12727837"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "d52768a9984da5d105a7b9034b3e8210"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "Overexpression of Hsp10 and Hsp60 increased the abundance of the anti-apoptotic Bcl-xl and Bcl-2, and reduced the protein content of the pro-apoptotic Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "12967636"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "4b283690e1b9f7b25006e5dd4e17929f"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "Ariadne: In particular, extracellular S100A4 down-regulates the pro-apoptotic bax and the angiogenesis inhibitor thrombospondin-1 genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15047714"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "2f2397774f3516a1c0be6e588078c2c3"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "cell death induced by Bax or Fas (CD 95) was partially inhibited (mean +/- SD, 65% +/- 8%) by Survivin, whereas XIAP, another IAP family member, almost completely blocked cell death (93% +/- 4%) under the same conditions.",
      "citation": {
        "db": "PubMed",
        "db_id": "9850056"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "c0ac87b975801671cceea20a28567d15"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": "However, in neurons, where BAX is a major mediator of apoptosis during development and disease [45], both the c-Jun N-terminal protein kinase (JNK)/c-Jun and the p53 pathways form distinct death-signaling modules that culminate in BAX dependent apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16530485"
      },
      "annotations": {},
      "source": 174,
      "target": 4,
      "key": "d384d7d77f3c653f456e741453449899"
    },
    {
      "line": 117,
      "relation": "directlyDecreases",
      "evidence": "Fig. 5C demonstrates that Akt could directly phosphorylate Bax in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "14766748"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 175,
      "target": 174,
      "key": "55d3fec5da22297576355b7aa66e6b01"
    },
    {
      "line": 117,
      "relation": "directlyDecreases",
      "evidence": "Fig. 2. Nicotine induces Bax phosphorylation at Ser-184, which results in inactivation of Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "15642728"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 175,
      "target": 174,
      "key": "97be2100a9b33d3a13cd0635284c0be7"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "17507791"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 68,
      "target": 169,
      "key": "e2175b56a68e5133c2772f06830b5215"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "Taken together, these results indicate that certain BH3-only activators, like Bim and Puma, can induce cytochrome c mobilization and mitochondrial apoptosis in the sole presence of reticular Bak.",
      "citation": {
        "db": "PubMed",
        "db_id": "19339988"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 68,
      "target": 169,
      "key": "318998b7f1a029ab0a10aa4d9b400c4c"
    },
    {
      "line": 114,
      "relation": "directlyIncreases",
      "evidence": "In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "17507791"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 68,
      "target": 174,
      "key": "a155e6190f323d7ff8c7fc0335ff36e0"
    },
    {
      "line": 407,
      "relation": "increases",
      "evidence": "BH3-only proteins are members of the BCL- 2 protein family; they trigger apoptosis and integrate diverse apoptotic stimuli into a common cell-death pathway that is governed by other multidomain BCL-2 family members.",
      "citation": {
        "db": "PubMed",
        "db_id": "16530485"
      },
      "annotations": {},
      "source": 68,
      "target": 4,
      "key": "9628a223ce67d27c39d71437361e4f9c"
    },
    {
      "line": 407,
      "relation": "increases",
      "evidence": "While the first transactivation is weak, and not sufficient to trigger apoptosis (at least in the in vitro cellular models so far evaluated), the induction of PUMA is strong and lethal.",
      "citation": {
        "db": "PubMed",
        "db_id": "15865927"
      },
      "annotations": {},
      "source": 68,
      "target": 4,
      "key": "9473b9449ce877bbf40c8b2a23b48177"
    },
    {
      "line": 407,
      "relation": "increases",
      "evidence": "These genes can be divided in three classes: one that controls cell-cycle arrest and senescence, one that controls apoptosis and one that regulates glucose metabolism and autophagy [42]. p53 is essentially known as a pro-apoptotic transcription factor that upregulates the expression of proteins such as BCL2-associated X protein (BAX), p53 upregulated modulator of apoptosis (PUMA) or NOXA.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "source": 68,
      "target": 4,
      "key": "7c975be61e6692f9cfd3dfa90687e6c9"
    },
    {
      "line": 407,
      "relation": "increases",
      "evidence": "Here, we show that Puma and Noxa, the well-known p53-inducible proapoptotic members of the Bcl-2 family, differentially participate in dual pathways of the induction of apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "17024184"
      },
      "annotations": {},
      "source": 68,
      "target": 4,
      "key": "dca8ea7a560e8969c9576f86602722c6"
    },
    {
      "line": 146,
      "relation": "directlyDecreases",
      "evidence": "Figure 2 | Extrinsic and intrinsic apoptotic signalling pathways in neurons. Black lines represent apoptotic pathways, blue lines represent survival pathways. The extrinsic death pathway is initiated by binding of the extracellular ligands, TNFa (tumour necrosis factor-a) or FAS (apoptosis antigen-1) ligand (FASL), to death receptors TNFR1 (TNF-receptor1) and FAS. TNFR1 activation leads to the formation of a TRADD RIP TRAF2 (TNF receptor death domain receptor interacting protein TNF associated factor 2) complex, which signals through the NFkB (nuclear factorkB) survival pathway (blue lines) or the JNK (cJun N teminal kinase)death pathway (black lines). RIP activates procaspase 2 and cleaves BID (BH3 (BCL2 (B-cell leukaemia/lymphoma-2) homology domain 3) interacting agonist). The TRADD FADD FLICE (TNF receptor death domain FAS associated death domain FADD like interleukin 1b) complex activates procaspase 8, triggering apoptosis through caspase 3 or cleavage of BID to tBID (truncated BID). FAS-mediated death occurs through a FADD-mediated activation of procaspase 8 or DAXX (death-associated protein )-mediated activation of JNK. JNK modifies BID to jBID, allowing its translocation to the mitochondrion and release of SMAC/DIABLO (second-mitochondrialderived activator of caspases). The intrinsic apoptotic pathway is initiated at the mitochondrion by diverse stimuli. Membrane permeabilization is mediated by BH3-only proteins, which sequester and inhibit the supression of BAX (B-cell lymphoma 2-associated protein X) by BCL2, allowing mitochondrial BAX translocation and the release of cytochrome c (Cyto c), SMAC/DIABLO, AIF (apoptosis-inducing factor) and HTRA2/OMI (high temperature requirement serine protease 2).",
      "citation": {
        "db": "PubMed",
        "db_id": "15322527"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 174,
      "key": "b65293534135f234547501808e9da4ed"
    },
    {
      "line": 146,
      "relation": "directlyDecreases",
      "evidence": "The pro-apoptotic protein, Bax, has been reported to translocate from cytosol to mitochondria following exposure of cells to apoptotic stresses including cytokine withdrawal and treatment with glucocorticoids and cytotoxic drugs. These observations, coupled with reports showing that Bax causes the release of mitochondrial cytochrome c, implicate Bax as a central mediator of the apoptotic process. In this report we demonstrate by subcellular fractionation a significant shift in Bax localization from cytosol to cellular membranes in two human tumor cell lines exposed to staurosporine or etoposide. Immunofluorescence studies confirmed that Bax specifically relocalized to the mitochondria. This redistribution of Bax occurred in concert with, or just prior to, proteolytic processing of procaspase-3, activation of DEVD-specific cleavage activity and degradation of poly(ADP-ribose) polymerase. However, Bax membrane translocation was independent of caspase activity as determined using the broad-range caspase inhibitor z-VAD-fmk. High level overexpression of the anti-apoptotic protein Bcl-2 prevented Bax redistribution to the mitochondria, caspase activation and apoptosis following exposure to staurosporine or etoposide. These data confirm the role of Bax in mitochondrial cytochrome c release, and indicate that prevention of Bax translocation to the mitochondrial membrane represents a novel mechanism by which Bcl-2 inhibits drug-induced apoptosis.",
      "citation": {
        "db": "Other",
        "db_id": "10713725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 174,
      "key": "f945521d20ff629b3c1e91e56d7d59f4"
    },
    {
      "line": 146,
      "relation": "directlyDecreases",
      "evidence": "Thus, Bcl-2 must change the conformation to inhibit tBid-induced oligomerization of integral membrane Bax monomers and small oligomers. The conformationally changed Bcl-2 sequesters the integral membrane form of Bax. If Bax is in excess, apoptosis resumes as Bcl-2 is consumed by the conformational change and in complexes with Bax.",
      "citation": {
        "db": "PubMed",
        "db_id": "16642033"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 174,
      "key": "4058ee25bacd2aca6ac1180316d89f23"
    },
    {
      "line": 146,
      "relation": "directlyDecreases",
      "evidence": "Each cell is under constant surveillance to maintain the integrity of its genome. Genomic lesions in a cell\nmust be repaired before the onset of DNA replication and cell division. In the scenario that the genomic\nlesion is not repairable, the damaged cells are disposed in an orderly manner known as programmed cell\ndeath or apoptosis. Apoptosis and cell cycle progression are two intimately linked phenomena. Uncontrollable\ncell proliferation perturbs the cellular homeostasis and this can lead to malignancies, as well as organ\ndysfunction and developmental abnormalities. The biological pathway controlling cell fate is sequentially\norganized at the molecular level. Recent studies have made important contributions in advancing our\nknowledge of the mechanisms of cell cycle control and apoptosis regulation. A oncogene-derived protein,\nBcl2, confers negative control in the pathway of cellular suicide machinery. A Bcl2-homologous protein, Bax,\npromotes cell death by competing with Bcl2. While Baxâ€“Bax homodimers act as apoptosis inducers, Bcl2â€“\nBax heterodimer formation evokes a survival signal for the cells. Both Bcl2 and Bax are transcriptional targets\nfor the tumour suppressor protein, p53, which induces cell cycle arrest or apoptosis in response to DNA\ndamage. In all, the coordinate performance of these molecules is crucial for controlling life and death of a cell.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 174,
      "key": "922e21c9a543d5ec91acafae965ea88d"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "Bcl-2 or Bcl-xL to function as inhibitors of apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "10409722"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "d3378d7252ccc1ce4bcc5c783598a8e1"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "Phosphorylation of MCL-1 by GSK3b induces ubiquitinylation and subsequent degradation of this anti-apoptotic Bcl-2 protein,92,9",
      "citation": {
        "db": "PubMed",
        "db_id": "19506320"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "ea77b15489372d39707c0ccbb6169420"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "Fig. 2. Pim-1 is post-transcriptionally regulated by stabilization on the mRNA and protein level and degraded by PP2A.The phosphorylation by Pim-1 results in an inactivation of repressors or activation of transcription factors or regulatory proteins, in the stabilization of proteins, which are involved in signaling pathways and in the inactivation of pro-apoptotic proteins.",
      "citation": {
        "db": "PubMed",
        "db_id": "15694833"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "e58dc094d3fd3718ff0106170bd62716"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "To investigate how the diagrams change when reference cell line change, we constructed the Property 1 diagrams with respect to OE-Bcl2 HCT116, OE-Bcl2 SKW6.4, and OE-Bcl2 T47D cell lines (Figure S3Aâ€“C). Although the conclusions based on Figure 3 are indeed valid for HCT116 and SKW6.4 cell lines (OE-Bcl2 HCT116 cells survive, OE-Bcl2 SKW6.4 cells die), they differ for T47D cells. When using a slice of the state space based on OE-Bcl2 T47D cells, it appears that these cells are classified as exhibiting mixed-type behaviors (Figure S3C), as experimentally observed, instead of mostly type I as suggested by Figure 3.",
      "citation": {
        "db": "Other",
        "db_id": "23675292"
      },
      "annotations": {
        "doid": {
          "162": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "bba78c8d36681f6f50cf6ddf4e4d9431"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "Several studies have further suggested that the upregulation of STAT3 directly confers a drug-resistance phenotype. For example, overexpression of this transcription factor protects epidermal keratinocytes or cervical carcinoma cells from ultraviolet radiation (UV)-induced apoptosis [74,75]. In addition, STAT3 deficiency sensitizes keratinocytes to UV-induced apoptosis. Interestingly, a simple application of a naked STAT3 plasmid on the skin is sufficient to prevent the effect of irradiation. This protective effect was also confirmed in colorectal cancer cell lines where STAT3 inactivation also enhances UV-induced cell death [57]. In multiple myeloma, the aberrant activation of STAT3 has also been shown to confer resistance to FASmediated apoptosis [28]. The inhibition of STAT3 signaling downregulates the expression of survival proteins and restores the sensitivity to cell-death receptors. Furthermore, a constitutively activated form of STAT3 has been shown in vivo to protect liver cells from FAS-mediated apoptosis and necrosis [76]. This has been related to an enhanced expression of anti-apoptotic proteins such as FLICE-inhibitory protein (FLIP), BCL2, or BCL-XL and a downregulation of FADD-like interleukin-1 b-converting enzyme (FLICE) and caspase 3.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "22891274d17c40b3ab722b436907e3e9"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "Bcl2 and 4 relatives, Bcl-xl, Bcl-w, A1 and Mcl-1, promote cell survival",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "79252834ec3f24614bd91c3380ff9b2d"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "AKT2 triggers BAD phosphorylation at Ser-136, creating a binding site for 14-3-3 protein (22, 24). When BAD forms a complex with 14-3-3, it is unable to heterodimerize with and inhibit the survival activity of Bcl-XL or Bcl-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "10594016"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "94c505d3c02f297481665b27d1971f67"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "In this study, we identify, by using mass spectrometry techniques and specific anti-phosphopeptide antibodies, Ser(87) and Thr(56) as the Bcl-2 residues phosphorylated by p38 MAPK and show that phosphorylation of these residues is always associated with a decrease in the antiapoptotic potential of Bcl-2 protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "16714293"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "5c0a0eb9f4cec26ecfe15f6db657c02c"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "Pro-death Bcl-2 family members are sequestered in the cytoplasm until activated, at which time they complex with Bcl-2 or Bcl-xL and inhibit their function",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "7129aad5a811a7815c36098847fa2503"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": "from full text - STAT-3 itself induces the anti-apoptotic factors Bcl-2 and Bcl-xL",
      "citation": {
        "db": "PubMed",
        "db_id": "18666314"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 4,
      "key": "3cfb2c870e07f53cf786a21ae50a454f"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "BCL-2 inhibits apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "16457154"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "d87f162deb2cf362acd5b4ef9c61a186"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Overexpression of the proto-oncogene bcl-2 protects cells from apoptosis induced by various stimuli. Overexpression of Bcl-2 leads to almost threefold higher levels of ATP and also decreased the 3-NPA-mediated induction of hydrogen peroxide by over 50%. Bcl-2-overexpressing PC12 cells were also protected from mitochondrial DNA damage.",
      "citation": {
        "db": "PubMed",
        "db_id": "15710238"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "708ca66edef497a3b6e55b3e32b23fd0"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "% Overexpression of Bcl-2 protected keratinocytes against H2O2-induced apoptosis, indicating the anti-apoptotic effect of Bcl-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "14675202"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "7a92020bac5fb655e0a717c3c2876861"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Certain damage signals release Bmf, which then binds prosurvival Bcl-2 proteins and triggers apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "14574334"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "47ad92274ba1c9359fea236a89d7cdc2"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Figure 1. Bcl-2 and Bcl-xL inhibit caspase-3 processing and cell death in CD95-stimulated cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11801595"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "925ab3437ade80c0d8f3efe13747682c"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Serum deprived peripheral blood monocytes rapidly undergo apoptosis, but when co-cultured with human SMCs, the monocytes survive 51. This effect was found to be mediated by an increase in Bcl-2 expression and increased activity of the Akt and MAPK pathways. Furthermore, the effect was blocked by a neutralizing antibody to VCAM-1, suggesting that the VCAM-1/VLA4 interaction may be essential 51.",
      "citation": {
        "db": "PubMed",
        "db_id": "18276911"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "16c4bae34bb184d6e3fdbf9c579427f2"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "longer term effects of VEGF on cell survival may be mediated through the upregulation of the antiapoptotic proteins BCL2 and A1",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "397cff8dadd581da8c81a81aef6e8f35"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "These reported that overexpression of E2F1 suppresses the expression of two apoptotic antagonists, BCL-2 and its family member MCL-1 (myeloid leukaemia cell differentiation protein 1), thereby leading to apoptosis.In both cases, transcriptional repression is direct and dependent on the DNA-binding domain of E2F1.",
      "citation": {
        "db": "PubMed",
        "db_id": "16530485"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "3b4197f03835793159a229b19cbd593d"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Treatment of colon cancer cells with 15S-HETE inhibits cell proliferation and induces apoptosis in a PPARgamma-dependent pathway involving augmentation of TIEG and reduction of Bcl-2 expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "14566836"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "90237df844cc85d3208839768bed3e84"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "# Pubmed:gene: A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "11126360"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "a6bc581d94e7c335e7a87b9a5fac71c4"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Enforced expression of Bcl-2 protein from plasmid vectors, in contrast, abrogates sensitivity to the apoptosis promoting effects of antiestrogens in breast cancer lines, while antisense BCL-2 prevents estrogen-mediated apoptosis suppression, thus establishing a direct functional connection between ER, Bcl-2, and suppression of apoptosis (Teixeira et al., 1995). expression of Bcl-2 or Bcl-XL can be downregulated in specific types of cancer and leukemia cells by smallmolecule drugs that modulate the activity of retinoic acid receptors (RAR), retinoid X receptors (RXR), PPAR?, vitamin D receptors (VDR), and certain other members of the SRTF superfamily. RAR and RXR ligands are already approved for treatment of some types of leukemia and lymphoma, and are in advanced clinical testing for solid tumors. PPAR? modulators have demonstrated antitumor activity in xenograft models of breast and prostate cancer (Kubota et al., 1998), sometimes displaying synergy with retinoids, probably due in part to the fact that PPAR? binds DNA as a heterodimer with RXR. antiapoptotic members of the Bcl-2-family (Bcl-2, Bcl-XL, Mcl-1, Bcl-W, Bfl-1, Bcl-B)",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "8b8d5c126484949b528a3c11f63f02f1"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "VEGF upregulates Bcl-2 expression and is associated with decreased apoptosis in neuroblastoma cells",
      "citation": {
        "db": "Other",
        "db_id": "11877669"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "5d0780a55a834b1975512b6b75be0741"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Treatment with rhBCL2A1 or rhBCL2 protein protects mice from sepsis by reducing apoptosis in multiple target tissues, demonstrating an unexpected, potent activity of extracellularly administered BCL2 BH4-domain proteins.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "a7dc64046a0c31145c8d704ae51bbd07"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "BNIP3 expressed in yeast and mammalian cells interacts with survival promoting proteins Bcl-2, Bcl-X(L), and CED-9.",
      "citation": {
        "db": "PubMed",
        "db_id": "10625696"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "f20db05a85690b1aea2e6e4e1c4eb735"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis",
      "citation": {
        "db": "Other",
        "db_id": "10201940"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "c7f9ffc1904695a51ff5809806de7295"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Bcl-2 inhibits MYC-mediated apoptosis in some but not all cell systems, although having no effect on the proliferative function of c-MYC (Hoffman and Liebermann, 1998; Nilsson and Cleveland, 2003).",
      "citation": {
        "db": "PubMed",
        "db_id": "18955973"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "aa66e24550bd2a5fbe5af4cf3523f863"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Adenoviral-mediated gene transfer of Bcl-2 prevents apoptosis of neonatal ventricular myocytes induced by TNFalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "9727009"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "db7dcd00b17115e46d6daee373e4865e"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "active Raf-1 improved Bcl-2-mediated resistance to apoptosis, whereas a kinase- inactive Raf-1 mutant abrogated apoptosis suppression by Bcl-2",
      "citation": {
        "db": "PubMed",
        "db_id": "8929532"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "84bacac9157fb4a556afa2d10dddb45c"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "These results demonstrate that the up-regulation of Bcl-2 expression in endothelial cells that constitute tumor microvessels enhances intratumoral microvascular survival and density and accelerates tumor growth. Furthermore, endothelial cells that overexpress Bcl-2 have more angiogenic potential than control cells, and IL-8-neutralizing antibodies attenuate their angiogenic activity in vitro and in vivo.",
      "citation": {
        "db": "PubMed",
        "db_id": "11280784"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "13bd6d30caaabaa383d8b5d0dba191be"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Overexpression of Hsp10 and Hsp60 increased the abundance of the anti-apoptotic Bcl-xl and Bcl-2, and reduced the protein content of the pro-apoptotic Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "12967636"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "d31f63e43e92da31136554551cc25b63"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Bcl-2 and Bcl-XL prevent neuronal apoptosis during development, neurodegenerative disease, and trauma",
      "citation": {
        "db": "PubMed",
        "db_id": "11574549"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "d734c6657f9bbad31bded56b198e89c6"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1",
      "citation": {
        "db": "PubMed",
        "db_id": "8752150"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "66ccfcc2a3252517d3e93e4c0180fde7"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "expression of BAFF and APRIL receptors (B-cell maturation antigen [BCMA], transmembrane activator and calcium modulator and cyclophilin ligand interactor [TACI], and BAFF-R) in a majority of 13 myeloma cell lines and in the purified primary myeloma cells of 11 patients. APRIL and BAFF were potent survival factors for exogenous cytokine-dependent myeloma cell lines and were autocrine growth factors for the RPMI8226 and L363 autonomously growing cell lines. These factors activated nuclear factor (NF)-kappaB, phosphatidylinositol-3 (PI-3) kinase/AKT, and mitogen-activated protein kinase (MAPK) kinase pathways and induced a strong up-regulation of the Mcl-1 and Bcl-2 antiapoptotic proteins in myeloma cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15070697"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "1db9dd249e6c69dd03877f605a15d6a7"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Finally, apoptotic events elicited by TIEG overexpression can be effectively prevented by ectopic co-expression of Bcl-2",
      "citation": {
        "db": "PubMed",
        "db_id": "10471833"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "9fdf9c1e27fc0207f93311eff24b96db"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Bcl-x(L) and Bcl-2 inhibit both apoptosis and proliferation.",
      "citation": {
        "db": "PubMed",
        "db_id": "14532118"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "1702e1b7013df549e4cb683e19e52941"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Well known is the case of TNF?, produced by tumor and immune cells, which leads to the survival of cancer cells by the upregulation of antiapoptotic proteins, that is, Bcl-2 [13?15], via the activation of the nuclear factor kappa B (NF?B) [16].",
      "citation": {
        "db": "PubMed",
        "db_id": "20339581"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "fc504186a504ccefebca1d4b10acbd9c"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Overexpression of Bcl-2 blocked apoptosis induced by IFNalpha totally abolished Bak activation, as well as decreased the amount of activated Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "12881711"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "c55a03ae6f7e87e3af64bb35f568c0e6"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "Recently the bcl-2 gene has been shown to block apoptosis and thus may promote tumour development.",
      "citation": {
        "db": "PubMed",
        "db_id": "7915536"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "c90e263a1ceaae4804c5a78bfce184bf"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "from full text - Figure 1",
      "citation": {
        "db": "PubMed",
        "db_id": "16484682"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "3c08c4c172fb7e7565a17380f4f0cc3e"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "anti-apoptotic gene BCL2",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "ed2c25c37b76b2ce2a636ab0d130237b"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "c-MYC overexpression accelerated apoptosis when these cells were deprived of IL-3 (Eischen et al., 2001b). Furthermore, c-MYC overexpression suppresses Bcl-2 protein and RNA levels, and restoration of Bcl-2 protein blocks this accelerated apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "18955973"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "0f73ef81b1233db4e5e4d59a8ef3f599"
    },
    {
      "line": 294,
      "relation": "decreases",
      "evidence": "SCLC and NSCLC cells, transfected with Bcl-2 oligonucleotide antisense, showed increased susceptibility to apoptosis and reduced overall viability [61].",
      "citation": {
        "db": "PubMed",
        "db_id": "19663788"
      },
      "annotations": {},
      "source": 181,
      "target": 4,
      "key": "353554ca4fd7f60976b50db9ae4040bd"
    },
    {
      "line": 148,
      "relation": "decreases",
      "evidence": "Figure 8. Inhibition of Bid-induced Bak and Bax oligomerization by Bcl-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "12624108"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 181,
      "target": 169,
      "key": "426f65665fdbb1014b8e163f2318c390"
    },
    {
      "line": 269,
      "relation": "decreases",
      "evidence": "Enforced expression of Bcl-2 protein from plasmid vectors, in contrast, abrogates sensitivity to the apoptosis promoting effects of antiestrogens in breast cancer lines, while antisense BCL-2 prevents estrogen-mediated apoptosis suppression, thus establishing a direct functional connection between ER, Bcl-2, and suppression of apoptosis (Teixeira et al., 1995). expression of Bcl-2 or Bcl-XL can be downregulated in specific types of cancer and leukemia cells by smallmolecule drugs that modulate the activity of retinoic acid receptors (RAR), retinoid X receptors (RXR), PPAR?, vitamin D receptors (VDR), and certain other members of the SRTF superfamily. RAR and RXR ligands are already approved for treatment of some types of leukemia and lymphoma, and are in advanced clinical testing for solid tumors. PPAR? modulators have demonstrated antitumor activity in xenograft models of breast and prostate cancer (Kubota et al., 1998), sometimes displaying synergy with retinoids, probably due in part to the fact that PPAR? binds DNA as a heterodimer with RXR. antiapoptotic members of the Bcl-2-family (Bcl-2, Bcl-XL, Mcl-1, Bcl-W, Bfl-1, Bcl-B)",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "source": 182,
      "target": 4,
      "key": "4e9fe4df0cb84e8776a747f570626fc1"
    },
    {
      "line": 269,
      "relation": "decreases",
      "evidence": "We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1",
      "citation": {
        "db": "PubMed",
        "db_id": "8752150"
      },
      "annotations": {},
      "source": 182,
      "target": 4,
      "key": "6a0cbed0a24179fa9a9e0a5ce1150d0a"
    },
    {
      "line": 269,
      "relation": "decreases",
      "evidence": "hydrogen peroxide (H2O2) upregulates the expression of Bfl-1, an antiapoptotic member of the Bcl-2 family, and that this is responsible for the antiapoptotic activity of ROS",
      "citation": {
        "db": "PubMed",
        "db_id": "15592513"
      },
      "annotations": {},
      "source": 182,
      "target": 4,
      "key": "7354f9d9787194cae9de1b8d73dfb13c"
    },
    {
      "line": 269,
      "relation": "decreases",
      "evidence": "longer term effects of VEGF on cell survival may be mediated through the upregulation of the antiapoptotic proteins BCL2 and A1",
      "citation": {
        "db": "PubMed",
        "db_id": "11350732"
      },
      "annotations": {},
      "source": 182,
      "target": 4,
      "key": "2b4b65628041f1ac2308f3464b09631a"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "Bcl2 and 4 relatives, Bcl-xl, Bcl-w, A1 and Mcl-1, promote cell survival",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 4,
      "key": "30092e53fa23d64a87f0836f948be0cb"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "Several studies have further suggested that the upregulation of STAT3 directly confers a drug-resistance phenotype. For example, overexpression of this transcription factor protects epidermal keratinocytes or cervical carcinoma cells from ultraviolet radiation (UV)-induced apoptosis [74,75]. In addition, STAT3 deficiency sensitizes keratinocytes to UV-induced apoptosis. Interestingly, a simple application of a naked STAT3 plasmid on the skin is sufficient to prevent the effect of irradiation. This protective effect was also confirmed in colorectal cancer cell lines where STAT3 inactivation also enhances UV-induced cell death [57]. In multiple myeloma, the aberrant activation of STAT3 has also been shown to confer resistance to FASmediated apoptosis [28]. The inhibition of STAT3 signaling downregulates the expression of survival proteins and restores the sensitivity to cell-death receptors. Furthermore, a constitutively activated form of STAT3 has been shown in vivo to protect liver cells from FAS-mediated apoptosis and necrosis [76]. This has been related to an enhanced expression of anti-apoptotic proteins such as FLICE-inhibitory protein (FLIP), BCL2, or BCL-XL and a downregulation of FADD-like interleukin-1 b-converting enzyme (FLICE) and caspase 3.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 4,
      "key": "dae1ac115a675a5a53e18a8c5f21001b"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "Bcl-2 or Bcl-xL to function as inhibitors of apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "10409722"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 4,
      "key": "8b3a3097fc5e6e715fedeb229124d239"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "from full text - STAT-3 itself induces the anti-apoptotic factors Bcl-2 and Bcl-xL",
      "citation": {
        "db": "PubMed",
        "db_id": "18666314"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 4,
      "key": "0f55a5f2e459dc14ee5a875e50e579d2"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "We report here that the phosphorylation of BAD at Ser-155 within the BH3 domain is a second phosphorylation-dependant mechanism that inhibits the death promoting activity of BAD. Phosphorylation at Ser-155, similar to phosphorylation at SER-112 and Ser-136, inhibits BAD-induced death-promoting activity but does so in a different manner. Phosphorylation at Ser-155 does not induce 14-3-3 binding and ctoplasmic sequestration but instead directly blocks BH3-dependent dimerization with Bcl-XL. The binding of Bcl-XL by the BH3 domain may cause Bcl-XL to release APAF-1 or regulate other Bcl-XL activites resulting in a caspase 9-initiated cascade of proteolysis and induction of apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "10837486"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 4,
      "key": "fac0990df09d39a3ca391a9b16c29c40"
    },
    {
      "line": 178,
      "relation": "decreases",
      "evidence": "Pro-death Bcl-2 family members are sequestered in the cytoplasm until activated, at which time they complex with Bcl-2 or Bcl-xL and inhibit their function",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 4,
      "key": "41565d03a8e5510f49a445fc18a8107c"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "To explore this further, we have blocked endogenous ErbB3 transcription, thereby engineering tumor cells with overexpressed, fully active ErbB2 but lacking ErbB3 (T. Holbro and N.E. Hynes, unpublished data). As a consequence, these cells have decreased PI-3K/PKB signaling, a reduction in D-type cyclin levels, and show an increase in the G1 phase of the cell cycle. A main effector of ErbB signaling, the PI-3K/PKB pathway, is particularly important in mediating cell survival 103 T. Holbro et al. / Experimental Cell Research 284 (2003) 99-110 since several PKB substrates directly control various apoptotic processes. The proapoptotic Bcl family member Bad, when phosphorylated by PKB [93], is retained in the cytosol where it is unable to inhibit survival proteins like Bcl-XL on the mitochondria [94]. In normal mammary cells, blocking ErbB1 activity leads to apoptosis by lowering phospho-Bad levels, [95], a characteristic that would be extremely desirable to retain in cancer cells. Another PKB target is caspase-9, whose activation is blocked by phosphorylation [96] Members of the forkhead family of transcription factors, when phosphorylated by PKB, are retained in the cytoplasm and are unable to stimulate expression of several critical genes for apoptosis, including FasL, BIM, and others (reviewed by Brunet et al. [97]). Moreover, PKB phosphorylates IKK-alpha, which in turn inactivates IkappaB, thus leading to activation of NF-kappaB. This transcription factor upregulates levels of the prosurvival Bcl-XL protein and several inhibitors of apoptosis (IAPs) (reviewed by Datta et al. [98]). In this regard, it has been reported that cell lines overexpressing ErbB2 are resistant to TNF-induced apoptosis through a PKB/NF-B pathway [99]. Another ErbB effector protein, signal transducer, and activator of transcription (Stat) has been implicated in survival of squamous cell carcinomas of the head and neck. ErbB1, activated as a result of autocrine TGF-alpha expression in tumor cells, constitutively activates Stat3 [100]. Blocking Stat3 in vivo is associated with decreased level of the antiapoptotic Bcl-XL and increased tumor cell death [101].",
      "citation": {
        "db": "PubMed",
        "db_id": "12648469"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "7cb08327489b19c8cff0ac0a670044ce"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "# Pubmed:gene: A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "11126360"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "c32308696998ea525a7c431730daff55"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "We demonstrate that the Bfl-1 protein suppresses apoptosis induced by the p53 tumor suppressor protein in a manner similar to other Bcl-2 family members such as Bcl-2, Bcl-xL and EBV-BHRF1",
      "citation": {
        "db": "PubMed",
        "db_id": "8752150"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "f41588d3dd70933da45e7bcc069c233c"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "Bcl-x(L) and Bcl-2 inhibit both apoptosis and proliferation.",
      "citation": {
        "db": "PubMed",
        "db_id": "14532118"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "54798aec5db32e8acea57240e06e6c38"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "BNIP3 expressed in yeast and mammalian cells interacts with survival promoting proteins Bcl-2, Bcl-X(L), and CED-9.",
      "citation": {
        "db": "PubMed",
        "db_id": "10625696"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "a8654ee56c0c4c7a07df210d5d630721"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "Activated caspase-3 cleaves proteins essential for cell survival, including bcl-x(L).",
      "citation": {
        "db": "PubMed",
        "db_id": "12907145"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "6ce3a8f73c51213d2f429cb70924230b"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "Overexpression of Hsp10 and Hsp60 increased the abundance of the anti-apoptotic Bcl-xl and Bcl-2, and reduced the protein content of the pro-apoptotic Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "12967636"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "aafd78cfab805eb6b64f18ee20fc0530"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction. In the absence of CSF-1, these macrophages undergo cell death by apoptosis, whereas constitutive expression of Ets2 rescues these cells from cell death, and bcl-xL is upregulated. These results strongly suggest a novel role of Ets2 in affecting apoptosis through its regulation of Bcl-xL transcription.",
      "citation": {
        "db": "PubMed",
        "db_id": "10082528"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "ac1c2968a4ec307f4a4aece21aef674d"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "Enforced expression of Bcl-2 protein from plasmid vectors, in contrast, abrogates sensitivity to the apoptosis promoting effects of antiestrogens in breast cancer lines, while antisense BCL-2 prevents estrogen-mediated apoptosis suppression, thus establishing a direct functional connection between ER, Bcl-2, and suppression of apoptosis (Teixeira et al., 1995). expression of Bcl-2 or Bcl-XL can be downregulated in specific types of cancer and leukemia cells by smallmolecule drugs that modulate the activity of retinoic acid receptors (RAR), retinoid X receptors (RXR), PPAR?, vitamin D receptors (VDR), and certain other members of the SRTF superfamily. RAR and RXR ligands are already approved for treatment of some types of leukemia and lymphoma, and are in advanced clinical testing for solid tumors. PPAR? modulators have demonstrated antitumor activity in xenograft models of breast and prostate cancer (Kubota et al., 1998), sometimes displaying synergy with retinoids, probably due in part to the fact that PPAR? binds DNA as a heterodimer with RXR. antiapoptotic members of the Bcl-2-family (Bcl-2, Bcl-XL, Mcl-1, Bcl-W, Bfl-1, Bcl-B)",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "457baf0530b516eea3bc44989396b410"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "Figure 1. Bcl-2 and Bcl-xL inhibit caspase-3 processing and cell death in CD95-stimulated cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11801595"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "431cf2be268693c9aab14cdf023993cb"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "Transduction of proliferating CD4+ T cells with a tetracycline-regulated retrovirus encoding for a dominant-interfering, degradation-resistant I-kappaBalpha (inhibitor of kappa B alpha factor) mutant induced apoptosis. Bcl-xL features as a prominent anti-apoptotic member among a number of early CD28-inducible genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "10925251"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "1b3b02abf861200c9b5a260bba47e8b2"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "tBID-induced cell death was inhibited completely by BclxL and zVAD-fmk, partially by Bcl2, but not at all by CrmA.",
      "citation": {
        "db": "PubMed",
        "db_id": "9727492"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "d8ce7603b27175d92bd3e579cbfc59b8"
    },
    {
      "line": 324,
      "relation": "decreases",
      "evidence": "BNIP3 suppresses the anti-apoptosis activity of BCL-xL in a BH3-dependent manner",
      "citation": {
        "db": "PubMed",
        "db_id": "9575197"
      },
      "annotations": {},
      "source": 183,
      "target": 4,
      "key": "16fec9a1f427844a0a6b586df9f49368"
    },
    {
      "line": 179,
      "relation": "directlyDecreases",
      "evidence": "NF?B family transcription factors can induce expression of antiapoptotic proteins that oppose the intrinsic (Bcl-XL, Bfl-1), extrinsic (FLIP), and convergence (cIAP2) pathways (Figure 2A), as well as suppressing expression of the death inducer Bax (intrinsic pathway) in some types of tumor cells (Karin and Lin, 2002). Further, hyperactivity of NF?B is now well documented in certain cancers (Karin et al., 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 174,
      "key": "c9780a254cf741bb41b1fd0e66295d62"
    },
    {
      "line": 179,
      "relation": "directlyDecreases",
      "evidence": "We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 174,
      "key": "a0106ce1a355801324675aeb64e105cc"
    },
    {
      "line": 180,
      "relation": "directlyDecreases",
      "evidence": "We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 183,
      "target": 169,
      "key": "de1bc065ac647ff009757c21b843721c"
    },
    {
      "relation": "hasVariant",
      "source": 184,
      "target": 185,
      "key": "c62b5da8a6efad959338890795819178"
    },
    {
      "relation": "hasVariant",
      "source": 184,
      "target": 186,
      "key": "b3b7e1ff91295f39015a1638809cfd79"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "It remains to be determined what the role of Ser-62 phosphorylation is in promoter selection or whether the phosphorylation is the consequence of targeting MYC to specific DNA sequences. Furthermore MYC mutated at Thr-58 fails to activate the expression of BIM, a proapoptotic BH3-only BCL2 family member, resulting in reduced apoptosis and enhanced tumorigenesis (38). Although MYC stimulates apoptosis by regulating many different genes (39, 40), MYC-stimulated expression of BIM is particularly relevant for repression of tumor development (41). BIM functions as a tumor suppressor, at least in MYC-driven B cell leukemia. This is independent of the status of the p53 tumor suppressor pathway that is viewed as an important mediator of MYC-induced apoptosis (39, 40).",
      "citation": {
        "db": "PubMed",
        "db_id": "16987807"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "ff532b7bc4cda609aaddfcba655f03cd"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "FoxO and RUNX3, a Runt domain-containing transcription factor, interact and bind concomitantly to the promoter of BIM, a pro-apoptotic Bcl-2 family member, which contains one FoxO binding site and two RUNX3- binding domains in close proximity (Figure 5). FoxO and RUNX3 cooperate to upregulate this pro-apoptotic gene and consequently promote apoptosis in gastric cancer cells (Yamamura et al., 2006).",
      "citation": {
        "db": "PubMed",
        "db_id": "18391970"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "884c162fad98555594af1311028bd257"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "Here, we show that RhoB activity increases in human breast and cervical cancer cell lines after treatment with DNA damaging agents. Furthermore, RhoB activity is necessary for DNA damage-induced cell death, as the stable loss of RhoB protein expression using shRNA partially protects cells and prevents the phosphorylation of c-Jun N-terminal kinases (JNKs) and the induction of the pro-apoptotic protein Bim after IR.",
      "citation": {
        "db": "PubMed",
        "db_id": "21373644"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "6ab3568e0a1a4d405c92d0174e9b7276"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "BH3-only proteins are members of the BCL- 2 protein family; they trigger apoptosis and integrate diverse apoptotic stimuli into a common cell-death pathway that is governed by other multidomain BCL-2 family members.",
      "citation": {
        "db": "PubMed",
        "db_id": "16530485"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "4c2084567160d4fe5ad4b37a11a40aa2"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "The forkhead box class O (FOXO) transcription factors family members, FOXO1a and FOXO3a, are phosphorylated in an AKT-dependent manner in SCF-stimulated BMMCs [76]. FOXO3a phosphorylation leads to its proteosomal degradation following ubiquitination thereby blocking its transcriptional control of the pro-apopototic factor, Bim. SCF also induces the AKT- and MAPK-dependent phosphorylation of Bim in mouse bone marrow-derived mast cells and it has been proposed that this also leads to its proteosomal degradation [76]. Thus these observations would account for the ablity of PI3K-AKT driven pathways to promote mast cell survival.",
      "citation": {
        "db": "PubMed",
        "db_id": "18775670"
      },
      "annotations": {
        "cl": {
          "0000097": true
        }
      },
      "source": 184,
      "target": 4,
      "key": "f0f7aa2211a40aed1c6c4ae771bd042c"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "In healthy cells, most Bim molecules were bound to LC8 cytoplasmic dynein light chain and thereby sequestered to the microtubule-associated dynein motor complex. Certain apoptotic stimuli disrupted the interaction between LC8 and the dynein motor complex.",
      "citation": {
        "db": "PubMed",
        "db_id": "10198631"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "5c12dc0dd2c8741375503bd53205cc6e"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "In MCF-7 cells, which were paclitaxel sensitive, the already high basal levels of FoxO3a and Bim protein increased dramatically after drug treatment, as did Bim mRNA, which correlated with apoptosis induction. This is the first demonstration that upregulation of FoxO3a by paclitaxel can result in increased levels of Bim mRNA and protein which can be a direct cause of apoptosis in breast cancer cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "14527951"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "c5e7d7f81b2d39f0f3141c549fba55b2"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "This resulted in the increased constitutive expression of the FKHRL1 targets Fas ligand and Bim, and promoted apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12970676"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "4eefc9565f35983eaafc9d1a0b80be81"
    },
    {
      "line": 143,
      "relation": "increases",
      "evidence": "Using reporter gene assays, we demonstrate that STI571 and FoxO3a activate Bim transcription through a FoxO-binding site (FHRE) located within the promoter.",
      "citation": {
        "db": "PubMed",
        "db_id": "15688014"
      },
      "annotations": {},
      "source": 184,
      "target": 4,
      "key": "331380880c0064c2d7b0980d29c49c88"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "Notably, Bim is the most downstream apoptotic effector of the TGFb pathway, and its downmodulation abrogates TGFb-dependent apoptosis in Snu-16 cells (Ohgushi et al., 2005).",
      "citation": {
        "db": "PubMed",
        "db_id": "18328430"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "27a3e52573369cd9342a5bf716e26e7c"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "Despite the fact that Siva-1 does not belong to the BCL-2 family, it specifically interacts with the anti-apoptotic protein BCL-XL and sensitizes MCF7 breast cancer cells expressing BCL-XL to UV radiation induced apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "14739602"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "9147f7bd87166cac5df5a7f20af9daa5"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "cdbb1432b7fdbd220bd7db009189e458"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "Mcl-1 binds to the BH3-only proteins Bim, Bid, Bik, Noxa and Puma (Chen et al., 2005), as well as Bak (Cuconati et al., 2003). Binding to Bid and Bim protects against tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-induced cell death. Either depletion of Mcl-1 (Nijhawan et al., 2003) or disruption of the interaction between Mcl-1 and Bak coincides with apoptosis following a cytotoxic stimulus",
      "citation": {
        "db": "PubMed",
        "db_id": "17404574"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "64fd570c61d7f236455621e983db8da2"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "BH3-only protein Bim and possibly also Bmf are critical initiators of spontaneous and drug-induced apoptosis of granulocytes, whereas",
      "citation": {
        "db": "PubMed",
        "db_id": "12433687"
      },
      "annotations": {
        "cl": {
          "0000094": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "ffa3a8c99b320a1aac7b5026f7c804c4"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "RUNX3-induced apoptosis depended on the expression of Bim, a proapoptotic BH3-only protein, and both RUNX3 and FoxO3a/FKHRL1 were required for induction of Bim expression.... In the Bim promoter, RUNX3 bound to two conserved RUNX-binding elements (RBE1 and RBE2), with RBE1 being immediately downstream of a FoxO-binding element.",
      "citation": {
        "db": "PubMed",
        "db_id": "16373335"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "d19578ab8620559e440d8ec992c187a7"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "JNK phosphorylates two members of the BH3-only subgroup of Bcl2-related proteins (Bim and Bmf)",
      "citation": {
        "db": "PubMed",
        "db_id": "12591950"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 4,
      "key": "04013e76c8e6f663f6963e0fe7d2861b"
    },
    {
      "line": 149,
      "relation": "directlyIncreases",
      "evidence": "We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 174,
      "key": "0b315dbeccb950e203841dde7e674294"
    },
    {
      "line": 150,
      "relation": "directlyIncreases",
      "evidence": "We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 184,
      "target": 169,
      "key": "22368e7243ef70a734779822d1d7bd4b"
    },
    {
      "line": 363,
      "relation": "decreases",
      "evidence": "In contrast, loss of the ERK MAP kinase phosphorylation sites encoded by exon 3, caused by substitution of Ser-55/65/73 with Ala residues (Bim3SA) or deletion of exon 3 (Bim-EL), increased serum withdrawal-induced apoptosis (Figure 6D). This increased apoptotic response is consistent with the hypothesis that the MAP kinase phosphorylation sites encoded by exon 3 act to inhibit Bim function. These phosphorylation sites may reduce Bim apoptotic activity by causing proteasomal degradation of Bim (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "18498746"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 185,
      "target": 184,
      "key": "af30367e0aece51dbe389bae2dd7cb52"
    },
    {
      "line": 214,
      "relation": "directlyIncreases",
      "evidence": "These data demonstrate that BimL is phosphorylated in vivo on Thr-56 and that JNK also phosphorylates BimL on at least one serine residue (Ser-44 and/or Ser-58)...JNK Phosphorylation of Bim on Thr-56 Increases Apoptotic Activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12591950"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 186,
      "target": 184,
      "key": "c921ea8e4d000af1164cac4c21c7ca44"
    },
    {
      "line": 366,
      "relation": "directlyIncreases",
      "evidence": "We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 174,
      "key": "e34859db33a0b13af941f4479720026e"
    },
    {
      "line": 367,
      "relation": "directlyIncreases",
      "evidence": "We examined direct activation of Bax or cBak by each BH3 peptide and found that the direct activation profile of cBak in response to various BH3 peptides was similar to that for Bax; Bim BH3 exhibited the highest degree of activation, Bid, Bmf, and Noxa BH3 constituted the next highest group, then, the group of Bik, Hrk and Puma BH3, and Bad BH3 showed the lowest activation (Fig. 3, B and C).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 169,
      "key": "223fa98a8bbbaa8ee5dcd751e27ceeb7"
    },
    {
      "line": 368,
      "relation": "increases",
      "evidence": "another family share only the short BH3 domain, which is necessary and probably sufficient for their killing activity this family contains Bim, Bik, Bad, Puma, Bid, Noxa, Hrk, and Bmf",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 4,
      "key": "6eba673d7939f7e3091a7d1dc15f7021"
    },
    {
      "line": 368,
      "relation": "increases",
      "evidence": "STAT3 is also able to prevent cell death through inhibition of the extrinsic apoptotic pathway. This pathway is activated upon binding of extracellular ligands such as FAS ligand (FAS-L) to cell-surface death receptors. Upon interaction with FAS-L, the FAS death receptor induces cell death through caspase-8 activation and truncation of the death agonist BID.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 4,
      "key": "d6f3b3395c8016549442194b275bff06"
    },
    {
      "line": 368,
      "relation": "increases",
      "evidence": "Mcl-1 binds to the BH3-only proteins Bim, Bid, Bik, Noxa and Puma (Chen et al., 2005), as well as Bak (Cuconati et al., 2003). Binding to Bid and Bim protects against tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-induced cell death. Either depletion of Mcl-1 (Nijhawan et al., 2003) or disruption of the interaction between Mcl-1 and Bak coincides with apoptosis following a cytotoxic stimulus",
      "citation": {
        "db": "PubMed",
        "db_id": "17404574"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 4,
      "key": "d9d722e4ef2256132f6fe4421e544cf9"
    },
    {
      "line": 368,
      "relation": "increases",
      "evidence": "Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage.",
      "citation": {
        "db": "PubMed",
        "db_id": "15326164"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 28,
      "target": 4,
      "key": "21d5e02e172ae2637957c6db1190882b"
    },
    {
      "line": 209,
      "relation": "decreases",
      "evidence": "Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "source": 110,
      "target": 4,
      "key": "16bad7485dedb47622544ab08dcd9568"
    },
    {
      "line": 209,
      "relation": "decreases",
      "evidence": "As shown in Fig. 3A, MIHA, MIHB, and OpIAP significantly reduced the amount of death caused by ICE, whereas MIHC did not provide detectable protection.",
      "citation": {
        "db": "PubMed",
        "db_id": "8643514"
      },
      "annotations": {},
      "source": 110,
      "target": 4,
      "key": "898e1a10f7534d89493e45fb12576452"
    },
    {
      "line": 157,
      "relation": "decreases",
      "evidence": "(2) Inhibitor of apoptosis protein (IAP) family members, inhibitor of apoptosis protein1 (cIAP1), and X-chromosome-linked IAP, are expressed in rat hepatocytes. cIAP2 is induced by cytokines in an NF-kappaB-dependent manner and overexpression of cIAP2 inhibits apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12044523"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "source": 111,
      "target": 4,
      "key": "4ecee830a52f0d2258b27cfdeb1a5b7a"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Survivin is a member of the inhibitor of apoptosis protein (IAP) family. We investigated the antiapoptotic mechanism of Survivin, as well as its expression in 60 human tumor cell lines used for the National Cancer Institute's anticancer drug screening program. In cotransfection experiments, cell death induced by Bax or Fas (CD 95) was partially inhibited (mean Â± SD, 65% Â± 8%) by Survivin, whereas XIAP, another IAP family member, almost completely blocked cell death (93% Â± 4%) under the same conditions. Survivin and XIAP also protected 293 cells from apoptosis induced by overexpression of procaspase-3 and -7 and inhibited the processing of these zymogens into active caspases. In vitro binding experiments indicated that, like other IAP-family proteins, Survivin binds specifically to the terminal effector cell death proteases, caspase-3 and -7, but not to the proximal initiator protease caspase-8. Using a cell-free system in which cytosolic extracts were derived from control- or Survivin-transfected cells and where caspases were activated either by addition of cytochrome c and dATP or by adding recombinant active caspase-8, Survivin was able to substantially reduce caspase activity, as measured by cleavage of a tetrapeptide substrate, AspGluValAsp-aminofluorocoumarin. Similar results were obtained in intact cells when Survivin was overexpressed by gene transfection and caspase activation was induced by the anticancer drug etoposide. Survivin was expressed in all 60 cancer cell lines analyzed, with highest levels in breast and lung cancers and lowest levels in renal cancers. These findings indicate that Survivin, which is commonly expressed in human tumor cell lines, can bind the effector cell death proteases caspase-3 and -7 in vitro and inhibits caspase activity and cell death in cells exposed to diverse apoptotic stimuli. Although quantitative differences may exist, these observations suggest commonality in the mechanisms used by IAP-family proteins to suppress apoptosis.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "0b79d1830f9161e9f48887d39d48c808"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Survivin is a bifunctional protein that acts as a suppressor of apoptosis and plays a central role in cell division. The protein is strongly expressed in the most common human neoplasms, has prognostic relevance for some of them and appears to be involved in tumor cell resistance to anticancer agents and ionizing radiation. On the basis of these findings, survivin has been proposed as an attractive target for new anticancer interventions. Several preclinical studies have demonstrated that down-regulation of survivin expression or function, accomplished by means of various strategies, reduced tumor growth potential, increased the apoptotic rate and sensitized tumor cells to chemotherapeutic drugs and radiation in different human tumor models. Moreover, the first survivin inhibitors recently entered clinical trials. Recent studies suggest a possible role for survivin in regulating the function of normal adult cells. However, the expression and function of survivin in normal tissues are still not well characterized and understood. Better knowledge of the role of survivin in tumor versus normal cells will be instrumental for the design of optimal strategies to selectively disrupt survivin in cancer.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "85e94c7b953549d467fcc0c4285ed6eb"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Transfection of siRNA for XIAP or survivin individually resulted in a partial abrogation of the antiapoptotic effects of nicotine",
      "citation": {
        "db": "PubMed",
        "db_id": "16601104"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "c5e719f0533135028c81b4e23b930e33"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Phosphorylation of survivin at Thr34, probably by Cdc2, is required for its anti-apoptotic activity",
      "citation": {
        "db": "PubMed",
        "db_id": "12773388"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "9b97acbf277927dc006b68d61fe0ea82"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "from full text - survivin is one of the most tumour-specific molecules (19), which antagonizes apoptosis (7), promotes tumour-associated angiogenesis (20) (BIRC5 = survivin)",
      "citation": {
        "db": "PubMed",
        "db_id": "18075512"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "9711f2d86a1be9409013901bd7ce1312"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "reduced survivin levels by combined genistein and tamoxifen was attributed to apoptosis in breast cancer cells [30]",
      "citation": {
        "db": "PubMed",
        "db_id": "20517637"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "d80ef8acfb5438a48c1bdbc42c50d938"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "a9b2eff74737f88a8c3bde033901b8b6"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Regulators of apoptosis are thought to work in concert, but the molecular interactions of this process are not understood. Here, we show that in response to cell death stimulation, survivin, a member of the inhibitor of apoptosis (IAP) gene family, associates with another IAP protein, XIAP, via conserved baculovirus IAP repeats. Formation of a survivin-XIAP complex promotes increased XIAP stability against ubiquitination/proteasomal destruction and synergistic inhibition of apoptosis, which is abolished in XIAPâ€“/â€“ cells. Therefore, orchestration of an IAP-IAP complex regulates apoptosis.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "aadab8633bc703101c66aa674b49a7d2"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "induction of a natural antisense of survivin, effector cell protease receptor-1 (EPR-1), in a human colon cancer cell line resulted in a downregulation of survivin expression, with a similar decrease in cell proliferation, an increase in apoptosis and an increase in the sensitivity to anticancer agents.",
      "citation": {
        "db": "PubMed",
        "db_id": "12441269"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "3ac1580ec0d75c12161728b9edbc67e4"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "These findings suggest that survivin expression played an important role in protecting the NNK-exposed HBE cells against apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "18635526"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "de31500b8d274cbcf3246cdf9efce469"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Survivin was detected in CD68-positive macrophages infiltrating human lipid streaks by immunohistochemistry. In advanced atherosclerotic plaques, only rare macrophages outside the necrotic core or occasional fibrous cap smooth muscle cells expressed survivin. In vitro, macrophage colony-stimulating factor-stimulated mouse macrophage survivin expression, proliferation and resistance to apoptosis. Conversely, prolonged oxidized low-density lipoprotein treatment abolished macrophage survivin expression and triggered apoptosis after 12 hours, despite enhanced XIAP and cIAP2 expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "17255535"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "5aa4c4b1e6e8a779e29158a59804aa57"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "In our study, we show that human survivin is the immediate downstream effector of the Cdc2/Cdk1 mediated survival signal. Survivin cooperates with Cdc2/Cdk1 to inhibit apoptosis following chemotherapy and promote senescence escape",
      "citation": {
        "db": "PubMed",
        "db_id": "20503268"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "340429e8bd3dc21f971e3011e046ccc5"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Survivin is a recently discovered protein belonging to the inhibitor of apoptosis (IAP) gene family. IAP molecules are characterized by both the presence of a zinc-binding fold termed the baculoviral IAP repeat and the ability to suppress apoptosis. In addition to inhibiting apoptosis, survivin is essential for proper cell division. Survivin is expressed during embryonal development but is absent in most normal, terminally differentiated tissues. Survivin is also upregulated in a variety of human cancers, and its expression in tumors is associated with a more aggressive phenotype, shorter survival times, and a decreased response to chemotherapy. The exact mechanism behind the ability of survivin to inhibit apoptosis is still unclear. Furthermore, it is not known why this protein is upregulated in cancer. The purpose of this article is to provide an overview of the current knowledge of survivin, including its role in cell division and its expression in normal and neoplastic tissues. Although much of the current research in this field is focused on human medicine, this area also has potential significance for veterinary species.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "5325b015aa58a9a5378d6c06e23d1301"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Survivin (BIRC5), a member of the inhibitor of apoptosis protein (IAP) family that inhibits caspases and blocks cell death is highly expressed in cancer and is associated with a poorer clinical outcome. Functioning simultaneously during cell division and apoptosis inhibition, survivin plays a pivotal role in determining cell survival. Survivin has consistently been identified by molecular profiling analysis to be associated with higher tumor grade, more advanced disease, abbreviated survival, accelerated rates of recurrence, and chemotherapy and radiation resistance. Survivin's differential expression in cancer compared to normal tissue and its role as a nodal protein in a number of cellular pathways make it a highly flexible therapeutic target, suitable for small-molecule inhibitiors, molecular antagonists, and vaccination-based therapies. By targeting survivin it is hoped that multiple tumor signaling circuitries may be simultaneously disabled. This effect may be applicable to many tumor histologies irrespective of specific genetic makeup. To date, survivin inhibitors have shown modest activity as single agents, but it is anticipated that when given in combination with cytotoxic chemotherapy or monoclonal antibodies they may exhibit enhanced efficacy. This review discusses the complex circuitry of survivin in human cancers and highlights clinical trials involving novel agents that target this important protein.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "e2467ea4d148ea4b85fa88239ae76b72"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "Evasion of apoptosis is a hallmark of cancer, but the molecular circuitries of this process are not understood. Here we show that survivin, a member of the inhibitor of apoptosis gene family that is overexpressed in cancer, exists in a novel mitochondrial pool in tumor cells. In response to cell death stimulation, mitochondrial survivin is rapidly discharged in the cytosol, where it prevents caspase activation and inhibits apoptosis. Selective targeting of survivin to mitochondria enhances colony formation in soft agar, accelerates tumor growth in immunocompromised animals, and abolishes tumor cell apoptosis in vivo. Therefore, mitochondrial survivin orchestrates a novel pathway of apoptosis inhibition, which contributes to tumor progression.",
      "citation": {
        "db": "Other",
        "db_id": "15489959"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "5cd0ad3d2077fbd099a6aa38b2e1da89"
    },
    {
      "line": 278,
      "relation": "decreases",
      "evidence": "STAT3 inhibition markedly decreased survivin expression, and forced expression of survivin rescued AGS cells from apoptosis induced by STAT3 inhibition.",
      "citation": {
        "db": "PubMed",
        "db_id": "15077160"
      },
      "annotations": {},
      "source": 113,
      "target": 4,
      "key": "ac2440d83bfcb8b686e9b25527df7ecb"
    },
    {
      "line": 279,
      "relation": "directlyDecreases",
      "evidence": "binds caspase-3 and -7 tightly with dissociation constants of 20.9 and 11.5 nM,.... Consistently, survivin potently inhibits the cleavage of a physiological substrate poly(ADP-ribose) polymerase and an artificial tetrapeptide by caspase-3 and -7 in vitro with apparent inhibition constants of 36.0 and 16.5 nM, respectively.",
      "citation": {
        "db": "PubMed",
        "db_id": "11170436"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 113,
      "target": 59,
      "key": "8febb964227142b7246f6014900cdfad"
    },
    {
      "line": 311,
      "relation": "increases",
      "evidence": "Caspase-mediated cleavage of Etk generated a C-terminal fragment, containing the complete SH2 and tyrosine kinase domains, but without intact pleckstrin homology and SH3 domains. This fragment has 4-fold higher kinase activity than that of the full-length Etk.",
      "citation": {
        "db": "PubMed",
        "db_id": "11278797"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 31,
      "target": 4,
      "key": "c0408375384865c1beecc682a21bc34b"
    },
    {
      "line": 311,
      "relation": "increases",
      "evidence": "The observed Etk-enhanced MDA-MB-468 cell apoptosis is associated with the Stat1 activation, as demonstrated by electrophoresis mobility shift assays and reporter gene assays.",
      "citation": {
        "db": "PubMed",
        "db_id": "14676838"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 31,
      "target": 4,
      "key": "c139491842ae98860779661fe7c1232a"
    },
    {
      "line": 311,
      "relation": "increases",
      "evidence": "The expression of wild type Bmx in 32D myeloid progenitor cells resulted in apoptosis in the presence of G-CSF, while cells expressing a kinase dead mutant of Bmx differentiated into mature granulocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "10962576"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 31,
      "target": 4,
      "key": "86dd5b2c687547f12773e518f700753e"
    },
    {
      "line": 15,
      "relation": "increases",
      "evidence": "Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. CASP3 was shown to cleave and activate caspases 6, 7 and 9, and itself could be processed by caspases 8, 9 and 10.",
      "citation": {
        "db": "PubMed",
        "db_id": "12687019"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 59,
      "key": "3d24dec88f1a4a08aee55dababde301b"
    },
    {
      "line": 15,
      "relation": "increases",
      "evidence": "A selective inhibitor of caspase-10, Z-AEVD-FMK, effectively blocked caspase-3 activation and significantly attenuated As(2)O(3)-triggered apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12388546"
      },
      "annotations": {
        "doid": {
          "1240": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 59,
      "key": "d48975685712048dad086c86cfee4021"
    },
    {
      "line": 162,
      "relation": "increases",
      "evidence": "we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3beta inhibitors lithium chloride and SB216763, and by GSK-3beta knockdown using short interfering RNA.",
      "citation": {
        "db": "PubMed",
        "db_id": "17666435"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 58,
      "target": 4,
      "key": "335ddcebe9cea61bef360e03992a6188"
    },
    {
      "line": 162,
      "relation": "increases",
      "evidence": "initiator caspases - casp8,10,9,1,5a,4a,12a,2",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 58,
      "target": 4,
      "key": "6c75063fc532ab57ff85c633e7e18972"
    },
    {
      "line": 162,
      "relation": "increases",
      "evidence": "We report here that expression of the NRIF3 family of transcriptional coregulators in a variety of breast cancer cell lines induces rapid and profound apoptosis (nearly 100% cell death within 24 h). Mechanistic studies showed that DD1-induced apoptosis occurs through a novel caspase 2-mediated pathway that involves mitochondrial membrane permeabilization but does not require other caspases. Interestingly, the cytotoxicity of NRIF3 and DD1 appears to be cell type specific, as they selectively kill breast cancer or related cells but not other examined cells of different origins",
      "citation": {
        "db": "PubMed",
        "db_id": "15082778"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 58,
      "target": 4,
      "key": "b5e9ba76a8a9ef6cd8df55c51552036a"
    },
    {
      "line": 42,
      "relation": "directlyDecreases",
      "evidence": "Mechanistically, vIAP targets two critical arms of the early and late cellular apoptotic response. It acts as a protein bridge to help target Bcl-2 to activated caspase-3 to inhibit its function as an effector of cell death  #[JL] caspase 3 converts BCL2 to a pro-apoptotic form",
      "citation": {
        "db": "PubMed",
        "db_id": "12794189"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 181,
      "key": "142c33d0a5ae6ce5176dd71d5e1fd584"
    },
    {
      "line": 43,
      "relation": "directlyIncreases",
      "evidence": "Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation.",
      "citation": {
        "db": "PubMed",
        "db_id": "10490026"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 66,
      "key": "0f9296a75074922dd00a6009ed4d303d"
    },
    {
      "line": 44,
      "relation": "increases",
      "evidence": "ROCK I is cleaved by caspase-3 at a conserved DETD1113/G sequence and its carboxy-terminal inhibitory domain is removed, resulting in deregulated and constitutive kinase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "11283607"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 59,
      "target": 26,
      "key": "c970e28c86ae31bb9aa15dbf11ab04c4"
    },
    {
      "line": 44,
      "relation": "increases",
      "evidence": "Two potential sites of caspase cleavage, resembling the prototypical caspase-3 cleavage sequence DEVD, are situated in this region in both human and mouse ROCK I, at positions 1110-1113 (DETD) and 1155-1158 (DEQD), respectively.",
      "citation": {
        "db": "PubMed",
        "db_id": "11283606"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 59,
      "target": 26,
      "key": "b9268b584cb8777e699be9866c7814d7"
    },
    {
      "line": 45,
      "relation": "directlyIncreases",
      "evidence": "figure 1 - conservation of caspase clevage sites",
      "citation": {
        "db": "PubMed",
        "db_id": "11973607"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 59,
      "target": 122,
      "key": "30f6414a8150077254ef66ca00e40122"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Caspase-8, caspase-7, and caspase-3 were involved in the induction of apoptosis (Fig. 5AGo), and this activity was observed within 1 h of TRAIL activation. In contrast, no activation of any caspase was detected in TECs not exposed to cytokines,. This supports that TRAIL signal transduction in TEC cells is blocked before caspase-8 activation. A gradual decrease in the concentration of full-length Bid in response to TRAIL is due to the cleavage of Bid by caspase-8 (Fig. 5AGo).",
      "citation": {
        "db": "PubMed",
        "db_id": "14715858"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "77a306814015e376472eb91b5a99eb5f"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Through cleavage of a distinct subset of cellular substrates, caspase-3 initiates many of the key changes witnessed during apoptosis, thus explaining how a diverse range of stimuli manifest identical phenotypic outcomes during cell death (13).",
      "citation": {
        "db": "PubMed",
        "db_id": "12748058"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "f0c0b0ea0b8c096f92e28a3d90b358ff"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice.",
      "citation": {
        "db": "PubMed",
        "db_id": "19570263"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "cd370775696b88c6cc8bad71031c723e"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "executioner caspases - casp3,6,7",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "bae798a790116be9446b3a84596788f8"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "The anti-caspase-3 effect of A1AT was further tested in vivo in the mouse lung...intramuscular administration of hA1AT-AAV serotype 5, which leads to persistent hA1AT expression,(27) inhibited apoptotic airspace destruction and oxidative stress (measured by catalase activity assay) caused by subsequent direct instillation of active caspase-3 into the mouse lung28 (Figure 7, a? d).",
      "citation": {
        "db": "PubMed",
        "db_id": "17003475"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "1beff6420df810db7c51ec11684fbc25"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema.",
      "citation": {
        "db": "PubMed",
        "db_id": "15944319"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "c21be2e55280a606dacf207b25ae9bc8"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Functionally, SMC proliferation was decreased by FSS (P < .001), and recombinant TFPI-2 was found to inhibit SMC proliferation (P < .001) and induce SMC apoptosis as indicated by activation of caspase-3 (P < .01)",
      "citation": {
        "db": "PubMed",
        "db_id": "20537494"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "4e6d7097ec8d4497e1116e3348e943c4"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "by Western analysis, electron microscopy, and immunoflourescence, there is increased expression of the autophagic proteins LC3B-II/LC3B-I, Atg4, Atg5-artg12, and Atg7, as well as increased numbers of different stages of autophagic vacuoles in the lungs of COPD patients in all GOLD categories, with a corresponding increase in caspase 3 activity, a marker of apoptosis in GOLD 3/4 patients.54",
      "citation": {
        "db": "PubMed",
        "db_id": "21857781"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "ac79f63b6c61d34a991b54ba1ebdb52a"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "KO mice showed a significantly greater infarction volume and DNA fragmentation in the cortex than WT mice at 24 hours after ischemia. At 8 hours, cytochrome c release into the cytoplasm was markedly higher in KO mice than in WT mice. Caspase-3 activation was also significantly enhanced in KO mice versus WT mice the deletion of the hsp70.1 gene increases cytochrome c release into the cytoplasm and subsequent caspase-3 activation, thereby exacerbating apoptosis after focal cerebral ischemia.",
      "citation": {
        "db": "PubMed",
        "db_id": "15243143"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "f8b09ce20d30bbabc41d71113cf9691f"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Activated caspase-9 subsequently activates caspase-3, an effector caspase, and then this, in turn, cleaves cellular substrates, leading to apoptosis [17].",
      "citation": {
        "db": "PubMed",
        "db_id": "19663788"
      },
      "annotations": {
        "doid": {
          "1909": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "728a4b85810495af20802ec4c065f987"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Cerulenin treatment caused a rapid release of cytochrome c from the mitochondrial intramembrane space into the cytosol followed by activation of caspases 9 and 3.",
      "citation": {
        "db": "PubMed",
        "db_id": "12181752"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "6477aeb9d9ede7bb9f7f8f5ff6c4896e"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Caspase 3 and 8 activation was also detected in the neo control cells after treatment with TRAIL, demonstrating the rapid activation of the caspase cascade similar to that seen with other death receptors. Bcl-2 overexpression in these cells blocked activation of these caspases, suggesting that bcl-2 expression of human cancer cells may be a critical factor in the therapeutic efficacy of TRAIL.",
      "citation": {
        "db": "PubMed",
        "db_id": "11439339"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "f4144476f8bfdc0caf6d11ebb62c28c4"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Exposure of hBEC to CS or CS extract (CSE) caused expression of endogenous ER stress markers GRP78 and CHOP and induction of apoptosis evidenced by nuclear condensation, membrane blebbing, and activation of caspase-3 and caspase-4",
      "citation": {
        "db": "PubMed",
        "db_id": "18394432"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "d22342d36a38894308b971d999cc8fcb"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Several studies have further suggested that the upregulation of STAT3 directly confers a drug-resistance phenotype. For example, overexpression of this transcription factor protects epidermal keratinocytes or cervical carcinoma cells from ultraviolet radiation (UV)-induced apoptosis [74,75]. In addition, STAT3 deficiency sensitizes keratinocytes to UV-induced apoptosis. Interestingly, a simple application of a naked STAT3 plasmid on the skin is sufficient to prevent the effect of irradiation. This protective effect was also confirmed in colorectal cancer cell lines where STAT3 inactivation also enhances UV-induced cell death [57]. In multiple myeloma, the aberrant activation of STAT3 has also been shown to confer resistance to FASmediated apoptosis [28]. The inhibition of STAT3 signaling downregulates the expression of survival proteins and restores the sensitivity to cell-death receptors. Furthermore, a constitutively activated form of STAT3 has been shown in vivo to protect liver cells from FAS-mediated apoptosis and necrosis [76]. This has been related to an enhanced expression of anti-apoptotic proteins such as FLICE-inhibitory protein (FLIP), BCL2, or BCL-XL and a downregulation of FADD-like interleukin-1 b-converting enzyme (FLICE) and caspase 3.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "645037cf4c96a18dff781a366c51d801"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "% A conjugate of doxorubicin and glutathione via glutaraldehyde (GSH-DXR) % inhibited glutathione S-transferase (GST) activity of rat hepatoma AH66 % cells, and treatment of the cells with GSH-DXR induced caspase-3 activation % and DNA fragmentation. Caspase-3 activation and DNA fragmentation were induced % following the suppression of GST-P expression by treatment with GSH-DXR.",
      "citation": {
        "db": "PubMed",
        "db_id": "11668494"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "39c98c323f3533f0fbe27c7d82311091"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "We provide data showing that 1. A modified caspase-3 containing beta-secretase cleavage site induces apoptosis in 293T cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11439695"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "3dce55f909ef614b661c7067a2de6f1f"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Up-regulation of p53 directly promotes Bax expression, which changes the integrity of mitochondria, leading to release of cytochrome c, activation of caspase-3 and eventually execution of apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "16000378"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "e50cdc906aea9705115400e69a10c4d0"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Preincubation with the caspase-9 inhibitor z-LEHD-fmk, the caspase-3 inhibitor z-DEVD-fmk, or the specific pan-caspase inhibitor Q-VD-oph decreased the percentage of propidium iodide-positive neurons",
      "citation": {
        "db": "PubMed",
        "db_id": "19235896"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "4794b18bd82d97b51910408dbe18ab54"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Upon activation of pro-apoptotic cell signaling, survivin is released from the mitochondria and inhibits caspases- 3 and -9.",
      "citation": {
        "db": "PubMed",
        "db_id": "21470426"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "2e162e7f727c98ec9c0a766415ededc2"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Combination treatment with LY294002 and TRAIL increased apoptosis of SK-N-SH cells compared with TRAIL alone; these results were further corroborated by complete inhibition of apoptosis by caspase-3 or pan-caspase inhibitor.",
      "citation": {
        "db": "PubMed",
        "db_id": "15065019"
      },
      "annotations": {
        "doid": {
          "769": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "fd77b788437121060614b28319dd44e5"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "The cytosolic protein APAF1, human homolog of C. elegans CED-4, participates in the CASPASE 9 (CASP9)-dependent activation of CASP3 in the general apoptotic pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "9753320"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "563483497d10eac6f022941c423271ef"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Also cathepsin L participates in cell apoptosis mediated by caspase III activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "10470376"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 4,
      "key": "861f604235b1b1f5a3df0b2f2dec06f0"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Ly-GDI, fibronectin-accelerated Ly-GDI cleavage, and fibronectin-accelerated apoptosis in TNF-alpha-treated PMN.",
      "citation": {
        "db": "PubMed",
        "db_id": "10947073"
      },
      "annotations": {},
      "source": 59,
      "target": 4,
      "key": "2404ee267f730ac2491155dc1bf05a18"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "Importantly, apoptosis inhibition with a caspase inhibitor (N-benzylcarboxy-Val-Ala-Asp-fluoromethyl-ketone) or a null mutation of caspase-3 blocked this DNA injury and apoptosis response and significantly ameliorated IFN-gamma-induced emphysema.",
      "citation": {
        "db": "PubMed",
        "db_id": "15944319"
      },
      "annotations": {},
      "source": 59,
      "target": 4,
      "key": "6b1a1d1f6ade8a7919c33075e402eb66"
    },
    {
      "line": 47,
      "relation": "increases",
      "evidence": "Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. CASP3 was shown to cleave and activate caspases 6, 7 and 9, and itself could be processed by caspases 8, 9 and 10.",
      "citation": {
        "db": "PubMed",
        "db_id": "12687019"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 62,
      "key": "6de4ac7a0aad0bf6225e534dce906cff"
    },
    {
      "line": 47,
      "relation": "increases",
      "evidence": "In contrast, caspase-7 could be activated by addition of recombinant caspase-3 but only minimally by recombinant caspase-9.",
      "citation": {
        "db": "PubMed",
        "db_id": "14686614"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 62,
      "key": "6539cfb0d7a7b12925f297ab89aa7d43"
    },
    {
      "line": 48,
      "relation": "directlyIncreases",
      "evidence": "Treatment with increasing amounts of caspase-3 for 30 minutes at 37Â°C specifically cleaved Gas2, thus producing a band showing similar electrophoretic mobility (Ã…31 kDa) with respect to Gas2 as detected in extracts of apoptotic cells...In summary we can conclude that Gas2 is a direct substrate of caspase-3 and that the aspartic residue 279 is critical both for its in vitro and in vivo proteolytic processing.",
      "citation": {
        "db": "PubMed",
        "db_id": "10564664"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 105,
      "key": "c617883caab9933348b7911a31d3c1e8"
    },
    {
      "line": 49,
      "relation": "increases",
      "evidence": "Finally, PD exposure induced apoptosis in U937 cells through caspase-3-dependent PARP and lamin A cleavage.",
      "citation": {
        "db": "PubMed",
        "db_id": "18351645"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 59,
      "target": 120,
      "key": "bdb2e82fc450f31f8d4bc10f16fbf41e"
    },
    {
      "line": 50,
      "relation": "directlyDecreases",
      "evidence": "A caspase activated DNase (CAD) was purified  [Enari et al. 1998]  and  [Liu et al. 1997]  and is normally kept in check by its inhibitor ICAD, DFF-45 which is eliminated when cleaved by caspase-3 and -7.",
      "citation": {
        "db": "PubMed",
        "db_id": "14744432"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 83,
      "key": "d39692e7e002eab97d144bb69b25da93"
    },
    {
      "line": 51,
      "relation": "directlyIncreases",
      "evidence": "We provide evidence that Etk is an in vitro and in vivo substrate for caspase 3 during apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "11278797"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 59,
      "target": 31,
      "key": "77930a2503fe431d7a958dd9b0d50ae1"
    },
    {
      "line": 52,
      "relation": "directlyIncreases",
      "evidence": "caspase-2 processing, during cell death induced by UV irradiation, depends both on caspase-9 and caspase-3 activity, while, during TNF-alpha-dependent apoptosis, capase-2 processing is independent of caspase-9 but still requires caspase-3. I",
      "citation": {
        "db": "PubMed",
        "db_id": "11399776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 58,
      "key": "df1cd5e000e66a2cb06febc3be1bb0e4"
    },
    {
      "line": 53,
      "relation": "directlyIncreases",
      "evidence": "figure 1 - conservation of caspase clevage sites",
      "citation": {
        "db": "PubMed",
        "db_id": "11973607"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 59,
      "target": 121,
      "key": "160e7855cb4e7f6e863e2a36a664aae5"
    },
    {
      "line": 54,
      "relation": "directlyDecreases",
      "evidence": "Activated caspase-3 cleaves proteins essential for cell survival, including bcl-x(L).",
      "citation": {
        "db": "PubMed",
        "db_id": "12907145"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 183,
      "key": "3b6309ee720b4c81aef5eea20ffb5ace"
    },
    {
      "line": 55,
      "relation": "increases",
      "evidence": "Furthermore, we have found that alveolar epithelial transfection with active caspase-3 causes the apoptosis of alveolar epithelial cells and the subsequent development of emphysema in mice.",
      "citation": {
        "db": "PubMed",
        "db_id": "19570263"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 191,
      "key": "5702c55fedd5ab74bdcc80286b9c7b1f"
    },
    {
      "line": 56,
      "relation": "directlyIncreases",
      "evidence": "p21-activated protein kinase gamma-PAK (Pak2, PAK I) is cleaved by CPP32 (caspase 3) during apoptosis and plays a key role in regulation of cell death. In vitro, CPP32 cleaves recombinant gamma-PAK into two peptides; 1-212 contains the majority of the regulatory domain whereas 213-524 contains 34 amino acids of the regulatory domain plus the entire catalytic domain.",
      "citation": {
        "db": "PubMed",
        "db_id": "9786869"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 59,
      "target": 148,
      "key": "021b8cbd5152dd6fcc8366b567edb6d1"
    },
    {
      "line": 56,
      "relation": "directlyIncreases",
      "evidence": "In the present study, PP1alpha has been shown to be capable of inactivating the caspase 3- cleaved PAK2 in vitro by dephosphorylation of Thr-402 in the activation loop.",
      "citation": {
        "db": "PubMed",
        "db_id": "18176785"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 59,
      "target": 148,
      "key": "55f47abbaf4dbed2b40015564d8b8de7"
    },
    {
      "line": 57,
      "relation": "decreases",
      "evidence": "caspase-3 prevented the inhibition of DNAS1L3 endonuclease activity by wild-type PARP-1",
      "citation": {
        "db": "PubMed",
        "db_id": "11694507"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 59,
      "target": 81,
      "key": "529115ab6415d2333e463403f0b5cd23"
    },
    {
      "line": 394,
      "relation": "increases",
      "evidence": "Exposure of hBEC to CS or CS extract (CSE) caused expression of endogenous ER stress markers GRP78 and CHOP and induction of apoptosis evidenced by nuclear condensation, membrane blebbing, and activation of caspase-3 and caspase-4",
      "citation": {
        "db": "PubMed",
        "db_id": "18394432"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 60,
      "target": 4,
      "key": "927ebdb93d2125cbc9c60553124b9741"
    },
    {
      "line": 394,
      "relation": "increases",
      "evidence": "initiator caspases - casp8,10,9,1,5a,4a,12a,2",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 60,
      "target": 4,
      "key": "d1b0862ba4c6d642e91396283ced60c8"
    },
    {
      "line": 276,
      "relation": "directlyIncreases",
      "evidence": "The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A.",
      "citation": {
        "db": "PubMed",
        "db_id": "8663580"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 61,
      "target": 120,
      "key": "044b863dc97e58dfe6ffb84577f6c93c"
    },
    {
      "line": 23,
      "relation": "directlyDecreases",
      "evidence": "Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined.",
      "citation": {
        "db": "PubMed",
        "db_id": "14744432"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 62,
      "target": 81,
      "key": "54fd55d1a667f6443529c073e2702c2f"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "both TRAIL and glucose starvation induced Bid cleavage and FLIP degradation following caspase 8 activation in a time-dependent manner, and ARK5 overexpression clearly delayed Bid cleavage, FLIP degradation, and caspase 8 activation. On the basis of the results of this study, we report that cell survival induced by ARK5 is, at least in part, due to inhibition of caspase 8 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "13679856"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "e4acf67899c7e637fdb4e9a405181866"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "BACKGROUND: Following cleavage by caspase 8, the C-terminus of Bid translocates from the cytosol to the mitochondria that is dependent upon structures formed by the mitochondrial-specific lipid cardiolipin. Once associated with mitochondria, truncated Bid (tBid) causes the potent release of cytochrome c, endonuclease G, and smac.",
      "citation": {
        "db": "PubMed",
        "db_id": "11716782"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "2a639eba2b3712c28ff85d964788a5b4"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "Apo2L/TRAIL-induced apoptosis involves caspase-8-mediated cleavage of BID.",
      "citation": {
        "db": "PubMed",
        "db_id": "12154014"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "09a45613dc48e1449616db652d8bc73d"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "STAT3 is also able to prevent cell death through inhibition of the extrinsic apoptotic pathway. This pathway is activated upon binding of extracellular ligands such as FAS ligand (FAS-L) to cell-surface death receptors. Upon interaction with FAS-L, the FAS death receptor induces cell death through caspase-8 activation and truncation of the death agonist BID.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "65f28abb7b5fd920ef6d41a5e6eb15f8"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "The activation of caspase 8 led to the cleavage of Bid in wild-type mice under various regimes (Fig. 3  C and data not shown).",
      "citation": {
        "db": "PubMed",
        "db_id": "11369777"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "39b2ff0d33e46e55657ffc83440b55f9"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage.",
      "citation": {
        "db": "PubMed",
        "db_id": "15326164"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "b962c5fa93d22269a3c9317eb80ccca8"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "Every cell in a multicellular organism has the potential to die by apoptosis, but tumour cells often have faulty apoptotic pathways. These defects not only increase tumour mass, but also render the tumour resistant to therapy. So, what are the molecular mechanisms of tumour resistance to apoptosis and how can we use this knowledge to resensitize tumour cells to cancer therapy?",
      "citation": {
        "db": "PubMed",
        "db_id": "12001989"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "2cda2d2a85e50ec31055cb2705386542"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "This sensitivity to TNFalpha was associated with a block in nuclear factor-kappaB-mediated cell survival signals. IGFBP-5 expression was also associated with a caspase-8-independent activation of Bid, increased levels of cytosolic second mitochondria-derived activator of caspase (Smac)/direct inhibitor of apoptosis proteins (IAP) binding protein with low pI (DIABLO), and an enhanced phosphorylation of c-Jun N-terminal kinase, both basally and in response to TNFalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "15802501"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "e52379e570998730ca22f0d4c728583a"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": "in certain cell types, i.e. hepatocytes, casp8 acts in addition by cleaving Bid which can then promote mitochondrial permeabilization and thus casp9 activation",
      "citation": {
        "db": "PubMed",
        "db_id": "14561771"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 28,
      "key": "3c09a387caa0f246fcf4515c03edb9a4"
    },
    {
      "line": 298,
      "relation": "directlyIncreases",
      "evidence": "when initiator caspases, such as caspase-8 and caspase-9, are activated by oligomerization, they cleave the precursor forms of effector caspases, such as caspase-3, caspase-6 and caspase-7",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 59,
      "key": "9211e24e4e3dd8975892b6c97cf644c4"
    },
    {
      "line": 298,
      "relation": "directlyIncreases",
      "evidence": "The death effector domain (DED) of FADD then binds to the DED of procaspase 8, which triggers the formation of activated caspase 8, the activation of caspase 3, and the apoptotic response.",
      "citation": {
        "db": "PubMed",
        "db_id": "16239906"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 59,
      "key": "0014c126c004d07398bcbfc17f34a5a9"
    },
    {
      "line": 307,
      "relation": "directlyDecreases",
      "evidence": "Here, we show that the apoptotic initiator protease caspase-9 is regulated during the cell cycle through periodic phosphorylation at an inhibitory site, Thr125.",
      "citation": {
        "db": "PubMed",
        "db_id": "17466630"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 65,
      "target": 64,
      "key": "51a0f08ae076704baeadde75b3d6f780"
    },
    {
      "line": 307,
      "relation": "directlyDecreases",
      "evidence": "Phosphorylation of Thr125, or its mutation to the acidic residue Glu, which mimics constitutive phosphorylation at the site, inhibits caspase-9 processing induced by constitutively active Apaf-1 [21]...Thr125 was first identified as an inhibitory phosphorylation- site caspase-9 using a cell-free system made from cytosolic extracts of human HeLa cells in which the intrinsic apoptotic pathway was activated by addition of cytochrome c [21].",
      "citation": {
        "db": "PubMed",
        "db_id": "19788417"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 65,
      "target": 64,
      "key": "428a578f6804f9a44a85c2a9330de59f"
    },
    {
      "line": 355,
      "relation": "decreases",
      "evidence": "Silencing FLIP expression significantly increased human sarcoma cells to both FasL-induced and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, and ectopic expression of IRF8 also significantly increased the sensitivity of these human sarcoma cells to FasL- and TRAIL-induced apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "19155307"
      },
      "annotations": {},
      "source": 71,
      "target": 4,
      "key": "dbe42f51d93af6c5307587c63fc87764"
    },
    {
      "line": 355,
      "relation": "decreases",
      "evidence": "cFLIP expression was necessary for the inhibition of poly-IC- induced apoptosis by insulin, because FLIP knockdown with siRNA efficiently restored poly-IC-induced apoptosis in HBECs in the presence of insulin (Fig. 6C, 6D).",
      "citation": {
        "db": "PubMed",
        "db_id": "21646299"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "source": 71,
      "target": 4,
      "key": "6f80c3a3c80500d0483408d7ca0c1885"
    },
    {
      "line": 355,
      "relation": "decreases",
      "evidence": "Several studies have further suggested that the upregulation of STAT3 directly confers a drug-resistance phenotype. For example, overexpression of this transcription factor protects epidermal keratinocytes or cervical carcinoma cells from ultraviolet radiation (UV)-induced apoptosis [74,75]. In addition, STAT3 deficiency sensitizes keratinocytes to UV-induced apoptosis. Interestingly, a simple application of a naked STAT3 plasmid on the skin is sufficient to prevent the effect of irradiation. This protective effect was also confirmed in colorectal cancer cell lines where STAT3 inactivation also enhances UV-induced cell death [57]. In multiple myeloma, the aberrant activation of STAT3 has also been shown to confer resistance to FASmediated apoptosis [28]. The inhibition of STAT3 signaling downregulates the expression of survival proteins and restores the sensitivity to cell-death receptors. Furthermore, a constitutively activated form of STAT3 has been shown in vivo to protect liver cells from FAS-mediated apoptosis and necrosis [76]. This has been related to an enhanced expression of anti-apoptotic proteins such as FLICE-inhibitory protein (FLIP), BCL2, or BCL-XL and a downregulation of FADD-like interleukin-1 b-converting enzyme (FLICE) and caspase 3.",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "source": 71,
      "target": 4,
      "key": "2fc02ec5c49abc71f3b27ced3e8ad94e"
    },
    {
      "line": 355,
      "relation": "decreases",
      "evidence": "Inhibition of COX-2 caused apoptosis of the anergy-resistant lupus T cells by augmenting Fas signaling and markedly decreasing the survival molecule c-FLIP (cellular homolog of viral FLICE inhibitory protein).",
      "citation": {
        "db": "PubMed",
        "db_id": "14991050"
      },
      "annotations": {},
      "source": 71,
      "target": 4,
      "key": "fa860aab131b3f51b1e8bd11845335f1"
    },
    {
      "line": 355,
      "relation": "decreases",
      "evidence": "Inhibition of PEA-15/PED or c-FLIP by small interfering RNA sensitizes human astrocytes to Fas-induced apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16554480"
      },
      "annotations": {
        "cl": {
          "0000127": true
        }
      },
      "source": 71,
      "target": 4,
      "key": "3330cab644c9af0bb88d8d2de28d565b"
    },
    {
      "line": 355,
      "relation": "decreases",
      "evidence": "casper-/- embryonic fibroblasts are highly sensitive to FasL- or TNF-induced apoptosis and show rapid induction of caspase activities.",
      "citation": {
        "db": "PubMed",
        "db_id": "10894163"
      },
      "annotations": {},
      "source": 71,
      "target": 4,
      "key": "63e065c0986c39721fbc42a07541ef3d"
    },
    {
      "line": 356,
      "relation": "decreases",
      "evidence": "Figure 3 | Neuronal anti-apoptotic brakes upstream of mitochondria. Black lines represent apoptotic pathways,blue lines represent survival pathways and red lines indicate inhibition or activation (arrows). TNF? (tumour necrosis factor-?)- and FASL (apoptosis antigen-1 (FAS) ligand) mediated death can be suppressed by sequestration by decoy receptors; FASL can bind to DCR3 (decoy receptor 3) or FDR (FAS decoy receptor), or to MET3, a HGF (hepatocyte growth factor) receptor,resulting in no downstream signalling. TNFR2 (tumour necrosis factor receptor 2) can be cleaved by metalloproteases into a soluble decoy receptor for TNF?, and TNF? signalling through the TNFR1 RIP TRAF2 (TNF receptor 1 receptor interacting protein TNF receptor associated factor 2) complex is inhibited by FLIP (FLICE-inhibitory protein), IAPs (inhibitor of apoptosis proteins) and HSP90 (heat shock protein 90). FLIP also prevents recruitment of procaspase 8 to FADD (FAS-associated death domain), inhibiting apoptosis by the TNFa FADD and Fas FADD pathways. Activation of procaspase 8 to caspase 8 is inhibited by BCL2 (B-cell leukaemia/lymphoma-2) and APC (activated protein C), preventing cleavage of BID (BH3 interacting domain death agonist) to tBID (truncated BID). tBID translocation to the mitochondrion is prevented by stabilization of the cytoskeletal networks by HSP27 (heat shock protein 27). FAS-associated phosphatase-1 (FAP1) prevents binding of FADD and DAXX (death-associated protein) to FAS, and HSP27 inhibits DAXX-mediated activation of ASK1 (apoptosis signal regulated kinase-1) and the JNK (c-Jun-N-teminal kinase)-death pathway. JNK activity is inhibited by HSP70 and its co-chaperone HSP40, and by the IAPs NIAP (neuronal IAP) and XIAP (X-chromosome linked IAP), with XIAP in a complex with its binding partners TAK1 (TGF?-activated kinase) and TAB1 (TAK1-binding protein). ER (endoplasmic reticulum)- mediated apoptosis is inhibited by ORP150 (oxygen regulated protein 150), which prevents activation of calcium-dependent proteases, and by BCL2 and BAR (bifunctional apoptosis regulator)-mediated suppression of BAP31 (B-cell receptorassociated protein 31). IAP proteins negatively regulate pro-death p75NTR (p75 neurotrophin receptor) signalling through NRAGE (neurotrophin receptor interacting MAGE homologue), preventing signalling through the JNK-death pathway. XIAP mediates survival (blue lines) by binding to the cytoplasmic domain of BMP (bone morphogenic protein) receptors, which recruit TAB1 and TAK1 to activate the NF-?B (nuclear factor-?B) survival pathway. IAPs, HSP27 and HSP90 bind to AKT/PKB (protein kinase B) to promote the AKT survival pathway (blue lines). AIP1, ASK1-interacting protein 1; ASK1, apoptosissignal- regulating kinase-1; I?B, inhibitory subunit of NF-?B kinase; NGF, nerve growth factor; NIK, NF-?B-inducing kinase; PDK1/2, 3-phosphoinositide dependent kinase 1/2; PI3K, phosphatidyl inositol-3-kinase; RAIDD, RIP-associated ICH-1 homologous protein with a death domain.",
      "citation": {
        "db": "PubMed",
        "db_id": "15322527"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 71,
      "target": 63,
      "key": "54f9a094bd51604d2cf15643c33efceb"
    },
    {
      "line": 356,
      "relation": "decreases",
      "evidence": "c-Flip inhibits apoptosis by blocking the activation of caspase-8.",
      "citation": {
        "db": "PubMed",
        "db_id": "17707332"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 71,
      "target": 63,
      "key": "ea8f01cd375d5b52d4567eaffd20c1eb"
    },
    {
      "line": 356,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11279218"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 71,
      "target": 63,
      "key": "a248b4b35df6f57068dbfb32973f01e1"
    },
    {
      "line": 356,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "9880531"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 71,
      "target": 63,
      "key": "6957fdcc72a83a5887e53fad1fc559c3"
    },
    {
      "relation": "hasVariant",
      "source": 73,
      "target": 74,
      "key": "e8c749ccb67bf827cfc9f14dbc303c0d"
    },
    {
      "relation": "hasVariant",
      "source": 73,
      "target": 75,
      "key": "1aba5f072b0e2e4ccc4d56d4a273d157"
    },
    {
      "line": 65,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "9520401"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 73,
      "target": 146,
      "key": "56a6736e2b91eb380388f419a16cad80"
    },
    {
      "relation": "hasVariant",
      "source": 79,
      "target": 80,
      "key": "b5c1d1cd3c6f7d440819d8b3e76780a7"
    },
    {
      "line": 303,
      "relation": "increases",
      "evidence": "siRNA silencing of either PKCepsilon or Akt in MCF-7 cells, which overexpress Akt, decreased Bcl-2 protein and mRNA levels. However, knockdown of PKCepsilon, but not Akt, led to the decrease in Bcl-2 at both protein and mRNA levels in MDA-MB-231 breast cancer cells, which overexpress PKCepsilon but contain little constitutively-active Akt. Knockdown of PKCepsilon decreased phosphorylation of cAMP response element-binding protein (CREB) at Ser133 in MDA-MB-231 cells, and depletion of CREB by siRNA decreased Bcl-2 at both the protein and mRNA levels",
      "citation": {
        "db": "PubMed",
        "db_id": "20198332"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 79,
      "target": 181,
      "key": "af89cb48899b1af2dc14ee15f3d0f708"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "The induction of CREB-mediated transcription was Ser-133-dependent, because caPKD1 failed to stimulate GAL4-CREBS133A-driven transcription. Similar results were obtained with co-transfection studies in COS-1 cells (results not shown), indicating that PKD1-induced CREB activation is not cell-specific.",
      "citation": {
        "db": "PubMed",
        "db_id": "17389598"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "19e8d5c17917e835618f382301ddcceb"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "Mutation of the CREB-binding site reduced cyclin D2 promoter activity 5-10-fold. CREB-1 is phosphorylated at serine 133, a critical site for activity, in both T cells and Epstein-Barr virus immortalized B cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16301994"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "4653be4971fd5bc63ba804eb3807f953"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "CREB activation via phosphorylation at serine 133 and resulting CREB mediated gene expression is a critical event which can have a significant effect on many cellular processes, including cell survival and plasticity.",
      "citation": {
        "db": "PubMed",
        "db_id": "19070599"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "2ca5d4215f438cddda16dccfa5a0cf3b"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "Inactivating the kinase A phosphorylation site by in vitro mutagenesis of the cloned CREB cDNA at Ser-133 completely abolished CREB transcriptional activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "2573431"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "949ff03d87bb536a6bed755d5c164b20"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "A constitutive active mutant of PKD1 stimulates GAL4-CREB-mediated transcription in a Ser-133-dependent manner, activates CRE-responsive promoters, and increases the expression of CREB target genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "17389598"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "8dda5fc04947fc4bd5764f03f2fd6522"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "We found that, in contrast to Akt1 that induces CREB phosphorylation at Ser-133 and CREB target gene expression, Akt2 was unable to induce CREB phosphorylation at Ser-133 in vivo and CREB target gene expression. This difference is specific to CREB as both Akt1 and Akt2 similarly inhibits FoxO1 mediated gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "17276404"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "8c75309ad47faac0162d3639d96d05a6"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "CaMKIV, and p38 MAPK were also the kinases involved in CREB Ser(133) phosphorylation induced by CD3/CD28.",
      "citation": {
        "db": "PubMed",
        "db_id": "11123304"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "b696060842dba6344f3380a873b6c91e"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "aken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "10067851"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "a374e3f51e27e7a102c326b84c391030"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "As shown in Fig. 6, TPA and the presence of caPKD1 clearly augmented Nur77 transcript levels. The PKD1-induced increase of Nur77 expression is mediated through CREB, as co-transfection with the dominant negative A-CREB or K-CREB resulted in reduced PKD1-induced Nur77 expression (Fig. 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "17389598"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "88e7456935d22c72917e84a1130f4b3d"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "pp60(v-src) induction of CREB was blocked by the p38 inhibitor SB203580 or by mutation of CREB at Ser133.",
      "citation": {
        "db": "PubMed",
        "db_id": "10066798"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "24c1e469331f1f1cbc7a2455dbf2a8d1"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "LDL promotes cAMP response element binding protein (CREB) activation (phosphorylation in Ser133). In transfection assays a dominant-negative of CREB inhibits NOR-1 promoter activity, while mutation of specific (cAMP response element) CRE sites in the NOR-1 promoter abolishes LDL-induced NOR-1 promoter activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "14962944"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "628e324b90ce8c994c4f52b1030b9b61"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "We found that the intracellular domain of Notch2 interacted with a phosphorylated form of the transcription factor CREB1, and together these proteins bound the transcriptional coactivator p300 to form a complex on the promoter of the gene encoding granzyme B. Our results suggest that the highly regulated, dynamic control of T cell cytotoxicity depends on the integration of Notch2 and CREB1 signals.",
      "citation": {
        "db": "PubMed",
        "db_id": "18724371"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "4306ea9f128638b1bc00157243cab75f"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "MSK1 is localized in the nucleus of unstimulated or stimulated cells, and phosphorylates CREB at Ser133 with a Km value far lower than PKA, MAPKAP-K1(p90Rsk) and MAPKAP-K2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9687510"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "eb8a8479b1e33c436b85f4f877af6164"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "Moreover, PP1 was shown to act as a major CTD phosphatase in nuclear extracts and to affinity-purify with RNA polymerase II. Both PP1 and the nuclear regulator NIPP1 have also been identified as components of the Tat-associated RNA polymerase II complex, which regulates transcription from the human immunodeficiency virus type 1 promoter (40, 275). The transcription factor CREB mediates the expression of cAMP-induced genes by binding to a conserved cAMP-responsive element. Phosphorylation of CREB on Ser-133, e.g., by PKA, promotes the recruitment of the histone acetyltransferase CBP, which facilitates access of the promoter region to the transcriptional machinery.",
      "citation": {
        "db": "PubMed",
        "db_id": "14715909"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "2659da39f579e2e4446a0fd87f117d4e"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "Protein kinase A phosphorylation of CREB at serine 133 facilitates transcription from cellular CREs by recruiting CBP/p300 via its KIX domain.",
      "citation": {
        "db": "PubMed",
        "db_id": "17449469"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "5b6861c00d81728f87603442bfa46122"
    },
    {
      "line": 415,
      "relation": "directlyIncreases",
      "evidence": "Their minimum consensus sequence Hyd-X-R-X-X-(S/T) (where Hyd is any hydrophobic amino acid), determined through peptide studies, provides only a rough template common to many protein kinases (11). Additional specificity is provided by residues adjacent to the phosphorylation site of the substrate, producing differences in substrate preference among these kinases. The differences can have important transcriptional implications; for example, although all three can phosphorylate CREB on the activating site Ser-133, only CaMKII phosphorylates an additional inhibitory site, Ser-142 (13).",
      "citation": {
        "db": "PubMed",
        "db_id": "11096122"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 80,
      "target": 79,
      "key": "7b82dbcd289da65e8b656ee797d890fb"
    },
    {
      "line": 379,
      "relation": "increases",
      "evidence": "To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "19109422"
      },
      "annotations": {},
      "source": 82,
      "target": 68,
      "key": "573b73f88190d99701bd73992456e39f"
    },
    {
      "line": 380,
      "relation": "increases",
      "evidence": "To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "19109422"
      },
      "annotations": {},
      "source": 82,
      "target": 174,
      "key": "f547f5f4178a820ba19b3bc1aad68ddd"
    },
    {
      "line": 381,
      "relation": "increases",
      "evidence": "To ascertain the importance of Chop in the induction of proapoptotic proteins upon IL3 withdrawal, Chop expression was suppressed by shRNAi (Figure 9A). This led to a decrease in the induced protein levels of Bim-EL, (Figure 9B), Puma (Figure 9C), and Bax (Figure 9D), all of which may contribute to apoptosis in growth factor-deprived Bcl-2 expressing cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "19109422"
      },
      "annotations": {},
      "source": 82,
      "target": 184,
      "key": "9bef85a66be5804a97d01c49cbc8ef7a"
    },
    {
      "line": 410,
      "relation": "decreases",
      "evidence": "Caspase-activated DNase (CAD) is a deoxyribonuclease that causes DNA fragmentation during apoptosis. In proliferating cells, CAD is complexed with ICAD (inhibitor of CAD) and its DNase activity is suppressed",
      "citation": {
        "db": "PubMed",
        "db_id": "11361146"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 83,
      "target": 84,
      "key": "4cd005e22eb8e7f3cb6d9875ceb85cfa"
    },
    {
      "line": 377,
      "relation": "increases",
      "evidence": "Caspase-activated DNase (CAD) is a deoxyribonuclease that causes DNA fragmentation during apoptosis. In proliferating cells, CAD is complexed with ICAD (inhibitor of CAD) and its DNase activity is suppressed",
      "citation": {
        "db": "PubMed",
        "db_id": "11361146"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 6,
      "key": "76a16b76352b4648c809404a7fb9afc3"
    },
    {
      "line": 377,
      "relation": "increases",
      "evidence": "Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined.",
      "citation": {
        "db": "PubMed",
        "db_id": "14744432"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 6,
      "key": "6f9ff321673d2cc5a6240c96ad8b2a68"
    },
    {
      "line": 377,
      "relation": "increases",
      "evidence": "Employing a cell-free apoptotic assay and NGF-treated PC12 nuclear extracts, we purified Ebp1 as a factor, which contributes to inhibition of DNA fragmentation by CAD.",
      "citation": {
        "db": "PubMed",
        "db_id": "16642037"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 6,
      "key": "0d0b5ed220bd86e8fb3e191e9c0d5639"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Caspase activation, the executing event of apoptosis, is under deliberate regulation. IAP proteins inhibit caspase activity, whereas Smac/Diablo antagonizes IAP. XIAP, a ubiquitous IAP, can inhibit both caspase-9, the initiator caspase of the mitochondrial apoptotic pathway, and the downstream effector caspases, caspase-3 and caspase-7. Smac neutralizes XIAP inhibition of caspase-9 by competing for binding of the BIR3 domain of XIAP with caspase-9, whereas how Smac liberates effector caspases from XIAP inhibition is not clear. It is generally believed that binding of Smac with IAP generates a steric hindrance that prevents XIAP from inhibiting effector caspases, and therefore small molecule mimics of Smac are not able to reverse inhibition of the effector caspases. Surprisingly, we show here that binding of a dimeric Smac N-terminal peptide with the BIR2 domain of XIAP effectively antagonizes inhibition of caspase-3 by XIAP. Further, we defined the dynamic and cooperative interaction of Smac with XIAP: binding of Smac with the BIR3 domain anchors the subsequent binding of Smac with the BIR2 domain, which in turn attenuates the caspase-3 inhibitory function of XIAP. We also show that XIAP homotrimerizes via its C-terminal Ring domain, making its inhibitory activity toward caspase-3 more susceptible to Smac.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "6e5b5e4eb7cd636d92d323e17410674f"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Surprisingly, we show here that binding of a dimeric Smac N-terminal peptide with the BIR2 domain of XIAP effectively antagonizes inhibition of caspase-3 by XIAP.",
      "citation": {
        "db": "PubMed",
        "db_id": "17724022"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "05b8a9abf6ebbc47124531d0d0de4668"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "A small series of peptide mimics was designed and synthesized to contain a heterocyclic ring in place of the potentially labile N-terminal peptide bond of the tetrapeptide containing the Smac-XIAP-binding motif. Two Smac mimics were shown to bind to the BIR3 domain of XIAP with moderate affinity and one displayed increased activity in cells relative to the Smac peptides. The structures of BIR3-XIAP in complex with a Smac peptide and a peptide mimic were solved and analyzed to elucidate the structure-activity relationship surrounding the Smac-binding domain within BIR3-XIAP.",
      "citation": {
        "db": "Other",
        "db_id": "17336535"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "23d93a9e3e6a1709b23c200ebc4744e4"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "The inhibitor of apoptosis (IAP) proteins bind and inhibit caspases via their baculovirus IAP repeat domains. Some of these IAPs are capable of ubiquitinating themselves and their interacting proteins through the ubiquitin-protein isopeptide ligase activity of their RING domain. The Drosophila IAP antagonists Reaper, Hid, and Grim can accelerate the degradation of Drosophila IAP1 and some mammalian IAPs by promoting their ubiquitin-protein isopeptide ligase activity. Here we show that Smac/DIABLO, a mammalian functional homolog of Reaper/Hid/Grim, selectively causes the rapid degradation of c-IAP1 and c-IAP2 but not XIAP and Livin in HeLa cells, although it efficiently promotes the auto-ubiquitination of them all. Smac binding to c-IAP via its N-terminal IAP-binding motif is the prerequisite for this effect, which is further supported by the findings that Smac N-terminal peptide is sufficient to enhance c-IAP1 ubiquitination, and Smac no longer promotes the ubiquitination of mutant c-IAP1 lacking all three baculovirus IAP repeat domains. In addition, different IAPs require the same ubiquitin-conjugating enzymes UbcH5a and UbcH6 for their ubiquitination. Taken together, Smac may serve as a key molecule in vivo to selectively reduce the protein level of c-IAPs through the ubiquitin/proteasome pathway.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "00033e6d860e255b88fe492dcc661bab"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Genetic alterations enhancing cell survival and suppressing apoptosis are hallmarks of cancer that significantly reduce the efficacy of chemotherapy or radiotherapy. The Inhibitor of Apoptosis Protein (IAP) family hosts conserved proteins in the apoptotic pathway whose over-expression, frequently found in tumours, potentiates survival and resistance to anticancer agents. In humans, IAPs comprise eight members hosting one or more structural Baculoviral IAP Repeat (BIR) domains. Cellular IAPs (cIAP1 and 2) indirectly inhibit caspase-8 activation, and regulate both the canonical and the non-canonical NF-ÎºB signaling pathways. In contrast to cIAPs, XIAP (X chromosome-linked Inhibitor of Apoptosis Protein) inhibits directly the effector caspases-3 and -7 through its BIR2 domain, and initiator caspase-9 through its BIR3 domain; molecular docking studies suggested that Smac/DIABLO antagonizes XIAP by simultaneously targeting both BIR2 and BIR3 domains. Here we report analytical gel filtration, crystallographic and SAXS experiments on cIAP1-BIR3, XIAP-BIR3 and XIAP-BIR2BIR3 domains, alone and in the presence of compound 9a, a divalent homodimeric Smac mimetic. 9a is shown to bind two BIR domains inter- (in the case of two BIR3) and intra-molecularly (in the case of XIAP-BIR2BIR3), with higher affinity for cIAP1-BIR3, relative to XIAP-BIR3. Despite the different crystal lattice packing, 9a maintains a right handed helical conformation in both cIAP1-BIR3 and XIAP-BIR3 crystals, that is likely conserved in solution as shown by SAXS data. Our structural results demonstrate that the 9a linker length, its conformational degrees of freedom and its hydrophobicity, warrant an overall compact structure with optimal solvent exposure of its two active moieties for IAPs binding. Our results show that 9a is a good candidate for pre-clinical and clinical studies, worth of further investigations in the field of cancer therapy.",
      "citation": {
        "db": "Other",
        "db_id": "23166698"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "c733f42898e754184a8e385f92a498a0"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Smac, a second mitochondria-derived activator of caspases, promotes caspase activation in the cytochrome c(cyto-c)/Apaf-1/caspase-9 pathway. Here, we show that treatment of multiple myeloma (MM) cells with dexamethasone (Dex) triggers the release of Smac from mitochondria to cytosol and activates caspase-9 without concurrent release of cyto-c and Apaf-1 oligomerization. Smac binds to XIAP (an inhibitor of apoptosis protein) and thereby, at least in part, eliminates its inhibitory effect on caspase-9. Interleukin-6, a growth factor for MM, blocks Dex-induced apoptosis and prevents release of Smac. Taken together, these findings demonstrate that Smac plays a functional role in mediating Dex-induced caspase-9 activation and apoptosis in MM cells.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "345dd65d92589bee3a97850d187feaea"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Inhibitors of apoptosis (IAPs) are crucial regulators of programmed cell death. The mechanism by which IAPs prevent apoptosis has previously been attributed to the direct inhibition of caspases. The function of mammalian IAPs is counteracted by cell death inducer second mitochondria-derived activator of caspases (Smac)/DIABLO during apoptosis. Here we show that cIAP1 and cIAP2 are E3 ubiquitin-protein isopeptide ligases (ubiquitin ligases) for Smac. cIAPs stimulate Smac ubiquitination both in vivo andin vitro, leading to Smac degradation. cIAP1 and cIAP2 associate with overlapping but distinct subsets of E2 (ubiquitin carrier protein) ubiquitin-conjugating enzymes. The substrate-dependent E3 activity of cIAPs is mediated by their RING domains and is dependent on the specific interactions between cIAPs and Smac. Similarly, Drosophila IAP1 also possesses ubiquitin ligase activity that mediates the degradation of the Drosophila apoptosis inducers Grim and HID. These results suggest a novel and conserved mechanism by which IAPs block apoptosis through the degradation of death inducers",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "835b690499cc039b6c2d491a19aef2a4"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Inhibitor of apoptosis proteins (IAPs) interact with and inhibit caspases-3, -7, and -9. This interaction can be inhibited by Smac/DIABLO, a polypeptide released from mitochondria upon initiation of the apoptotic signaling process. Here we demonstrate that the first 4â€“8 N-terminal amino acids of Smac/DIABLO fused to theDrosophila antennapaedia penetratin sequence, a carrier peptide, enhance the induction of apoptosis and long term antiproliferative effects of diverse antineoplastic agents including paclitaxel, etoposide, 7-ethyl-10-hydroxycamptothecin (SN-38), and doxorubicin in MCF-7 breast cancer cells. Similar effects were observed in additional breast cancer and immortalized cholangiocyte cell lines. Further analysis demonstrated that the Smac-penetratin fusion peptide crossed the cellular membrane, bound XIAP and cIAP1, displaced caspase-3 from cytoplasmic aggregates, and enhanced drug-induced caspase action in situ. These studies demonstrate that inhibition of IAP proteins can modulate the efficacy of antineoplastic agents.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "b19dcbbc65ecbcf7e05d08f5de7d87fd"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes. Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the IAPs and promotes caspase activation.",
      "citation": {
        "db": "Other",
        "db_id": "11140637"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "fc579ee5b2373f7b68143d719631e79a"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "X-linked inhibitor of apoptosis protein (XIAP), the most potent member of the inhibitor of apoptosis protein (IAP) family, plays a crucial role in the regulation of apoptosis. XIAP is structurally characterized by three baculovirus IAP repeat (BIR) domains that mediate binding to and inhibition of caspases and a RING domain that confers ubiquitin ligase activity. The caspase inhibitory activity of XIAP can be eliminated by the second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) during apoptosis. Here we report the identification and characterization of a novel isoform of Smac/DIABLO named Smac3, which is generated by alternative splicing of exon 4. Smac3 contains an NH2-terminal mitochondrial targeting sequence required for mitochondrial targeting of Smac3 and an IAP-binding motif essential for Smac3 binding to XIAP. Smac3 is released from mitochondria into the cytosol in response to apoptotic stimuli, where it interacts with the second and third BIR domains of XIAP. Smac3 disrupts processed caspase-9 binding to XIAP, promotes caspase-3 activation, and potentiates apoptosis. Strikingly, Smac3, but not Smac/DIABLO, accelerates XIAP auto-ubiquitination and destruction. Smac3-stimulated XIAP ubiquitination is contingent upon the physical association of XIAP with Smac3 and an intact RING domain of XIAP. Smac3-accelerated XIAP destabilization is, at least in part, attributed to its ability to enhance XIAP ubiquitination. Our study demonstrates that Smac3 is functionally additive to, but independent of, Smac/DIABLO.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "11c5c02db61b16cc591d65fcee618aa0"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Second mitochondria-derived acti\nvator of caspase/direct inhibito\nr of apoptosis-binding protein\nwith low pI (Smac/DIABLO) is a proapoptogenic mi\ntochondrial protein that\nis released to the\ncytosol in response to diverse apoptotic stimuli,\nincluding commonly used chemotherapeutic drugs.\nIn the cytosol, Smac/DIABLO interacts and antagonize\ns inhibitors of apoptosi\ns proteins (IAPs), thus\nallowing the activation of caspases and apopto\nsis. This activity has pr\nompted the synthesis of\npeptidomimetics that could potent\nially be used in cancer therap\ny. For these reasons, several\nauthors have analyzed the expressi\non levels of Smac/DIABLO in samp\nles of patients from different\ntumors. Although dissimilar results have been found\n, a tissue-specific role\nof this protein emerges\nfrom the data. The objective of\nthis review is to present the\ncurrent knowledge of the Smac/\nDIABLO role in cancer and its possible use as a\nmarker or therapeutic target for drug design",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "3b2b89096a504fd8dc72d38f82cc76cb"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "During apoptosis, Smac (second mitochondria-derived activator of caspases)/DIABLO, an IAP (inhibitor of apoptosis protein)-binding protein, is released from mitochondria and potentiates apoptosis by relieving IAP inhibition of caspases. We demonstrate that exposure of MCF-7 cells to the death-inducing ligand, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), results in rapid Smac release from mitochondria, which occurs before or in parallel with loss of cytochrome c. Smac release is inhibited by Bcl-2/Bcl-xL or by a pan-caspase inhibitor demonstrating that this event is caspase-dependent and modulated by Bcl-2 family members. Following release, Smac is rapidly degraded by the proteasome, an effect suppressed by co-treatment with a proteasome inhibitor. As the RING finger domain of XIAP possesses ubiquitin-protein ligase activity and XIAP binds tightly to mature Smac, an in vitro ubiquitination assay was performed which revealed that XIAP functions as a ubiquitin-protein ligase (E3) in the ubiquitination of Smac. Both the association of XIAP with Smac and the RING finger domain of XIAP are essential for ubiquitination, suggesting that the ubiquitin-protein ligase activity of XIAP may promote the rapid degradation of mitochondrial-released Smac. Thus, in addition to its well characterized role in inhibiting caspase activity, XIAP may also protect cells from inadvertent mitochondrial damage by targeting pro-apoptotic molecules for proteasomal degradation.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "cdeaeecf00f29e7b29b29fdfc88ff3b2"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer cells. Several compounds targeting IAPs and inducing cell death in cancer cells have been developed. Some of these are synthesized mimicking the N-terminal tetrapeptide sequence of Smac/DIABLO, the natural endogenous IAPs inhibitor. Starting from such conceptual design, we generated a library of 4-substituted azabicyclo[5.3.0]alkane Smac-mimetics. Here we report the crystal structure of the BIR3 domain from XIAP in complex with Smac037, a compound designed according to structural principles emerging from our previously analyzed XIAP BIR3/Smac-mimetic complexes. In parallel, we present an in silico docking analysis of three Smac-mimetics to the BIR3 domain of cIAP1, providing general considerations for the development of high affinity lead compounds targeting three members of the IAP family.",
      "citation": {
        "db": "Other",
        "db_id": "18992220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "0a4cf736d70a3553aef8d2b4a35d348f"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "The four residues at the amino-terminus of mature Smac/DIABLO are an IAP binding motif (IBM). Upon exit from mitochondria, mature Smac interacts with inhibitor of apoptosis proteins (IAPs), abrogating caspase inhibition. We used the ubiquitin fusion model to express mature Smac in the cytosol. Transiently expressed mature Smac56-239 (called Smac56) and Smac60-239 (called Smac60), which lacks the IBM, interacted with X-linked inhibitor of apoptosis protein (XIAP). However, stable expression produced wild type Smac56 that failed to homodimerize, interact with XIAP, and potentiate caspase activation. Cytosolic Smac60 retained these functions. Cytosolic Smac56 apparently becomes posttranslationally modified at the dimer interface region, which obliterated the epitope for a monoclonal antibody. Cytosolic SmacÎ´, which has the IBM but lacks amino acids 62â€“105, homodimerized and weakly interacted with XIAP, but failed to potentiate apoptosis. These findings suggest that the IBM of Smac is a recognition point for a posttranslational modification(s) that blocks homodimerization and IAP interaction, and that amino acids 62â€“105 are required for the proapoptotic function of Smac.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "20fb4c2c3e8811451828279e09a631fd"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Small molecules designed to mimic the binding of Smac protein to X-linked inhibitor of apoptosis protein (XIAP) are being pursued as a promising new class of anticancer drugs. Herein, we report the design, synthesis, and comprehensive structure-activity relationship studies of a series of conformationally constrained bicyclic Smac mimetics. Our studies led to the discovery of a number of highly potent and cell-permeable Smac mimetics and yielded important new insights into their structure-activity relationship for their binding to XIAP and for their activity in inhibition of cancer cell growth. Determination of the crystal structure of one potent Smac mimetic, compound 21, in complex with XIAP BIR3 provides the structural basis for its high-affinity binding to XIAP and for the design of highly potent Smac mimetics.",
      "citation": {
        "db": "Other",
        "db_id": "18954041"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "b98132ceba2a6d8c467bb726b154fc3b"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Inhibitor of apoptosis proteins (IAPs) can block apoptosis through binding to active caspases and antagonizing their function. IAP function can be neutralized by Smac/Diablo, an IAP-binding protein that is released from mitochondria during apoptosis. In addition to their ability to interact with caspases, certain IAPs also display ubiquitin-protein isopeptide ligase activity because of the presence of a RING domain. However, it is not known whether the ubiquitin-protein isopeptide ligase activities of human IAPs contribute to their apoptosis inhibitory activity or whether this IAP property can be modulated through association with Smac/Diablo. Here we demonstrate that the ubiquitin ligase activities of XIAP, and to a lesser extent c-IAP-1 and c-IAP2, are potently repressed through binding to Smac/Diablo. We also show that mutation of the XIAP RING domain rendered this IAP a less effective inhibitor of apoptosis, suggesting that the ubiquitin ligase activity of XIAP contributes to its anti-apoptotic function. These data suggest that Smac/Diablo potentiates apoptosis by simultaneously antagonizing caspase-IAP interactions and repressing IAP ubiquitin ligase activities.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "116d5d326468479c9c64d052d0fadd7b"
    },
    {
      "line": 77,
      "relation": "decreases",
      "evidence": "Thus, we conducted our structural studies on a complex composed of the BIR3 domain of XIAP (Fig. 1a) and a 9-mer peptide (A1'-E9') derived from the N terminus of mature Smac (Fig. 1b) that was able to prevent XIAP from inhibiting caspase-9 (data not shown).",
      "citation": {
        "db": "PubMed",
        "db_id": "11140637"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 77,
      "target": 112,
      "key": "a0ed9b3e03be98e3ebf91d926f67bd6f"
    },
    {
      "relation": "hasVariant",
      "source": 86,
      "target": 87,
      "key": "d4c9b66ea073cbb83f6dddb09d8de9e1"
    },
    {
      "line": 416,
      "relation": "increases",
      "evidence": "eIF2alpha phosphorylation at serine 51 promotes expression of stress-induced genes, such as the transcription factors ATF4 and CHOP (Scheuner et al., 2001). Expression of these genes, as well as GADD34, under conditions of ER stress or amino acid deprivation, requires activity of the upstream eIF2alpha kinases PERK and GCN2 (Harding et al., 2000a; Novoa et al., 2001).",
      "citation": {
        "db": "PubMed",
        "db_id": "12606582"
      },
      "annotations": {},
      "source": 87,
      "target": 147,
      "key": "257230c2a23a778077aee5ad5c66a3c8"
    },
    {
      "line": 416,
      "relation": "increases",
      "evidence": "Since we and others have shown that the initiation of translation at the authentic start codon of ATF4 is dependent on PERK phosphorylation of eIF2{alpha} (18, 28),",
      "citation": {
        "db": "PubMed",
        "db_id": "15314157"
      },
      "annotations": {},
      "source": 87,
      "target": 147,
      "key": "1028cae64a3467a6efca105138de6525"
    },
    {
      "line": 416,
      "relation": "increases",
      "evidence": "Endoplasmic reticulum stress induced by tunicamycin and thapsigargin protects against transient ischemic brain injury: Involvement of PARK2-dependent mitophagy",
      "citation": {
        "db": "Other",
        "db_id": "25126734"
      },
      "annotations": {},
      "source": 87,
      "target": 147,
      "key": "4a774900992d7269247dbbe9e3491975"
    },
    {
      "relation": "hasVariant",
      "source": 88,
      "target": 89,
      "key": "23da90602836c4e57e4afc16675e0af2"
    },
    {
      "line": 296,
      "relation": "directlyIncreases",
      "evidence": "The NH(2) terminus of MKP-1 was also found to inhibit the activation of the serum response element (SRE) by preventing MAPK-mediated phosphorylation of the regulatory serine 383 residue on Elk-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "15899879"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 89,
      "target": 88,
      "key": "0a997d7ed0af63842095c19c42816402"
    },
    {
      "line": 296,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of the C-terminal domain of Elk-1, especially at serine 383, is important for its transactivation activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "9367995"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 89,
      "target": 88,
      "key": "87e884a1abe7f1a7fcb6748d81bb4d2e"
    },
    {
      "line": 296,
      "relation": "directlyIncreases",
      "evidence": "Elk-1-dependent transactivation is regulated by phosphorylation at serine-383 and -389, and each of the MAPK has been shown to be competent to phosphorylate this nuclear factor at these residues in vitro (33, 34, 35, 36, 37).",
      "citation": {
        "db": "PubMed",
        "db_id": "11441089"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 89,
      "target": 88,
      "key": "ef17a0c7b209709b7fae18a03d02fcbf"
    },
    {
      "line": 296,
      "relation": "directlyIncreases",
      "evidence": "Indeed, Ser383 plays a vital role, as mutation of Ser383 virtually eliminated hRev7-mediated enhancement of Elk-1 activity (Fig. 4D).",
      "citation": {
        "db": "PubMed",
        "db_id": "17296730"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 89,
      "target": 88,
      "key": "4a755f23d69e09688e8f144103f56aed"
    },
    {
      "line": 296,
      "relation": "directlyIncreases",
      "evidence": "Subsequent studies with dominant negative Elk-1, wild type, and variant GAL4-Elk-1 fusion proteins confirmed that phosphorylation of Elk-1 at serines 383 and 389 in the C-terminal region of Elk-1 is an important downstream target associated with activation of an SRE by E2.",
      "citation": {
        "db": "PubMed",
        "db_id": "11145955"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 89,
      "target": 88,
      "key": "1dc55a09d21bd5a387d20bc458d5cd86"
    },
    {
      "line": 116,
      "relation": "increases",
      "evidence": "endonuclease G and apoptosis-inducing factor (AIP) might induce cell death independently of caspase activation",
      "citation": {
        "db": "PubMed",
        "db_id": "15286739"
      },
      "annotations": {},
      "source": 90,
      "target": 4,
      "key": "55983407b4d7ea7d4d42debddd3ff685"
    },
    {
      "line": 313,
      "relation": "directlyIncreases",
      "evidence": "Interestingly, in western blot analysis, p300 (encoded by EP300) and its coactivator cAMP response element-binding protein (CREB) level were significantly down-regulated.",
      "citation": {
        "db": "Other",
        "db_id": "22285928"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 91,
      "target": 79,
      "key": "d1ce119e747abd36339324ce89b531a7"
    },
    {
      "line": 313,
      "relation": "directlyIncreases",
      "evidence": "stimulate gene expression by promoting the phosphorylation of CREB (P-CREB), thereby enhancing its association with the histone acetylase paralogs p300 and CBP (CBP/p300)",
      "citation": {
        "db": "PubMed",
        "db_id": "17476304"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 91,
      "target": 79,
      "key": "9f40fa9131bbabc9ed162c3de7052d1f"
    },
    {
      "line": 144,
      "relation": "increases",
      "evidence": "Thus, FADD is not only necessary for recruitment and activation of caspase-8, but also for recruitment and activation of caspase-10 at the TRAIL and the CD95 DISCs.",
      "citation": {
        "db": "PubMed",
        "db_id": "12198154"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 93,
      "target": 57,
      "key": "f139af0f13c78c94be27032c87513190"
    },
    {
      "line": 145,
      "relation": "directlyIncreases",
      "evidence": "At such low concentration, ethanol-induced apoptosis in human hepatocellular carcinoma (HepG2) cells is triggered by activation of the Fas receptor, a member of the tumor necrosis family, with subsequent activation of the intracellular adapter protein FADD (Fas Associated Death Domain) and caspase-8.",
      "citation": {
        "db": "PubMed",
        "db_id": "17088943"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 93,
      "target": 63,
      "key": "3d71db1b687d0c0baff47c231ec5791e"
    },
    {
      "line": 145,
      "relation": "directlyIncreases",
      "evidence": "Blocking the death receptor complex by expression of FADD-DN additionally inhibited SM-induced internucleosomal DNA cleavage and caspase-6-mediated nuclear lamin cleavage.",
      "citation": {
        "db": "PubMed",
        "db_id": "12482751"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 93,
      "target": 63,
      "key": "e891b3a758e75efaaa2af4455b265822"
    },
    {
      "line": 345,
      "relation": "directlyIncreases",
      "evidence": "At such low concentration, ethanol-induced apoptosis in human hepatocellular carcinoma (HepG2) cells is triggered by activation of the Fas receptor, a member of the tumor necrosis family, with subsequent activation of the intracellular adapter protein FADD (Fas Associated Death Domain) and caspase-8.",
      "citation": {
        "db": "PubMed",
        "db_id": "17088943"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 42,
      "target": 93,
      "key": "16476439987f61d7bb886408b62beccb"
    },
    {
      "line": 371,
      "relation": "directlyIncreases",
      "evidence": "Fas activation by ligand (FasL)",
      "citation": {
        "db": "PubMed",
        "db_id": "10024361"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 42,
      "key": "e5081af0e1cb1f041ab9cbb15f571157"
    },
    {
      "line": 371,
      "relation": "directlyIncreases",
      "evidence": "The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38.",
      "citation": {
        "db": "PubMed",
        "db_id": "17082815"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 42,
      "key": "b968db869d773226a42c195ca170f257"
    },
    {
      "line": 371,
      "relation": "directlyIncreases",
      "evidence": "Activation of the Fas and TNFR family of death receptors induces a â€œprototypicâ€ apoptotic pathway through the recruitment of adaptor proteins such as FADD and upstream caspases such as caspase-8.",
      "citation": {
        "db": "PubMed",
        "db_id": "19109899"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 42,
      "key": "1c817bcd4ec977d8e73231d853d15a1d"
    },
    {
      "line": 371,
      "relation": "directlyIncreases",
      "evidence": "Necroptosis can be induced by the ligation of death receptors, including CD95 (also known as FAS; which binds the ligand CD95L (also known as FASL))29, TNF receptor 1 (TNFR1), TNFR2 (Refs 6, 13, 30), TNF-related apoptosis-inducing ligand receptor 1 (TRAILR1) and TRAILR2 (Ref. 9.)",
      "citation": {
        "db": "PubMed",
        "db_id": "20823910"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 44,
      "target": 42,
      "key": "f0a1a295875e9a291c9ced1a785745f6"
    },
    {
      "line": 1,
      "relation": "decreases",
      "evidence": "Flot-2 not only physically interacted with Fas, but also was required for Fas protein expression. Deletion of Flot-2 up-regulated the hyperoxia induced Fas expression in a time dependent manner, using Western Blot Analysis (Fig. 2C).",
      "citation": {
        "db": "PubMed",
        "db_id": "24204853"
      },
      "annotations": {},
      "source": 94,
      "target": 42,
      "key": "0a68a8b639b947455d5801e96c13fa28"
    },
    {
      "line": 2,
      "relation": "increases",
      "evidence": "Furthermore, silence of Flot-2 down-regulated the expression of XIAP ...after hyperoxia (Fig. 5C).",
      "citation": {
        "db": "Other",
        "db_id": "24204853"
      },
      "annotations": {},
      "source": 94,
      "target": 112,
      "key": "7fb846396fb7243b9fd94928868c76a9"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "Deletion of Flot-2 decreased the expression of survivin at both basal level and after hyperoxia in a time-dependent manner, determined using Western Blot Analysis and Real-time PCR (Fig. 5A and B).",
      "citation": {
        "db": "Other",
        "db_id": "24204853"
      },
      "annotations": {},
      "source": 94,
      "target": 113,
      "key": "cdec0d6442e8d61575e51cb196308d22"
    },
    {
      "line": 4,
      "relation": "decreases",
      "evidence": "Silencing of Flot-2 promoted the hyperoxia-induced cleavage of caspase-8 (active form) and caspase-8 activities (Fig 3D, E).",
      "citation": {
        "db": "Other",
        "db_id": "24204853"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 94,
      "target": 63,
      "key": "370ac0d9a9194b7cbb2a2df57595da61"
    },
    {
      "line": 5,
      "relation": "decreases",
      "evidence": "deletion of Flot-2 robustly increased hyperoxia induced caspase-3 and Poly (ADP-ribose) polymerase (PARP) activation indicated by increased cleaved (active) forms, using Western Blot Analysis (Fig. 1D).",
      "citation": {
        "db": "Other",
        "db_id": "24204853"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 94,
      "target": 59,
      "key": "b27722a61b1195952cbe3e56ccf32fca"
    },
    {
      "line": 438,
      "relation": "decreases",
      "evidence": "Deletion of Flot-2 promoted cell death and caspase-3 dependent apoptosis. Deletion of Flot-2  up-regulated cytosolic SMAC.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 94,
      "target": 77,
      "key": "7c9776982cc78653d5c323e8a244f9f4"
    },
    {
      "relation": "hasVariant",
      "source": 95,
      "target": 96,
      "key": "0aa839f0ce0cd85f4e603e85e8b9e263"
    },
    {
      "line": 16,
      "relation": "directlyDecreases",
      "evidence": "Insulin disrupts IRS-dependent transactivation by FKHR, and phosphorylation of Ser-256 by PKB is necessary and sufficient to mediate this effect.",
      "citation": {
        "db": "PubMed",
        "db_id": "10358076"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 96,
      "target": 95,
      "key": "e0ebef8e9c23f1e3373d245d1672510a"
    },
    {
      "line": 16,
      "relation": "directlyDecreases",
      "evidence": "We found that the phosphorylation of Ser-256 and introduction of a negative charge at this site (by replacing Ser-256 with an aspartate) also inhibits transactivation by FKHR, even when the phosphorylation of Thr-24 and Ser-319 has been prevented by replacing these residues with alanine.",
      "citation": {
        "db": "PubMed",
        "db_id": "12228231"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 96,
      "target": 95,
      "key": "b71b3a7ade278e1577396072d0103c49"
    },
    {
      "line": 16,
      "relation": "directlyDecreases",
      "evidence": "FKHR is phosphorylated by protein kinase B (PKB) at Thr24, Ser256 and Ser319 in response to growth factors, stimulating the nuclear exit and inactivation of this transcription factor.",
      "citation": {
        "db": "PubMed",
        "db_id": "11980723"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 96,
      "target": 95,
      "key": "8cf7f332b613391a1461aaee391498df"
    },
    {
      "relation": "hasVariant",
      "source": 97,
      "target": 98,
      "key": "38c39fb7dc3fde7761133af851218648"
    },
    {
      "line": 0,
      "relation": "directlyDecreases",
      "evidence": "phosphorylation reduces the ability of FOXO3-DNA interaction",
      "citation": {
        "db": "PubMed",
        "db_id": "23819440"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 98,
      "target": 97,
      "key": "78feed7e866ab9074561a8891ad3a602"
    },
    {
      "line": 163,
      "relation": "positiveCorrelation",
      "evidence": "Such apoptotic response of LT-2809 cells is characterised by increased expression of Gas2 which becomes proteolytically processed.",
      "citation": {
        "db": "PubMed",
        "db_id": "16465235"
      },
      "annotations": {},
      "source": 105,
      "target": 4,
      "key": "fdb5604280c2de6ee82f9c49a368187d"
    },
    {
      "line": 163,
      "relation": "positiveCorrelation",
      "evidence": "These results indicate that Gas2 is cleaved when apoptosis is prevalent in the autopod.",
      "citation": {
        "db": "PubMed",
        "db_id": "10049561"
      },
      "annotations": {},
      "source": 105,
      "target": 4,
      "key": "dba4034c1203ca001efcaf0ec851fb1d"
    },
    {
      "line": 425,
      "relation": "negativeCorrelation",
      "evidence": "Depletion of GSTP1 by itself could induce cell death, including apoptosis, in human lung fibroblast-derived HFL-1 cells....the authors reported the association between GSTP1 gene polymorphism and susceptibility to chronic obstructive pulmonary disease (COPD).",
      "citation": {
        "db": "Other",
        "db_id": "14710442"
      },
      "annotations": {},
      "source": 106,
      "target": 4,
      "key": "d622af1ed333dbfd359eefb8c21b1ec5"
    },
    {
      "line": 118,
      "relation": "increases",
      "evidence": "Figure 6 Both the serine protease activity and the IAP binding activity of HtrA2 contribute to its proapoptotic function",
      "citation": {
        "db": "PubMed",
        "db_id": "11604410"
      },
      "annotations": {},
      "source": 53,
      "target": 4,
      "key": "6a7b8ed137ec1148ffcd8140113a5f37"
    },
    {
      "line": 118,
      "relation": "increases",
      "evidence": "Figure 5 Omi can potentiate caspase activation and apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "11606597"
      },
      "annotations": {},
      "source": 53,
      "target": 4,
      "key": "6c70af040c9205733749063a07471b0e"
    },
    {
      "line": 412,
      "relation": "directlyDecreases",
      "evidence": "Omi/HtrA2 is a pro-apoptotic mitochondrial serine protease involved in both forms of apoptosis, caspase-dependent as well as caspase-independent cell death. However, the impact of Omi/HtrA2 in the apoptotic cell machinery that takes place in vivo under pathological conditions such as cerebral ischemia remains unknown. The present study was monitored in order to examine whether Omi/HtrA2 plays a decisive role in apoptosis observed after focal cerebral ischemia in rats. Male adult rats were subjected to 90min of focal cerebral ischemia followed by reperfusion and treated with vehicle or ucf-101, a novel and specific Omi/HtrA2 inhibitor, prior reperfusion. Focal cerebral ischemia/reperfusion induced a mitochondrial up-regulation of Omi/HtrA2 and significantly increased cytosolic accumulation of Omi/HtrA2. Furthermore, ischemia led to activation of caspase-3 and degradation X-linked inhibitor of apoptosis protein (XIAP). Treatment of animals prior ischemia with ucf-101, the specific inhibitor of Omi/HtrA2, was able to (1) reduce the number of TUNEL-positive cells, to (2) attenuate the XIAP-breakdown and to (3) reduce the infarct size. This study shows for the first time that focal cerebral ischemia in rats results in Omi/HtrA2 translocation from the mitochondria to the cytosol, where it participates in neuronal cell death. Blocking the proteolytic activity of Omi/HtrA2 with specific inhibitors, such as the ucf-101, could be a novel way to afford neuroprotection and minimize cellular damage in cerebral ischemia/reperfusion.",
      "citation": {
        "db": "Other",
        "db_id": "16978742"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 112,
      "key": "983c901dd59b430145f245cdc3d9c837"
    },
    {
      "line": 412,
      "relation": "directlyDecreases",
      "evidence": "Proteome analysis of supernatant of isolated mitochondria exposed to recombinant tBid, a proapoptotic Bcl-2 member, revealed the presence of the serine protease Omi, also called HtrA2. This release was prevented in mitochondria derived from Bcl-2-transgenic mice. Release of Omi under apoptotic conditions was confirmed in vivo in livers from mice injected with agonistic anti-Fas antibodies and was prevented in livers from Bcl-2 transgenic mice. Omi release also occurs in apoptotic dying but not in necrotic dying fibrosarcoma L929 cells, treated with anti-Fas antibodies and TNF, respectively. The amino acid sequence reveals the presence of an XIAP interaction motif at the N-terminus of mature Omi. We demonstrate an interaction between endogeneous Omi and recombinant XIAP. Furthermore we show that endogenous Omi is involved in enhanced activation of caspases in cytosolic extracts.",
      "citation": {
        "db": "Other",
        "db_id": "11803371"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 112,
      "key": "d3bcd819e46314bb7862640ae74f2107"
    },
    {
      "line": 412,
      "relation": "directlyDecreases",
      "evidence": "Only those BIR domain-containing proteins that are potent caspase inhibitors (c-IAP1, c-IAP2, XIAP, Livin {alpha}, Livin {beta}, and DIAP1) are enzymatic substrates of Omi.",
      "citation": {
        "db": "PubMed",
        "db_id": "12815069"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 112,
      "key": "14db1b8e0976f8f10d61d1355950677f"
    },
    {
      "line": 412,
      "relation": "directlyDecreases",
      "evidence": "The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 112,
      "key": "fac6d666ba8c6558bc831f45745b9e43"
    },
    {
      "line": 412,
      "relation": "directlyDecreases",
      "evidence": "X chromosome-linked inhibitor of apoptosis (XIAP) is an endogenous inhibitor of caspase-3, -7, and -9. Smac/DIABLO, an inhibitor of XIAP, is released from mitochondria upon receiving apoptotic stimuli and binds to the BIR2 and BIR3 domains of XIAP, thereby inhibiting its caspase-inhibitory activity. Here we report that a serine protease called HtrA2/Omi is released from mitochondria and inhibits the function of XIAP by direct binding in a similar way to Smac. Moreover, when overexpressed extramitochondrially, HtrA2 induces atypical cell death, which is neither accompanied by a significant increase in caspase activity nor inhibited by caspase inhibitors, including XIAP. A catalytically inactive mutant of HtrA2, however, does not induce cell death. In short, HtrA2 is a Smac-like inhibitor of IAP activity with a serine protease-dependent cell death-inducing activity.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 112,
      "key": "0817b4375d9f5ebea5c6985e5a0731c9"
    },
    {
      "relation": "hasVariant",
      "source": 114,
      "target": 115,
      "key": "09b8d15333299a7def87660da0607c47"
    },
    {
      "relation": "hasVariant",
      "source": 114,
      "target": 116,
      "key": "08831b388c3e14449cf4902d6ae04187"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "PMA activates the endogenous IKK epsilon Complex, which phosphorylates both S32 and S36 of IkappaBalpha. Dominant-Negative IKK epsilon blocks induction of NF-kappaB by PMA or T Cell Receptor Cross-Linking but Not TNFalpha or IL-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "10882136"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 55,
      "target": 8,
      "key": "9870b14a330410f56c8cb67ef53b475c"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "Expression of a kinase-inactive IKK-i/IKKepsilon mutant in breast cancer cells reduced NF-kappaB activity as judged by transfection assays of reporters driven either by NF-kappaB elements or the promoters of two NF-kappaB target genes, cyclin D1 and relB.mportantly, the kinase-inactive IKK-i/IKKepsilon mutant reduced the endogenous levels of these genes as well.",
      "citation": {
        "db": "PubMed",
        "db_id": "16357145"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 55,
      "target": 8,
      "key": "5d2e6ecda009479990de764f2b6c0828"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "IKKrepsilon activates the nuclear factor-kappaB (NF-kappaB) pathway in both cell lines and breast cancers.",
      "citation": {
        "db": "PubMed",
        "db_id": "17574021"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 55,
      "target": 8,
      "key": "5a98ec895cc16f78bae0efc934818d4a"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "Overexpression of wild-type IKK-i phosphorylated serine residues Ser32 and Ser36 of IkappaB-alpha (preferentially Ser36), and significantly stimulated NF-kappaB activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "10421793"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 55,
      "target": 8,
      "key": "6fb57923eba778ba577ce0170c2d6fd1"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "Thus, IKKepsilon and TBK1 have a pivotal role in coordinating the activation of IRF3 and NF-kappaB in the innate immune response (via TLR3 activation).",
      "citation": {
        "db": "PubMed",
        "db_id": "12692549"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 55,
      "target": 8,
      "key": "ca143a6f235bdef754dd88691eb16040"
    },
    {
      "line": 7,
      "relation": "increases",
      "evidence": "IL-6 induced the resistance of IPF lung fibroblasts to Fas-induced apoptosis due to the increased expression of the anti-apoptotic protein BCL-2, in contrast to IL-6 stimulated normal lung fibroblasts, which were more sensitive to Fas-induced apoptosis due to the increased expression of the pro-apoptotic protein Bax.",
      "citation": {
        "db": "Other",
        "db_id": "24478703"
      },
      "annotations": {},
      "source": 118,
      "target": 174,
      "key": "1586e8b2352174f520ec1e5cb5425670"
    },
    {
      "line": 8,
      "relation": "increases",
      "evidence": "IL-6 treatment stimulated lung Stat3 activation and prevented AEC apoptosis",
      "citation": {
        "db": "Other",
        "db_id": "20443866"
      },
      "annotations": {},
      "source": 118,
      "target": 33,
      "key": "d27346645eba274f22def33887aa04ea"
    },
    {
      "line": 427,
      "relation": "decreases",
      "evidence": "Vascular-endothelial growth factor (VEGF) appears to be necessary to maintain alveolar cell survival, and blockade of VEGF receptors (VEGFR2) in rats induces apoptosis of alveolar cells and an emphysema-like pathology \n\nVEGFR2 Is a synonym of KDR (source : HGNC)",
      "citation": {
        "db": "Other",
        "db_id": "15602009"
      },
      "annotations": {},
      "source": 119,
      "target": 4,
      "key": "cfd08b0fa9ca65c4823b28c1f17941cf"
    },
    {
      "line": 428,
      "relation": "decreases",
      "evidence": "Vascular-endothelial growth factor (VEGF) appears to be necessary to maintain alveolar cell survival, and blockade of VEGF receptors (VEGFR2) in rats induces apoptosis of alveolar cells and an emphysema-like pathology",
      "citation": {
        "db": "Other",
        "db_id": "15602009"
      },
      "annotations": {},
      "source": 119,
      "target": 191,
      "key": "eee70f1040d78985905d76274f9e1f6d"
    },
    {
      "line": 288,
      "relation": "directlyDecreases",
      "evidence": "Finally, PD exposure induced apoptosis in U937 cells through caspase-3-dependent PARP and lamin A cleavage.",
      "citation": {
        "db": "PubMed",
        "db_id": "18351645"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "e21a4570eb1947c9dbbcc578656130e1"
    },
    {
      "line": 288,
      "relation": "directlyDecreases",
      "evidence": "Here we found that rabbitpox virus CrmA/SPI-2 inhibits the cleavage of lamin A mediated by a caspase in our cell-free system of apoptosis. In the presence of CrmA/SPI-2, nuclear apoptosis in vitro was blocked at an intermediate stage after collapse of the chromatin against the nuclear periphery and before nuclear shrinkage and disintegration into apoptotic body-like fragments.",
      "citation": {
        "db": "PubMed",
        "db_id": "8955067"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "2e40436843848a7f64d99eb168b73225"
    },
    {
      "line": 288,
      "relation": "directlyDecreases",
      "evidence": "Furthermore, exposure of MCF-7 cells with caspase-6 knockdown to staurosporine resulted in complete inhibition of lamin A/C cleavage, without any effect on p23 or PARP cleavage (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19325570"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "ce8bf2c7bcee1991ea9fa22a49c3ba38"
    },
    {
      "line": 288,
      "relation": "directlyDecreases",
      "evidence": "The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A.",
      "citation": {
        "db": "PubMed",
        "db_id": "8663580"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 120,
      "key": "5cb1b69859ec5b43c8b40f856c890f82"
    },
    {
      "line": 289,
      "relation": "increases",
      "evidence": "Here we found that rabbitpox virus CrmA/SPI-2 inhibits the cleavage of lamin A mediated by a caspase in our cell-free system of apoptosis. In the presence of CrmA/SPI-2, nuclear apoptosis in vitro was blocked at an intermediate stage after collapse of the chromatin against the nuclear periphery and before nuclear shrinkage and disintegration into apoptotic body-like fragments.",
      "citation": {
        "db": "PubMed",
        "db_id": "8955067"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 120,
      "target": 4,
      "key": "894bb92ccca23d31e4d1c3611e12b1bb"
    },
    {
      "line": 212,
      "relation": "directlyDecreases",
      "evidence": "Our previous work showed that the degradation of lamin B1 in glucocorticoid-treated thymocytes occurs via a Ca2+-sensitive mechanism and that exogenous Ca2+ promotes lamin degradation in isolated thymocyte nuclei from untreated cells",
      "citation": {
        "db": "PubMed",
        "db_id": "8798402"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 121,
      "key": "62f4697d3b7dff0250beee1fa703658b"
    },
    {
      "line": 212,
      "relation": "directlyDecreases",
      "evidence": "Induction of apoptosis was demonstrated by DNA fragmentation, cleavage of poly (ADP-ribose) polymerase and Lamin B.",
      "citation": {
        "db": "PubMed",
        "db_id": "15318945"
      },
      "annotations": {
        "doid": {
          "3347": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 121,
      "key": "2161404e21442259f3ebb9fec073f885"
    },
    {
      "line": 212,
      "relation": "directlyDecreases",
      "evidence": "While lamin B is cleaved by caspase 6, the protease responsible for the cleavage of LAP2 and Nup153 was probably caspase 3, since (1) cleavage of both proteins was specifically prevented by in vivo addition of caspase 3 inhibitor Ac-DEVD-CHO and (2) consensus sites for these caspases are present in both proteins.",
      "citation": {
        "db": "PubMed",
        "db_id": "10318766"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 121,
      "key": "f3b86c4481a2b313c2a5f3ad21db850f"
    },
    {
      "line": 212,
      "relation": "directlyDecreases",
      "evidence": "The functions of gelsolin have been described above, but it is also a substrate for the apoptotic enzyme caspase-3 (150) that cleaves the actin-binding domain of gelsolin from its calcium-binding domain. Evidence for CASP3 activation includes observed increased abundance of the cleavage products of CASP3 targets , including ACTG1, GSN, KRT18, ACTB and ACTA2, as well as decreased abundance of full-length targets of CASP3 which include VIM, KRT20, YWHAB, LMNB1, and ACTA1.",
      "citation": {
        "db": "PubMed",
        "db_id": "10400609"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 121,
      "key": "d4494df3b90b4d96aa9467c9edb10a94"
    },
    {
      "line": 212,
      "relation": "directlyDecreases",
      "evidence": "figure 1 - conservation of caspase clevage sites",
      "citation": {
        "db": "PubMed",
        "db_id": "11973607"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 121,
      "key": "90ccb642e0ef387461c6b598f071e535"
    },
    {
      "line": 212,
      "relation": "directlyDecreases",
      "evidence": "Lamins are, however, substrates for members of the interleukin-1 beta-converting enzyme (ICE) family of cysteine proteases that are activated during apoptosis and function downstream of Bcl-2 in the cell death pathway . . . Thus, lamin breakdown by proteolytic degradation facilitates the nuclear events of apoptosis perhaps by facilitating nuclear breakdown.",
      "citation": {
        "db": "PubMed",
        "db_id": "8978814"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 121,
      "key": "a250e912a94531d28b63524177b81805"
    },
    {
      "line": 213,
      "relation": "increases",
      "evidence": "Induction of apoptosis was demonstrated by DNA fragmentation, cleavage of poly (ADP-ribose) polymerase and Lamin B.",
      "citation": {
        "db": "PubMed",
        "db_id": "15318945"
      },
      "annotations": {
        "doid": {
          "3347": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 121,
      "target": 4,
      "key": "c1370c03938df47d7a8ca4eb19f08bc6"
    },
    {
      "line": 369,
      "relation": "directlyDecreases",
      "evidence": "Induction of apoptosis was demonstrated by DNA fragmentation, cleavage of poly (ADP-ribose) polymerase and Lamin B.",
      "citation": {
        "db": "PubMed",
        "db_id": "15318945"
      },
      "annotations": {
        "doid": {
          "3347": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 122,
      "key": "895004dbafd8e2603c633af6438b0e3a"
    },
    {
      "line": 369,
      "relation": "directlyDecreases",
      "evidence": "figure 1 - conservation of caspase clevage sites",
      "citation": {
        "db": "PubMed",
        "db_id": "11973607"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 122,
      "key": "f186a074ee2360095432f3e99e4424d0"
    },
    {
      "line": 370,
      "relation": "increases",
      "evidence": "Induction of apoptosis was demonstrated by DNA fragmentation, cleavage of poly (ADP-ribose) polymerase and Lamin B.",
      "citation": {
        "db": "PubMed",
        "db_id": "15318945"
      },
      "annotations": {
        "doid": {
          "3347": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 122,
      "target": 4,
      "key": "557eb67d6bfb096bf35b15da64e4cd34"
    },
    {
      "line": 426,
      "relation": "increases",
      "evidence": "we demonstrate a pivotal role for the autophagic protein LC3B in CS-induced apoptosis and emphysema, suggestive of novel therapeutic targets for COPD treatment",
      "citation": {
        "db": "Other",
        "db_id": "20956295"
      },
      "annotations": {},
      "source": 50,
      "target": 4,
      "key": "cdf4c22fba828b5d7dee4268de17b0bb"
    },
    {
      "line": 386,
      "relation": "directlyIncreases",
      "evidence": "In this paper, we present a comprehensive pathway map of EGFR signaling and other related pathways. The map reveals that the overall architecture of the pathway is a bow-tie (or hourglass) structure with several feedback loops.  See figure 2: The bow-tie architecture of the EGFR signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16729045"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 126,
      "target": 20,
      "key": "897d7f3074d8df9a4414b41666d49f5e"
    },
    {
      "relation": "hasVariant",
      "source": 127,
      "target": 128,
      "key": "f5edfb0c87eb7a4f51091e02b72905ec"
    },
    {
      "relation": "hasVariant",
      "source": 127,
      "target": 129,
      "key": "9c7db960a4728ad46d96520563f0718d"
    },
    {
      "line": 306,
      "relation": "increases",
      "evidence": "Figure 5. Overexpressed MEKK1 (S957A/S994A) blocks RIP-induced activation of IKK-beta and NF-kB.",
      "citation": {
        "db": "PubMed",
        "db_id": "11369754"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 127,
      "target": 114,
      "key": "4a2bf993ce7caa459011f2f0e59e4cb4"
    },
    {
      "line": 306,
      "relation": "increases",
      "evidence": "Expression of kinase-inactive MEKK1 attenuated TNF-â€“induced IKK activation, whereas expression of active MEKK1 was sufficient for IKK activation (Figure 6C).",
      "citation": {
        "db": "PubMed",
        "db_id": "12600818"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 127,
      "target": 114,
      "key": "710da6b6e9c1ed55c6209b141d563158"
    },
    {
      "line": 306,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "9819420"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 127,
      "target": 114,
      "key": "662380df40169bbda836d8dd76ad447e"
    },
    {
      "line": 306,
      "relation": "increases",
      "evidence": "We also show that MEKK1 can induce the activation of both IKK-alpha and IKK-beta in vivo. Finally, we show that IKK-alpha is present in the MEKK1-inducible, high molecular weight IkappaB kinase complex and treatment of this complex with MEKK1 induces phosphorylation of IKK-alpha in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "9689078"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 127,
      "target": 114,
      "key": "83216befe9551c0ab5528f8188c47420"
    },
    {
      "line": 280,
      "relation": "directlyIncreases",
      "evidence": "Figure 6 Phosphorylation of MEKK1 at Ser-957 and Ser-994 is important for RIP-induced MEKK1 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11369754"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 128,
      "target": 127,
      "key": "4a20997594df081c10dad877acf61e53"
    },
    {
      "line": 84,
      "relation": "directlyIncreases",
      "evidence": "Figure 6 Phosphorylation of MEKK1 at Ser-957 and Ser-994 is important for RIP-induced MEKK1 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11369754"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 127,
      "key": "ab57858a1c14cafebb87dd8c412fd526"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "Since IKKalpha is activated by NF-kB-inducing kinase (NIK), we overexpressed native NIK using an adenovirus vector that resulted in enhanced phospho-IkBa and nuclear p65 in detached cells compared to control detached cells but did not result in a significantly greater number of cells surviving to 24 h.",
      "citation": {
        "db": "PubMed",
        "db_id": "10788610"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 130,
      "target": 7,
      "key": "1c92898b63d86ceef628c158f3fea92a"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "To test whether TAK1, NIK, or PI3K is involved in mediating iron-induced IKK activation, we used an adenoviral vector expressing a DN mutant of each kinase and a green fluorescent protein-expressing vector as a control. Transduction of each DN at m.o.i. of 50 completely prevents iron-induced IKK activation (Fig. 2, A?C). Furthermore, use of the PI3K inhibitor LY294002 results in similar abrogation of IKK activation (Fig. 2D). Addition of U0126, the MEK1 inhibitor, also prevents IKK activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17172471"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 130,
      "target": 7,
      "key": "f445f828fe26a41a8cca3eefeb050a98"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "Molecular and biochemical analysis indicates that nuclear transcription factor kappaB (NF-kappaB)-inducing kinase (NIK) mediates IKK activation and NF-kappaB transcriptional activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "15212763"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 130,
      "target": 7,
      "key": "5915d59621c0123ce76eb90838ceafdb"
    },
    {
      "line": 185,
      "relation": "directlyIncreases",
      "evidence": "Figure 3 Ser-176 in the activation loop of IKK-alpha is a major site of phosphorylation by NIK",
      "citation": {
        "db": "PubMed",
        "db_id": "9520446"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 130,
      "target": 74,
      "key": "b7505969b6632f9fbe63ac31d0393db3"
    },
    {
      "line": 185,
      "relation": "directlyIncreases",
      "evidence": "# full text # Akt phosphorylates threonine-23 in IKK{alpha} (35), whereas NIK phosphorylates serine-176 in the kinase loop of IKK{alpha} (54)",
      "citation": {
        "db": "PubMed",
        "db_id": "16613850"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 130,
      "target": 74,
      "key": "36385246cb1a74f42005cdd2b22873c8"
    },
    {
      "relation": "hasVariant",
      "source": 131,
      "target": 132,
      "key": "4b3095073167efb8fa3a4fb93f2904f6"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Here we report that ASK1 proapoptotic activity is antagonized by association with 14-3-3 proteins.",
      "citation": {
        "db": "PubMed",
        "db_id": "10411906"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "3ebbe1193e2bd2e82bb9db8074757e22"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Biochemical analysis showed that cytoplasmic p21(Cip1/WAF1) forms a complex with the apoptosis signal-regulating kinase 1 (ASK1) and inhibits stress-activated MAP kinase cascade",
      "citation": {
        "db": "PubMed",
        "db_id": "10064589"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "da94e0867c83624fa3b45802eb7520d6"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Hsp72 blocked both the homo-oligomerization of ASK1 and ASK1-dependent apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "12391142"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "960051616010083eaba8618d8232600a"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "We further used ASK1 siRNA to verify the involvement of ASK1 in ceramide-induced cell death. A reduced ASK1 protein level in ASK1 siRNA-transfected Jurkat T cells was confirmed as compared with vector control-transfected cells (Figure 5D left panel). After ceramide treatment, ASK1 siRNA-transfected EGFP+ cells showed lower percentages of apoptotic cells than the vector control group (Figure 5D right panel; Figure S3B).",
      "citation": {
        "db": "PubMed",
        "db_id": "18270325"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "422d4a5c1d85cd727dd080d1cb92055e"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "MAP3K5 mediates rapamycin induced apoptosis via phosphorylation of c-Jun in p53- deficient mouse embryonic fibroblasts",
      "citation": {
        "db": "PubMed",
        "db_id": "16530485"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "6372d3e4c9ce0231b003038cc9e0f6dc"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Our data suggest that association of Trx with ASK1 through a single Cysteine (C32 or C35) is necessary and sufficient for Trx activity in inducing ASK1 ubiquitination/degradation leading to inhibition of ASK1-induced apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12089063"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "4ff99943341f62aee8a8a3073a67f62c"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Apoptosis signal-regulating kinase 1 (ASK1) is a MAP kinase kinase kinase (MAPKKK) that activates the JNK and p38 MAP kinase cascades and is activated in response to oxidative stress such as hydrogen peroxide (H(2)O(2))",
      "citation": {
        "db": "PubMed",
        "db_id": "11689443"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "e2156d4679500748e03efdb0ad327897"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Redox-sensing molecules such as thioredoxin (TRX) and glutaredoxin (GRX) bind to apoptosis signal-regulating kinase 1 (ASK1) and suppress its activation",
      "citation": {
        "db": "PubMed",
        "db_id": "12723971"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "66e5b20135d7cb430b20ace5b96ba68a"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Overexpression of ASK1 induced apoptotic cell death, and ASK1 was activated in cells treated with tumor necrosis factor-alpha (TNF-alpha).  Moreover, TNF-alpha-induced apoptosis was inhibited by a catalytically inactive form of ASK1",
      "citation": {
        "db": "PubMed",
        "db_id": "8974401"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "0550cbd15c0f8c81de84af2de5c716f1"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "We found that Raf-1 interacts with the proapoptotic, stress-activated protein kinase ASK1 (apoptosis signal-regulating kinase 1) in vitro and in vivo",
      "citation": {
        "db": "PubMed",
        "db_id": "11427728"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "557e1427afe1e499e139e3ae0b2d621b"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "In this study, we found that H-Ras interacted with ASK1 to cause the inhibition of both ASK1 activity and ASK1-induced apoptosis in vivo",
      "citation": {
        "db": "PubMed",
        "db_id": "15115616"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "243f9c64dd5018ed176a9494025e828f"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Overexpression of Rb inhibited ASK1-induced apoptosis; in addition, an ASK1 mutant incapable of binding Rb could not induce apoptosis, indicating that ASK1 has to overcome the antiapoptotic properties of Rb to kill cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15210709"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "fa67cf16398a273265a729375d574f09"
    },
    {
      "line": 346,
      "relation": "increases",
      "evidence": "Moreover, mGSTM1-1 repressed ASK1-dependent apoptotic cell death.",
      "citation": {
        "db": "PubMed",
        "db_id": "11278289"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 4,
      "key": "5eef9595ae8b96718c692b2c584ee7da"
    },
    {
      "line": 347,
      "relation": "directlyIncreases",
      "evidence": "three MAP kinase kinase kinases (MAP3K4, MAP3K5, MAP3K9) that phosphorylate and activate the MAP kinase kinases MAP2K4 and MAP2K7 (molecules that phosphorylate threonine and tyrosine residues within the activation loop of JNK)",
      "citation": {
        "db": "Other",
        "db_id": "23940728"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 126,
      "key": "a7d3e9e9571f08ccb42ccb048e84bbf9"
    },
    {
      "line": 347,
      "relation": "directlyIncreases",
      "evidence": "SKRP1 specifically enhanced the activation of MKK7 by ASK1",
      "citation": {
        "db": "PubMed",
        "db_id": "11959862"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 126,
      "key": "a795130bb1ae32a597c7fa21388098c5"
    },
    {
      "line": 376,
      "relation": "directlyDecreases",
      "evidence": "AKT2 interacts with and phosphorylates ASK1 at Ser-83 resulting in inhibition of its kinase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12697749"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 131,
      "key": "2a592ca7e86557c0346c453b56b48512"
    },
    {
      "line": 376,
      "relation": "directlyDecreases",
      "evidence": "Because ceramide up-regulated Txnip expression and reduced thioredoxin activity, we therefore investigated the effect of ceramide on ASK1 activity. The inhibitory residue serine 83 (Ser83) of ASK1 was dephosphorylated after ceramide treatment in both Jurkat T cells (Figure 5A) and 10I cells (Figure S2). This is consistent with the previous findings that Akt/PKB phosphorylates ASK1 Ser83,47 whereas ceramide inhibits Akt/PKB.4,6,48,49",
      "citation": {
        "db": "PubMed",
        "db_id": "18270325"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 131,
      "key": "bca07cdfcbdede5607c2b2ba492da74d"
    },
    {
      "line": 376,
      "relation": "directlyDecreases",
      "evidence": "AKT phosphorylates and inhibits apoptosis signal-regulating kinase 1 (ASK1) at Ser83, thereby promoting cell survival (Yuan et al., 2003; Zhang et al., 2005; Wu et al., 2006).",
      "citation": {
        "db": "PubMed",
        "db_id": "18794886"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 131,
      "key": "d6c551fa44ee6c30286cd32b32f0f8f9"
    },
    {
      "line": 376,
      "relation": "directlyDecreases",
      "evidence": "Akt decreased ASK1 kinase activity stimulated by both oxidative stress and overexpression in 293 cells by phosphorylating a consensus Akt site at serine 83 of ASK1.",
      "citation": {
        "db": "PubMed",
        "db_id": "11154276"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 131,
      "key": "b32399fa5423457587a3b9a03361295f"
    },
    {
      "line": 376,
      "relation": "directlyDecreases",
      "evidence": "Dissociated Akt1 binds to SEK1 and ASK1 and inhibits their enzyme activity by phosphorylating SEK1 on the Ser-80 residue and ASK1 on the Ser-83 residue.",
      "citation": {
        "db": "PubMed",
        "db_id": "15911620"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 131,
      "key": "799f955037b286d9024de50f182b3a7b"
    },
    {
      "relation": "hasVariant",
      "source": 133,
      "target": 134,
      "key": "2e80dfcc94195c181f51d769f847239a"
    },
    {
      "line": 293,
      "relation": "directlyIncreases",
      "evidence": "TAK1 can also activate IkappaB kinase (IKK) that leads to degradation of IkappaB and subsequent NF-kappaB activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16893890"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 133,
      "target": 7,
      "key": "58ad2b721c1973640cc6a4f759821340"
    },
    {
      "line": 159,
      "relation": "directlyIncreases",
      "evidence": "15486195;14555991",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 135,
      "target": 185,
      "key": "ead66e8d781e60a927186a7c097d4f7a"
    },
    {
      "line": 160,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "10972974"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 135,
      "target": 156,
      "key": "ded62c8c4e187e2a8e2a9cd3b0bd62d8"
    },
    {
      "line": 161,
      "relation": "directlyIncreases",
      "evidence": "PhosphoElm data from PMID 15212693",
      "citation": {
        "db": "PubMed",
        "db_id": "12792650"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 135,
      "target": 65,
      "key": "3dcc13af398604ab3ce07fd4dccda17a"
    },
    {
      "line": 126,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "10490655"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 137,
      "target": 156,
      "key": "4a94308a74736df093b146a20927d165"
    },
    {
      "line": 127,
      "relation": "directlyIncreases",
      "evidence": "15486195;14555991",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 137,
      "target": 185,
      "key": "fd40c56613cc9a67862b81ee4c67f21a"
    },
    {
      "line": 128,
      "relation": "directlyIncreases",
      "evidence": "PhosphoElm data from PMID 15212693",
      "citation": {
        "db": "PubMed",
        "db_id": "12792650"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 137,
      "target": 65,
      "key": "fa6c46a4efc3a8d087460fd3307f8557"
    },
    {
      "relation": "hasVariant",
      "source": 123,
      "target": 124,
      "key": "50c0d00d0ac688eb532f69b4c3d07bf1"
    },
    {
      "relation": "hasVariant",
      "source": 123,
      "target": 125,
      "key": "af5bbd078f479c3ad1dc854204c715ba"
    },
    {
      "line": 193,
      "relation": "directlyDecreases",
      "evidence": "We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 140,
      "target": 169,
      "key": "4380c2f0d6afd22963f2fa7d36f568a4"
    },
    {
      "line": 194,
      "relation": "directlyDecreases",
      "evidence": "We increased Bax or cBak to the levels at which they significantly permeabilize liposomes on their own, and found that they were directly inhibited by Bcl-xL or Mcl-1, in a dose dependent manner (Fig. 5A).",
      "citation": {
        "db": "PubMed",
        "db_id": "21041309"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 140,
      "target": 174,
      "key": "ee57aa4a7279d45eb34ee05c23aaf153"
    },
    {
      "relation": "hasComponent",
      "source": 141,
      "target": 8,
      "key": "18daf0568be38eabc155940e935136eb"
    },
    {
      "relation": "hasComponent",
      "source": 142,
      "target": 8,
      "key": "931cba4379cc41ee585acf65e96e0de0"
    },
    {
      "relation": "hasVariant",
      "source": 143,
      "target": 144,
      "key": "9189bbd696e08ae7137bdc34b83014b8"
    },
    {
      "relation": "hasVariant",
      "source": 143,
      "target": 145,
      "key": "a168833b9b225c376b1d124a625abee5"
    },
    {
      "line": 403,
      "relation": "decreases",
      "evidence": "Low shear for 6 h resulted in a reduction of IkappaBalpha levels, an activation of NF-kappaB, and an increase in kappaB-dependent vascular cell adhesion molecule 1 (VCAM-1) mRNA expression and endothelial-monocyte adhesion",
      "citation": {
        "db": "PubMed",
        "db_id": "12620896"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 143,
      "target": 8,
      "key": "b17278e8579319945351553b4e274712"
    },
    {
      "line": 403,
      "relation": "decreases",
      "evidence": "Induction of RAW264.7-derived NO inhibited lipopolysaccharide-induced endothelial VCAM-1 expression, which was reversed by the NO synthase inhibitor Nomega-monomethyl-L-arginine. These findings indicate that NO inhibits NF-kappaB activation and VCAM-1 expression by increasing the expression and nuclear translocation of IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "9388244"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 143,
      "target": 8,
      "key": "ea94c1623d222ab8a9960103bb307a3a"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "62d7a11d8e8f64cc30c48f9058975e62"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The actual recognition of N-terminally phosphorylated IKappaBs is carried out by aWD repeat- and F box-containing protein called beta-TrCP (Ben-Neriah, 2002). Upon ubiquiti-nation, the IKappaB proteins are rapidly degraded by the proteasome,",
      "citation": {
        "db": "PubMed",
        "db_id": "11983155"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "6fa347af3b2146f95fac42942e2f4716"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "TNF induced NF-kappaB activation as measured by DNA binding but deletion of PKR abolished this activation.This inhibition was associated with suppression of inhibitory subunit of NF-kappaB (IkappaB)alpha kinase (IKK) activation, IkappaBalpha phosphorylation and degradation, p65 phosphorylation and nuclear translocation, and NF-kappaB-dependent reporter gene transcription.",
      "citation": {
        "db": "PubMed",
        "db_id": "16924232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "3b2ebd3f89c3b6df59c02b7d808784f9"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The incubation of ECs for 1 h in the presence of TNF-a alone induced significant degradation of IkB-a.",
      "citation": {
        "db": "PubMed",
        "db_id": "20351055"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "7000d803db07785940c27322f9822453"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Stimulation of the MDMs with CSM for 30 min induced the phosphorylation of IRAK which was abolished by adding NAC (Fig. 6A). Moreover, CSM and LPS (as a control) degradated I?B-? and preincubation of MDMs with NAC suppressed the degradation of I?B-? induced by CSM (Fig. 6D).",
      "citation": {
        "db": "PubMed",
        "db_id": "19409098"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "1050c9fb745cb5ad1041a227525b815b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "In turn, IKK2 phosphorylates inhibitor of NF-kappaB (I-kappaBalpha), leading to its ubiquitination and subsequent degradation by the proteasome. This frees up the p65 and p50 subunits of NF-kappaB, which translocate to the nucleus. Intranuclear NF-kappaB then binds to kappaB recognition sites in the 5'-promoter (upstream) region of inflammatory genes, resulting in increased gene transcription, messenger RNA, and synthesis of inflammatory proteins.",
      "citation": {
        "db": "PubMed",
        "db_id": "16865089"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "97a8a454d125e095d4e339b2884b9695"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "PKC (protein kinase C) enzymes which phosphorylate IkappaBalpha, leading to its degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "15330761"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "39aa7b4aefbe31618a903e845c00611b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "overexpressing PKC-zeta results in lower steady-state protein levels of free IkappaBalpha, which is dependent on S293.",
      "citation": {
        "db": "PubMed",
        "db_id": "10764587"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "04b4e4e4eaba319c185d8768776f76b4"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "In contrast to the serine 32/34 phosphorylation that triggers ubiquitination and degradation of IkappaBalpha, c-Abl-mediated phosphorylation at tyrosine 305 is associated with an increase of the IkappaBalpha protein stability. We also demonstrate that c-Abl targets the nuclear subpopulation of IkappaBalpha for phosphorylation and induces it to accumulate in the nucleus",
      "citation": {
        "db": "PubMed",
        "db_id": "12167702"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "c8b6239740df0ffd62ed9865631b22f7"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "SUMO-1 modification was found to antagonize IkappaBalpha ubiquitination and protect it from degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "10788439"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "09be8ad86dbcb12d26f883128e64a888"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "366525fc7e0ecd67fa479bd4f50f96b1"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The IRAK4:IRAK1:TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1 and TAB2.  This interaction induces phosphorylation of TAB2 and TAK1.  TAK1 is subsuequently activated in the cytoplasm, leading to the activation of IKK.  Activation leads to phosphorylation and degradation of IKB and consequent release of NFKB. Activation of TAK1 also results in the activation of MAP kinases and JNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "3570078743c8c35a733799e5b8df1960"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "TNF-alpha induced both phosphorylation and degradation of IKappaB-alpha in A549 cells within several minutes",
      "citation": {
        "db": "PubMed",
        "db_id": "15489375"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "d928db79b006f8e59791bab63bb2134a"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "In human neutrophils, TNF-alpha (200 U/ml) induced rapid I kappa B-alpha degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "15162444"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "da53d8f0dcdd710423380d7081480654"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "As shown in Fig. 10C, TNF-a rapidly induced complete degradation of I-kB-a",
      "citation": {
        "db": "PubMed",
        "db_id": "10946303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "23abe19a09f9c83e30a9ae8222cbcb82"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Reconstitution of NEMO-deficient Jurkat cells with wild-type, but not NEMOL329P, restored TNF-alpha-induced IkappaB degradation. Similar results were obtained for TNF-alpha-induced IkappaB degradation (Fig. 3c, d) and NF-kappaB binding (Fig. 3e) in NEMO-deficient mouse embryonic fibroblast (MEF) subclones reconstituted with wildtype NEMO or NEMOL329P.",
      "citation": {
        "db": "PubMed",
        "db_id": "16547522"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "e55831160379775caf2c67b68f16ce6c"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "We investigated its role in NF-?B activation and ROS production induced by TNF-? by using rapamycin (sirolimus), a well-characterized immunosuppressant and potent inhibitor of the signaling cascade. As described above, the phosphorylation and subsequent degradation of I?B play a critical role in regulating NF-?B translocation to the nucleus and subsequent transcriptional regulation. In Figure 6, we asked if rapamycin has any effect on TNF-?-induced degradation of I?B?; clearly, it did. I?B? is largely stabilized by the pretreatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "18463678"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "fa2702e8d5ecbdb83de7c02bf8f2347f"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "OPN also induces NFkappaB activation through phosphorylation and degradation of IkappaBalpha by inducing the IKK activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12771144"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "6d14b1ef479bb8de86ad801eac72cef9"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Pretreatment with EGF protected monolayers by increasing native PKC-beta1 activity, decreasing IkappaBalpha phosphorylation/degradation, suppressing NF-kappaB activation (p50/p65 subunit nuclear translocation/activity), enhancing stable actin (increased F-actin-to-G-actin ratio), increasing stability of actin cytoskeleton, and reducing barrier hyperpermeability.",
      "citation": {
        "db": "PubMed",
        "db_id": "14602581"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "ec3a55db40143031d37f4dc6679cc786"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Treatment of A549 cells with TGF-beta1-induced IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 Ser536 phosphorylation, and kappaB-luciferase activity. The TGF-beta1-mediated increases in IKKalpha/beta phosphorylation, p65 Ser536 phosphorylation, and kappaB-luciferase activity were inhibited by LY 294002, an Akt inhibitor",
      "citation": {
        "db": "PubMed",
        "db_id": "17307160"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "907e476b7307d4c9d2de7969f1af3821"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "phosphorylation and ubiquitination-dependent degradation of IkappaBalpha, the cytoplasmic inhibitor of NFkappaB, via the inducible IkappaB kinase (IKK) complex, liberates NFkappaB to translocate into the nucleus and to transcriptionally activate its target genes, including the IL2 gene",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "5aed1e9148d974dd2b64d1d9fccf7d83"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "CD86 stimulation also increased the level of IkappaB-alpha phosphorylation but in a protein kinase C-independent manner",
      "citation": {
        "db": "PubMed",
        "db_id": "15024018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "3937733bcee177ff24e9b4ad9f0b2556"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11976320"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "89ddf14e07adb7e1e019db18f01c7d24"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Cytoplasmic and total cell protein extracts were analyzed by Western blotting for total IkBa and IkBa phosphorylated at serine residues 32 and 36. LPS exposure induced the rapid (within 15 min) phosphorylation and degradation of IkBa in both THP-1 cells (p,0.0001 for both processes; Figure 8, A and B) and elutriated primary human monocytes (p =0.003 and p,0.0001, respectively, ANOVA post hoc contrast of LPS vs. control for each; Figure 8, C and D).",
      "citation": {
        "db": "PubMed",
        "db_id": "19956541"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "0ceedafc6998a093db7bb595e5a2a848"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The lipopolysaccharide-induced degradation of IL-1R-associated kinase 1, IkappaBalpha, and IkappaBbeta was inhibited by elafin",
      "citation": {
        "db": "PubMed",
        "db_id": "16980310"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "7cabc541d572595b95b7995706f9849e"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Moreover, immunopurified beta-TrCP ubiquitinates phosphorylated IkappaBalpha at specific lysines in the presence of Ub-activating (E1) and -conjugating (Ubch5) enzymes.",
      "citation": {
        "db": "PubMed",
        "db_id": "9990853"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "729e889cebdd435e86fc7fdb2b791259"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "It also associates specifically with phosphorylated IkappaBalpha and beta-catenin destruction motifs, probably functioning in multiple transcriptional programs by activating the NF-kappaB pathway and inhibiting the beta-catenin pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "11850407"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "d8d6c3c66ce6699a3a629325d6cca7de"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "fro full text Results - Plumbagin inhibited TPA-induced DNA-binding activities of NF-kB, c-Fos, and c-Jun/IkBa degradation and phosphorylation in A549 cells",
      "citation": {
        "db": "PubMed",
        "db_id": "19768635"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "7c4efca165e71a8162f2e2f10f5f50db"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "ursodeoxycholic acid UDCA inhibited TGF-beta1-induced degradation of nuclear factor kappaB (NF-kappaB) and its inhibitor IkappaB (p < 0.05).",
      "citation": {
        "db": "PubMed",
        "db_id": "14514686"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "3c16c12b2fa1d44e36a4954e667f0a5d"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "the I-kappaB kinase (IKK) is present and may phosphorylate I-kappaB during platelet activation. Coupled with intracellular calcium flux, this leads to I-kappaB dissociation from the NF-kappaB/I-kappaB complex and proteolysis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12297126"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "d5d9231c526742ab516672216e9a5163"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "5d50763857cfd7547e6e2ee35cf697e5"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Expression of SphKG82D dramatically blocked the degradation of IKBa (Fig. 5a) and inhibited the NF-KB DNA binding activity in a dose-dependent manner (Fig. 5, b and c).",
      "citation": {
        "db": "PubMed",
        "db_id": "11777919"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "614cea52eda7f244875cd1750dea1720"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Activation of NF-kappaB by TNF-alpha occurred within 15 min and coincided with rapid degradation of IkappaBalpha. Co-treatment with NO donors did not prevent IkappaBalpha phosphorylation or degradation. However, after 2 h of TNF-alpha stimulation, NO donors inhibited NF-kappaB activation and augmented IkappaBalpha resynthesis and nuclear translocation by 2.5- and 3-fold, respectively. This correlated with a 75% reduction in TNF-alpha-induced VCAM-1 expression. In a time-dependent manner, NO donors alone caused the nuclear translocation of IkappaBalpha",
      "citation": {
        "db": "PubMed",
        "db_id": "9388244"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "0897a888dfad0cd25c9def47af67706e"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "907bb66e74167408e7df8eefc0d6fc6e"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Consistent with this, these reagents also eliminate the ability of the Skp1-CUL1-HOS-ROC1 E3 ligase complex to support the ubiquitination of IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "10748083"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "f291d796d7606e8ee8753f528c636d0b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "We demonstrated recently that BCL11B controls expression from the IL (interleukin)-2 promoter through direct binding to the US1 (upstream site 1). In the present study, we provide evidence that BCL11B also participates in the activation of IL-2 gene expression by enhancing NF-kappaB (nuclear factor kappaB) activity in the context of TCR (T-cell receptor)/CD28-triggered T-cell activation. The enhanced IkappaB degradation in cells with increased levels of BCL11B was specific for T-cells activated through the TCR, but not for cells activated through TNFalpha (tumour necrosis factor alpha) or UV light, and was caused by increased activity of IkappaB kinase, as indicated by its increase in phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18831712"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "ea330d5286540b79fd0849e8ad3b5708"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The activation of TLR2 by Pam3CSK4 induced the degradation of the NF-kB inhibitor IkBa in human monocyte-derived macrophages. NF-kB activation was blocked by S1P at low micromolar concentrations. Statistically significant inhibition of TLR2-dependent NF-kB activation was observed with 1 mM S1P, which argues in favour of a receptor-dependent and physiologically relevant effect (Figure 4A).",
      "citation": {
        "db": "PubMed",
        "db_id": "18411230"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "565af14d5825d39a7e2814d2751a3198"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The degradation of IKappaB-alpha at 20 min after stimulation by LPS was completely abolished in the presence of paxilline",
      "citation": {
        "db": "PubMed",
        "db_id": "16951373"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "409f1a86f7fffd97b4888fbd5d374d42"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "5alpha-dihydrotestosterone achieved this effect through maintenance of IkappaBalpha protein levels in the face of phorbol ester, a stimulus that results in IkappaBalpha degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "8824277"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "5114151e19ba631a5a4c19129660a9a9"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "0f9b7083052f9bff68ac6df0c057d3ba"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Moreover, IGF-I-mediated dephosphorylation of IkappaBalpha protects this molecule from tumor necrosis factor alpha (TNFalpha)-stimulated degradation; therefore, IGF-I also inhibits the nuclear translocation of NFkappaB (p65) induced by TNFalpha exposure.",
      "citation": {
        "db": "PubMed",
        "db_id": "10973957"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "cf926160af77450c211b39faaa4e479f"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
      "citation": {
        "db": "PubMed",
        "db_id": "10699758"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "464e560dbce77e9737d96ee301f3e895"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Here we show that beta-arrestin2 directly interacts with IkappaBalpha (inhibitor of NF-kappaB, the key molecule in innate and adaptive immunity) and thus prevents the phosphorylation and degradation of IkappaBalpha. Consequently, beta-arrestin2 effectively modulates activation of NF-kappa",
      "citation": {
        "db": "PubMed",
        "db_id": "15125834"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "83876963bf8549b98d32455a465b9b3b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "reducing endogenous levels of ASC using siRNA enhanced TNF- and LPS-induced degradation of the IKK substrate, IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "12486103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "f75eb58a1bb49ae1fabfe21db8b9a591"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The Bcl-2-mediated loss of IkappaBalpha could be prevented by the proteasome inhibitor lactacystin, consistent with the notion that the targeted degradation of IkappaBalpha consequent to overexpression of Bcl-2 utilizes the ubiquitin-proteasome pathway.  This was further tested in human 293 cells in which the N-terminal region of IkappaBalpha was identified to be an important regulatory site for Bcl-2. Deletion of this region or a serine to alanine substitution mutant at amino acids 32 and 36, which are defective for both phosphorylation and degradation, were more resistant than wild type IkappaBalpha to the inhibitory effects of Bcl-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9727009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "dad9caeca3481bf334f48b5331e2c557"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "NFKB PDTC Preclinical treatment (44) PS-341 Preclinical treatment (45,46)",
      "citation": {
        "db": "PubMed",
        "db_id": "14587863"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "1577054ca9411d6eb5fdf95a9be83512"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "# from full text # Here we show that UVC radiation leads to activation of a signaling pathway, distinct from the IKK pathway, which induces I?B? degradation in a manner dependent on phosphorylation of a cluster of C-terminal sites. The kinase that phosphorylates these sites is CK2.",
      "citation": {
        "db": "PubMed",
        "db_id": "14580335"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "9e03dc6c1ca3c8881577278c19e92f55"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Figures 2C and D show that exposure to hyperoxia induced a degradation of I?B?, supporting the EMSA data for hyperoxia-induced NF-?B activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15477018"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "90b9055203d59283886b458bc4de075a"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "from the paper:",
      "citation": {
        "db": "PubMed",
        "db_id": "11909978"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "1537c1167812c8cbaa203ea8ce9ca8ec"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
      "citation": {
        "db": "PubMed",
        "db_id": "18955562"
      },
      "annotations": {
        "cl": {
          "0000767": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "e47548cb63266aa67f60cfa6b174548b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "10779355"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "a2e29620c86e1b828ce70b09f5b72c18"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "MIP-1alpha treatment stimulated the degradation of IkappaBalpha, a cytoplasmic inhibitor of NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "11152622"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "2f493ddda3168e2e2fcf96f13606dc03"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Similar to wild-type A549 cells, treatment with TNF-? for 30 min induced I?B? degradation in vector control cells (Fig. 4B). On the other hand, TNF-?-induced I?B? degradation was blunted in DN I?B mutant cells (Fig. 4B), further supporting that these DN I?B mutant cells are less efficient in response to a NF-?B activator compared to the vector control cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15477018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "153d0fd38fe84ac01d70ae180785d250"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "CSM-induced activation of TLR-4 has been shown to induce IRAK1 phosphorylation and TRAF6 degradation. An increase in IkB phosphorylation and degradation is also observed which ultimately leads to the translocation of NF-kB (p65) into the nucleus. The ability of cigarette smoke condensate (CSC) to activate NF-kB has also been demonstrated in another study using U937 cells. CSC has been shown to induce the activation of IKK (-a and -b) at 15 minutes post treatment, which resulted in increased phosphorylation of I?-B? at serine 32, resulting in Ik-Ba degradation and subsequent activation of NF-kB [53].",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "05c968029fa2e99ec7b5b86af6543c5b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "agents that inhibit NF?B activation are desired, and are currently being pursued,based on strategies that seek to maintain levels of endogenous NF?B-inhibiting I?B-family proteins, by either suppressing the IkB kinases (IKKs) responsible for phosphorylation of IkBalpha (which induces its polyubiquitination) or blocking the proteolytic activity of the 26s proteasome responsible for degrading IkB following ubiquitination (Figure 2A).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "89d42d98cf5635dca8d133571237efa9"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Inducers of NF-kB, which include inflammatory cytokines, reactive oxygen species, and viral products, activate a dimeric IkB kinase (IKK) complex, which phophorylates IkBa leading to subsequent ubiquitination and degradation of IkBa and release of NF-kB proteins [33,34].",
      "citation": {
        "db": "PubMed",
        "db_id": "14561188"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "1ed6196a3e2b2b3804bf24fe09547349"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "We found that IL-1 caused rapid phosphorylation of ERK1/2, JNK, p38, MKK3/6, Akt, IKK, c-Jun, ATF-2, ATF-1, CREB, p65, and IKBa, induced the degradation of IKBa and IKBe, and activated the synthesis of c-fos (Fig. 4)",
      "citation": {
        "db": "PubMed",
        "db_id": "19074142"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "eeb7bf54d37cd0bfd1be65ac9436b608"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Ubiquitin-tagged Ikappa Balpha  is degraded by the proteasome releasing NF-kappa B for migration to the nucleus. As a first approach to check the role of NF-kappa B in PKR-induced apoptosis, the NF-kappa B induction pathway was blocked by using the specific proteasome inhibitors, lactacystin and PSI.",
      "citation": {
        "db": "PubMed",
        "db_id": "10373514"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "ad394371a2e0423aeea47a7618cb67d9"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "neutrophil stimulation with pro-inflammatory signals results in degradation of IkappaBalpha that occurs in both cytoplasm and nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12244195"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "c84a6dccfb8e31e2990653e9eaa43a99"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "PAR-4 was found to directly inhibit the phosphorylation and degradation of I kappa B alpha, which led to the loss of NF kappa B activity causing repression of endogenous and radiation-induced Bcl-2 protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "12170775"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "bda45af89c3c14a451186c1d7d66fd85"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "CHUK specifically phosphorylates IkappaB-alpha on both serine 32 and serine 36, modifications that are required for targeted degradation of IkappaB-alpha via the ubiquitin-proteasome pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "9244310"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "2bfa6fe0e04ffe4b7e19eca345d9e11c"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Activation of NF-kappaB mainly occurs via IkappaB kinase (IKK)-mediated phosphorylation of inhibitory molecules, including IkappaBalpha",
      "citation": {
        "db": "PubMed",
        "db_id": "15653325"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "7d0293e988b5b57ce816f431a3ef54fb"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "SAA induced IkappaB-alpha degradation, RelA serine 536 (S536) phosphorylation, NF-kappaB transcriptional activity",
      "citation": {
        "db": "PubMed",
        "db_id": "15724247"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "d33831fcc964d7dd3ac9a77e33f69b5a"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "To exclude off-target effects, SphK1 expression was also downregulated with siRNAs targeted to two other regions of the SphK1 sequence and both inhibited TNF-alpha-induced phosphorylation of IkBalpha and IKKalpha/beta (Supplementary Fig. 2a). Similar results were obtained in several other cell types (Supplementary Fig. 2b), suggesting that SphK1 has a general role in the canonical NF-kappaB pathway.  To conclusively demonstrate the involvement of SphK1, we also used pharmacological and genetic approaches. The specific SphK1 inhibitor, SK1-I, which decreases intracellular S1P levels 6, reduced TNF-alpha-induced I?B? degradation and phosphorylation of IKKalpha/beta (Fig. 1b)",
      "citation": {
        "db": "PubMed",
        "db_id": "20577214"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "34c4aeec7720464450b4fc714f68c8b9"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The mechanism of adiponectin action in endothelial cells has been further investigated. TNF-A activates nuclear transcription factor NF-KB in these cells by stimulating protein kinase NIK (NF-kB inducing kinase), which phosphorylates the NF-kB inhibitor, IkB, initiating its degradation and thus leading to NF-KB activation. NF-KB stimulates the expression of cytokines and adhesion molecules involved in the inflammatory process.",
      "citation": {
        "db": "PubMed",
        "db_id": "15916985"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "ec91a1d0db2ac28fc180d16efb6053d6"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "HSP27 does not affect I-kappaBalpha phosphorylation but enhances the degradation of phosphorylated I-kappaBalpha by the proteasome. The interaction of HSP27 with the 26S proteasome is required to activate the proteasome and the degradation of phosphorylated I-kappaBalpha. A protein complex that includes HSP27, phosphorylated I-kappaBalpha, and the 26S proteasome is formed",
      "citation": {
        "db": "PubMed",
        "db_id": "12897149"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "7a0b18a5f0293985a363e35e9b56ea0a"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
      "citation": {
        "db": "PubMed",
        "db_id": "20200353"
      },
      "annotations": {
        "cl": {
          "0000097": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "806ec8322be7e64b2a79f38ced7fe35c"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "ctivation of NF-kappaB by TNF and IL-1 is initiated by the phosphorylation of the inhibitory subunit, IkappaB, which targets IkappaB for degradation and leads to the release of active NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "9418855"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "ef9a55a4bb5f1798f37d8236fb743eed"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "These studies provide new evidence that the protein kinase CKII physically associates with I kappa B alpha in vivo, induces multisite (serine/threonine) phosphorylation, and is required for the basal and HIV-induced degradation of I kappa B alpha in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "8622692"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "1da0b820e7d7992a8faa7759d3a546bd"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Furthermore, TWEAK induced rapid phosphorylation of IkappaB-alpha in human keratinocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15140220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "d7589dd8eddb4c0b4e27b5625ba5e51e"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "The microtubule disassembly also induced IkappaB degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11306700"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "580e0b72d939b50f789fd0ee95d98a3b"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "BetaTrCP and HOS are closely related F-box proteins, which play key roles in ubiquitination and degradation of beta-catenin and IkappaB through associating with those phosphorylated substrates and recruiting SCF E3 ubiquitin ligase",
      "citation": {
        "db": "PubMed",
        "db_id": "11850814"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "db7a127b37fc89e8046731bff8e7ad5c"
    },
    {
      "line": 420,
      "relation": "directlyDecreases",
      "evidence": "Immunoblotting analyses revealed that constitutively active AKT2 significantly promoted IkBalpha degradation (Fig. 4D).",
      "citation": {
        "db": "PubMed",
        "db_id": "12048203"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 143,
      "target": 143,
      "key": "ef6413934b4cd838c4394a919c3cfb81"
    },
    {
      "line": 418,
      "relation": "directlyIncreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 143,
      "key": "35d80c6608517198448dc7184bb41292"
    },
    {
      "line": 418,
      "relation": "directlyIncreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 143,
      "key": "ee2696e33170192df8f510b04a30f305"
    },
    {
      "line": 418,
      "relation": "directlyIncreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 143,
      "key": "776969075a661bc5df71407f7bbf0b4d"
    },
    {
      "line": 418,
      "relation": "directlyIncreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 143,
      "key": "8afd53e7fb43740fd126845962615d3d"
    },
    {
      "line": 418,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 143,
      "key": "a78467dc22917dad60c30dff65ec72f9"
    },
    {
      "line": 64,
      "relation": "directlyIncreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 143,
      "key": "75ade5588a1c06284cd0b3bbff0d2329"
    },
    {
      "line": 64,
      "relation": "directlyIncreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 143,
      "key": "8e79514205cb7153c0d9f7119957e2eb"
    },
    {
      "line": 64,
      "relation": "directlyIncreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 143,
      "key": "0ed06f0216caa8cb697431c3981d8def"
    },
    {
      "line": 64,
      "relation": "directlyIncreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 143,
      "key": "56950447ae60a29655d8e45bd9d70ac3"
    },
    {
      "line": 64,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 143,
      "key": "07e4f4ed9265b4974da8091e9172d629"
    },
    {
      "line": 325,
      "relation": "directlyDecreases",
      "evidence": "In most cell types, the NFkB p50-p65 dimer is bound to one of the closely related endogneous  inhibitory proteins, collectively referred to as IkB, and is held inactive in the cyotplasm. A variety of extracellular signaling, including LPS, cytokines, stress factors have been reported to activate NFkb through phosphorylation of IkB at serine-32 and serine-36, dissociation of IkB from the complex, and translocation of the p50-p65 dimer fromt he cytolplasm to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12882972"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 146,
      "target": 8,
      "key": "48abf20f574a193f4cc5b49a5b644cf1"
    },
    {
      "line": 85,
      "relation": "increases",
      "evidence": "Caspase-dependent activation of kinases including PAK2, MEKK1, and PKCd also promotes cytoplasmic and nuclear apoptosis. Interestingly, MEKK1 activation enhances caspase activation, suggesting that kinases may amplify or initiate the caspase cascade.",
      "citation": {
        "db": "PubMed",
        "db_id": "10400609"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 148,
      "target": 4,
      "key": "36200f071592d3a79f82d592c8887895"
    },
    {
      "line": 10,
      "relation": "association",
      "evidence": "\"Our findings could suggest the presence of a physical interaction between PARP-1 and SIRT1.\" (p. 875)",
      "citation": {
        "db": "Other",
        "db_id": "16628003"
      },
      "annotations": {},
      "source": 81,
      "target": 56,
      "key": "dc193fe8bca8c3637f71cd341e4b7599"
    },
    {
      "line": 10,
      "relation": "association",
      "evidence": "Our findings could suggest the presence of a physical interaction between PARP-1 and SIRT1. (p. 875)",
      "citation": {
        "db": "PubMed",
        "db_id": "20060806"
      },
      "annotations": {},
      "source": 81,
      "target": 56,
      "key": "d67712b65dc1d04229c586b5c22c0b9c"
    },
    {
      "line": 332,
      "relation": "decreases",
      "evidence": "Collectively, these studies suggest that the persistent single-strand breaks formed upon PARP-1 inhibition, which promote the collapse of replication forks and would normally be repaired by homologous recombination, cannot be repaired effectively in the absence of functional BRCA1 or BRCA2. This results in the accumulation of chromosomal abnormalities, cell cycle arrest in G2/M, and apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "16140981"
      },
      "annotations": {},
      "source": 81,
      "target": 4,
      "key": "5b1ebfec56ddcf4ff1ed4b9f1093a639"
    },
    {
      "line": 103,
      "relation": "decreases",
      "evidence": "If PCNA is rendered non-functional or is absent or present in low quantities in the cell, apoptosis occurs",
      "citation": {
        "db": "PubMed",
        "db_id": "11682006"
      },
      "annotations": {},
      "source": 149,
      "target": 4,
      "key": "9a543a39402d8c106a0b4d73fa4704df"
    },
    {
      "line": 6,
      "relation": "increases",
      "evidence": "Using cultured LF and Western immunoblotting, we found that PDGF-A increased the phosphorylation of serine 253 in FoxO3a in a time and concentration related manner",
      "citation": {
        "db": "PubMed",
        "db_id": "23819440"
      },
      "annotations": {},
      "source": 151,
      "target": 98,
      "key": "c6bde52b34fb54c23269bbf33da3be48"
    },
    {
      "relation": "hasVariant",
      "source": 152,
      "target": 153,
      "key": "6de7019ea0d75ac2fd1424982a3761d8"
    },
    {
      "line": 217,
      "relation": "directlyIncreases",
      "evidence": "Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "11141077"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 168,
      "key": "c286481830e92aeb9d06d01742b4e515"
    },
    {
      "line": 217,
      "relation": "directlyIncreases",
      "evidence": "9748166;11222751;10075713",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 168,
      "key": "d6215f4757da5fb84ae0bef83ba06795"
    },
    {
      "line": 217,
      "relation": "directlyIncreases",
      "evidence": "PDK-1 is a downstream molecule of PI3K, which activates among many others, PKC-z (37). This protein kinase is a member of the atypical PKCs. Unlike conventional or novel PKCs, it does not require diacylglycerol or phorbol esters for its activation and its function is Ca2+ independent (38). To achieve catalytic potential, PKC-z needs to be phosphorylated on threonine 410 (T410) through PDK-1 (37, 39).",
      "citation": {
        "db": "PubMed",
        "db_id": "14604996"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 168,
      "key": "eb61f738287c657cec5532c4793979e7"
    },
    {
      "line": 217,
      "relation": "directlyIncreases",
      "evidence": "The ability of PDK1 to phosphorylate PKC-zeta and -delta in vitro was also markedly inhibited by the PRK2 fragment. Additionally, generation of the PRK2 fragment in vivo inhibited by >90% the phosphorylation of endogenous PKC-zeta by PDK1.",
      "citation": {
        "db": "PubMed",
        "db_id": "11781095"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 168,
      "key": "d1eaa6f4c87bf9076fd95bc88ea76369"
    },
    {
      "line": 218,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "14500370"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 159,
      "key": "c4da4c3fbb53a4f7c69b72937cbc4343"
    },
    {
      "line": 218,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "12068001"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 159,
      "key": "57c224052d3f60315894fd62c2478d4d"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "PDK1 has now been shown to play a central role in activating many of the AGC subfamily members (reviewed in [150,151]). Apart from phosphorylating PKB on Thr308, PDK1 phosphorylates the equivalent residues on PKC isoforms [48,152,153], p70-S6K [32,154], the three isoforms of SGK [27,28,155] and PKA [156] (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "10698680"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 22,
      "key": "918f7d95d78d2215b0e5c47fae91fe85"
    },
    {
      "line": 219,
      "relation": "directlyIncreases",
      "evidence": "PDK1 also phosphorylates several AGC kinase members at the conserved activation-loop Ser or Thr residue, some PKC isoforms and p70 S6K",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 22,
      "key": "ae853de080a67d7f5e5ea92fa146f565"
    },
    {
      "line": 220,
      "relation": "directlyIncreases",
      "evidence": "PDK1 phosphorylated the activation loop sites of PKCzeta and PKCdelta in vitro and in a phosphoinositide 3-kinase (PI 3-kinase)-dependent manner in vivo in human embryonic kidney (293) cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "9748166"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 161,
      "key": "e6a6a871c1b8b6c7093a91003d3b7f92"
    },
    {
      "line": 221,
      "relation": "directlyIncreases",
      "evidence": "Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "11141077"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 167,
      "key": "f3c59b2a024ac42b600c0b917f822b85"
    },
    {
      "line": 221,
      "relation": "directlyIncreases",
      "evidence": "PDK1 phosphorylated the activation loop sites of PKCzeta and PKCdelta in vitro and in a phosphoinositide 3-kinase (PI 3-kinase)-dependent manner in vivo in human embryonic kidney (293) cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "9748166"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 152,
      "target": 167,
      "key": "db34db8deabf8e073cf15119e014d970"
    },
    {
      "line": 421,
      "relation": "increases",
      "evidence": "This raised the possibility that PDK1 might be able to phosphorylate itself at this residue, leading to its own activation. That this is indeed the case is supported by the finding that bacterially expressed PDK1 possesses a high activity and is phosphorylated at Ser-241. PDK1 expressed in bacteria was active and phosphorylated at Ser-241, suggesting that PDK1 can phosphorylate itself at this site, leading to its own activation.",
      "citation": {
        "db": "Other",
        "db_id": "10455013"
      },
      "annotations": {},
      "source": 153,
      "target": 152,
      "key": "2327787e3ab27fe044eb96d7c66418b6"
    },
    {
      "line": 439,
      "relation": "increases",
      "evidence": "The NE-PlGF-JNK/PKCÂ¿ pathway contributes to the pathogenesis of LE cell apoptosis and emphysema. PlGF and its downstream signaling molecules may be potential therapeutic targets for COPD.",
      "citation": {
        "db": "Other",
        "db_id": "25186164"
      },
      "annotations": {},
      "source": 154,
      "target": 4,
      "key": "3e850d62308cc4d4c5ffa5beea25518e"
    },
    {
      "line": 383,
      "relation": "increases",
      "evidence": "In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "17507791"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 155,
      "target": 169,
      "key": "ceed6d0f72d075e27ced765af8ef9170"
    },
    {
      "line": 384,
      "relation": "increases",
      "evidence": "In this study, we found that Noxa and Puma synergistically activate Bax and Bak, and induce apoptosis. Although Noxa activates Bak by inactivating Mcl-1 and Bcl-X(L), gene knockdown studies revealed that neither Mcl-1 nor Bcl-X(L) is involved in this synergism. Moreover, Puma, but not Noxa, directly activated Bax in the absence of Bak, and Noxa enhanced Puma-mediated Bax activation in Bak-deficient cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "17507791"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 155,
      "target": 174,
      "key": "076798da4fecfc58f29db43e7caabdff"
    },
    {
      "line": 68,
      "relation": "increases",
      "evidence": "CHOP activates Gadd 34 and Gadd 34 deletion likewise protects against ER stress-induced cell death",
      "citation": {
        "db": "PubMed",
        "db_id": "22675432"
      },
      "annotations": {},
      "source": 54,
      "target": 2,
      "key": "90b9dd4026e5323947f494be4a34c812"
    },
    {
      "relation": "hasVariant",
      "source": 159,
      "target": 160,
      "key": "f3d18e340666def4ed89acb7290bf623"
    },
    {
      "line": 34,
      "relation": "directlyIncreases",
      "evidence": "10867018;15383279;11741879;15024053;11948398",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 159,
      "target": 166,
      "key": "74a0da92cef81e2e9459c120429844c6"
    },
    {
      "line": 36,
      "relation": "directlyIncreases",
      "evidence": "10867018;15383279;11741879;15024053;11948398",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 159,
      "target": 165,
      "key": "85dc0661d04960aaedbfcd2a72eef74f"
    },
    {
      "line": 37,
      "relation": "directlyIncreases",
      "evidence": "91317794;16116087;11162562;17081983",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 159,
      "target": 124,
      "key": "4c37545ee225ee02d10752aead4777a3"
    },
    {
      "line": 207,
      "relation": "directlyIncreases",
      "evidence": "PKC alpha directly phosphorylates and activates Raf-1 both in vitro and in vivo.",
      "citation": {
        "db": "PubMed",
        "db_id": "8321321"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 159,
      "target": 179,
      "key": "c4f0f67c83233655352a5c13477511ab"
    },
    {
      "relation": "hasVariant",
      "source": 161,
      "target": 162,
      "key": "ad8961cc693ad5879ce4455054766806"
    },
    {
      "line": 129,
      "relation": "increases",
      "evidence": "activated PKCdelta catalytic domain triggered the redistribution and activation of Bax",
      "citation": {
        "db": "PubMed",
        "db_id": "15304079"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 161,
      "target": 174,
      "key": "49ebc2852fc651266397f2b5c87a9792"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.",
      "citation": {
        "db": "PubMed",
        "db_id": "15024053"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 161,
      "target": 166,
      "key": "3daf702e0ab1b020f4ec761f5f9b6e11"
    },
    {
      "line": 130,
      "relation": "directlyIncreases",
      "evidence": "10867018;15383279;11741879;15024053;11948398",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 161,
      "target": 166,
      "key": "98a84b573cfb1b41ad06b7886e0eca92"
    },
    {
      "line": 131,
      "relation": "directlyIncreases",
      "evidence": "10867018;15383279;11741879;15024053;11948398",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 161,
      "target": 165,
      "key": "981529f891d36728684cb7fd0d44fead"
    },
    {
      "line": 131,
      "relation": "directlyIncreases",
      "evidence": "Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.",
      "citation": {
        "db": "PubMed",
        "db_id": "15024053"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 161,
      "target": 165,
      "key": "097e61aaaf936ffbd289ec5bace871c3"
    },
    {
      "line": 154,
      "relation": "directlyIncreases",
      "evidence": "To verify the effect of enzastaurin on kinase activity of nPKC isoforms, we performed PKCd and PKCeta immunoprecipitations, followed by immunoblot analysis with phospho-specific antibodies. Consistent with the data, our results show marked inhibition of catalytic Thr-505 (Figure 1E top panel) and moderate inhibition of regulatory Ser-643 (data not shown) and Ser-660 PKCd phosphorylation (Figure 1E, middle panel) as well as marked inhibition of both catalytic Thr-566 (homologous to Thr-514; Figure 1F, top panel) and regulatory Ser-729 (homologous to Ser-660) PKCeta phosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "17023575"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 162,
      "target": 161,
      "key": "52c32bb1ca15ff6cbb4990375f866932"
    },
    {
      "line": 98,
      "relation": "directlyIncreases",
      "evidence": "To obtain information about PKCepsilon-signaling, we investigated the effects of constitutively active rat PKCepsilon (PKCepsilonA/E, alanine 159 is replaced by glutamic acid) in HeLa cells in a doxycycline-inducible vector. Upon induction of PKCepsilonA/E expression by doxycycline, the major part of PKCepsilonA/E was localized to the Golgi. This led (i) to phosphorylations of PKCepsilon(S729), Elk-1(S383), PDK1(S241) and Rb(S807/S811)",
      "citation": {
        "db": "PubMed",
        "db_id": "19168130"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 163,
      "target": 89,
      "key": "731385af146b84cd8aaacac7583d1081"
    },
    {
      "relation": "hasVariant",
      "source": 167,
      "target": 168,
      "key": "13db7d526ee2c5bbf43fa8269e23852c"
    },
    {
      "line": 308,
      "relation": "directlyDecreases",
      "evidence": "Under these circumstances, ceramide activated PKCzeta, leading to phosphorylation of the PKB-PH domain on Thr(34). This phosphorylation inhibited phosphatidylinositol 3,4,5-trisphosphate (PIP(3)) binding to PKB, thereby preventing activation of the kinase by insulin.",
      "citation": {
        "db": "PubMed",
        "db_id": "14560023"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 167,
      "target": 18,
      "key": "5173f664eda420f77893a518c6cda1ea"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "Our findings suggest that insulin, via PIP(3), provokes increases in PKC-zeta enzyme activity through (a) PDK-1-dependent T410 loop phosphorylation, (b) T560 autophosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "11141077"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 168,
      "target": 167,
      "key": "ad6b35409fc7676462b1c87962a44ca6"
    },
    {
      "line": 169,
      "relation": "directlyIncreases",
      "evidence": "PDK-1 is a downstream molecule of PI3K, which activates among many others, PKC-z (37). This protein kinase is a member of the atypical PKCs. Unlike conventional or novel PKCs, it does not require diacylglycerol or phorbol esters for its activation and its function is Ca2+ independent (38). To achieve catalytic potential, PKC-z needs to be phosphorylated on threonine 410 (T410) through PDK-1 (37, 39).",
      "citation": {
        "db": "PubMed",
        "db_id": "14604996"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 168,
      "target": 167,
      "key": "c05f747dfc6187b0c442065b6b5d51db"
    },
    {
      "relation": "hasVariant",
      "source": 164,
      "target": 165,
      "key": "9a551be7fac1b412dbe98994894a1d12"
    },
    {
      "relation": "hasVariant",
      "source": 164,
      "target": 166,
      "key": "1f80bb89ef44bd149ce33cc2d07a3568"
    },
    {
      "line": 404,
      "relation": "directlyIncreases",
      "evidence": "Consistently, H2O2, but not TNF, induced phosphorylation of PKD and translocation of PKD from endothelial cell membrane to cytoplasm where it associates with the JNK upstream activator, apoptosis signal-regulating kinase 1 (ASK1).",
      "citation": {
        "db": "PubMed",
        "db_id": "15755722"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 164,
      "target": 131,
      "key": "6bbc0fc91ece280924da9b871df0a6bf"
    },
    {
      "line": 316,
      "relation": "directlyIncreases",
      "evidence": "PKCm/PKD binds to PKCh selectively through its PH domain PKCh acts as a direct activator for PKCm/PKD to trigger downstream cellular processes",
      "citation": {
        "db": "PubMed",
        "db_id": "12473186"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 165,
      "target": 164,
      "key": "d73721f46d7a811fbc2be75f1fc9a80a"
    },
    {
      "line": 316,
      "relation": "directlyIncreases",
      "evidence": "Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.",
      "citation": {
        "db": "PubMed",
        "db_id": "15024053"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 165,
      "target": 164,
      "key": "a0a9d255cb4e587c600d7a021f7128b3"
    },
    {
      "line": 312,
      "relation": "directlyIncreases",
      "evidence": "Here we show that activation of PKD in response to oxidative stress requires two sequential signaling events, i.e., phosphorylation of Tyr463 by Abl, which in turn promotes a second step, phosphorylation of the PKD activation loop (Ser738/Ser742). We show that this is mediated by PKCdelta (protein kinase Cdelta), a kinase that is activated by Src in response to oxidative stress.",
      "citation": {
        "db": "PubMed",
        "db_id": "15024053"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 166,
      "target": 164,
      "key": "7c81ace664053bb8f7ab5d2af0ddc77e"
    },
    {
      "relation": "hasVariant",
      "source": 170,
      "target": 171,
      "key": "8c6409072e54ad9b614037c17eadbe8e"
    },
    {
      "relation": "hasVariant",
      "source": 170,
      "target": 172,
      "key": "63986964cd4f7312e9b2b19f11ce2aec"
    },
    {
      "relation": "hasVariant",
      "source": 170,
      "target": 173,
      "key": "298024fa96192da66cfb320f239f13ac"
    },
    {
      "line": 304,
      "relation": "directlyDecreases",
      "evidence": "The above data raised the possibility that phosphorylation of these three specific residues (S380, T382, and T383) might be required to maintain PTEN in a stable yet relatively inactive state.",
      "citation": {
        "db": "PubMed",
        "db_id": "10866658"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "phosphatase activity",
          "identifier": "0016791"
        }
      },
      "source": 171,
      "target": 170,
      "key": "b0a5aa1e9172bbb5d9b784d888ed57bb"
    },
    {
      "line": 304,
      "relation": "directlyDecreases",
      "evidence": "Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17565999"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "phosphatase activity",
          "identifier": "0016791"
        }
      },
      "source": 171,
      "target": 170,
      "key": "b796991f010b8264a3b58f0653a9db04"
    },
    {
      "line": 274,
      "relation": "directlyDecreases",
      "evidence": "The above data raised the possibility that phosphorylation of these three specific residues (S380, T382, and T383) might be required to maintain PTEN in a stable yet relatively inactive state.",
      "citation": {
        "db": "PubMed",
        "db_id": "10866658"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "phosphatase activity",
          "identifier": "0016791"
        }
      },
      "source": 172,
      "target": 170,
      "key": "34df7f8d18cb00fe5e1313f7d7adb16c"
    },
    {
      "line": 274,
      "relation": "directlyDecreases",
      "evidence": "Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17565999"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "phosphatase activity",
          "identifier": "0016791"
        }
      },
      "source": 172,
      "target": 170,
      "key": "0ad820cffb4c64a3e9afc6a356f5f010"
    },
    {
      "line": 132,
      "relation": "directlyDecreases",
      "evidence": "Moreover, substituting Ser-380/Thr-382/Thr-383 to phosphomimic residues reversed the phosphatase activity of the S385A mutation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17565999"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "phosphatase activity",
          "identifier": "0016791"
        }
      },
      "source": 173,
      "target": 170,
      "key": "85e64497dc78d6748ca5fd236a2afb26"
    },
    {
      "line": 132,
      "relation": "directlyDecreases",
      "evidence": "The above data raised the possibility that phosphorylation of these three specific residues (S380, T382, and T383) might be required to maintain PTEN in a stable yet relatively inactive state.",
      "citation": {
        "db": "PubMed",
        "db_id": "10866658"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "phosphatase activity",
          "identifier": "0016791"
        }
      },
      "source": 173,
      "target": 170,
      "key": "4e13c9c41fc5b03b2d5c3d9712677054"
    },
    {
      "line": 433,
      "relation": "negativeCorrelation",
      "evidence": "The apoptotic index of pulmonary vascular endothelial cells was negatively correlated with COXII expression",
      "citation": {
        "db": "Other",
        "db_id": "21092633"
      },
      "annotations": {},
      "source": 176,
      "target": 4,
      "key": "8bd2e848406f393f21995cdd5b18bd83"
    },
    {
      "relation": "hasVariant",
      "source": 177,
      "target": 178,
      "key": "5545903bd632ef43f910232d05025244"
    },
    {
      "line": 390,
      "relation": "increases",
      "evidence": "As shown in Fig. 7B, the level of the phosphorylated JNK showed a 71% reduction in the presence of Rac1 siRNA. On the contrary, the active Rac1-induced cells showed a 4.1-fold increase of JNK phosphorylation as compared to the control cells (Fig. 7C).",
      "citation": {
        "db": "PubMed",
        "db_id": "20808927"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 20,
      "key": "234ef31694411fbc9bf179ecc4c0c0ba"
    },
    {
      "line": 390,
      "relation": "increases",
      "evidence": "The neurotrophin receptor p75 can induce apoptosis both in vitro and in vivo p75 activates Rac GTPase, which in turn activates c-jun N-terminal kinase (JNK), including an injury-specific JNK3, in an NGF-dependent manner",
      "citation": {
        "db": "PubMed",
        "db_id": "11756498"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 20,
      "key": "436f2c5aa490cf65d9413c18a4d5e509"
    },
    {
      "line": 390,
      "relation": "increases",
      "evidence": "The small GTP-binding protein Rac is a downstream effector of the oncogene product p21-ras. Rac is involved in actin polymerization, Jun kinase activation, and intracellular superoxide anion production, through distinct pathways in tumor cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11593437"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 20,
      "key": "ccc2704a5f0d29fd2c780ced5dee4173"
    },
    {
      "line": 390,
      "relation": "increases",
      "evidence": "activation of Jnk was inhibited by dominant-negative Ras and Rac1 and by the phosphoinositide 3-kinase inhibitor",
      "citation": {
        "db": "PubMed",
        "db_id": "9171350"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 20,
      "key": "e547bd501dbeef56167b553601ec05bb"
    },
    {
      "line": 390,
      "relation": "increases",
      "evidence": "A signaling cascade from the Fas receptor via ceramide, Ras, Rac1, and JNK/p38-K to GADD153 is demonstrated employing transfection of transdominant inhibitory N17Ras, N17Rac1, c-Jun, or treatment with a specific p38-K inhibitor. The critical function of this signaling cascade is indicated by prevention of Fas- or C6-ceramide-induced apoptosis after inhibition of Ras, Rac1, or JNK/p38-K.",
      "citation": {
        "db": "PubMed",
        "db_id": "9268362"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 20,
      "key": "117f5ec9ee1cd22256993b67f3d98437"
    },
    {
      "line": 390,
      "relation": "increases",
      "evidence": "FIGURE 6. Activated Rac induces phosphorylation of JNK1.",
      "citation": {
        "db": "PubMed",
        "db_id": "20018857"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 20,
      "key": "8f57945483dc024c5cfef9f88f70b175"
    },
    {
      "line": 391,
      "relation": "increases",
      "evidence": "The neurotrophin receptor p75 can induce apoptosis both in vitro and in vivo p75 activates Rac GTPase, which in turn activates c-jun N-terminal kinase (JNK), including an injury-specific JNK3, in an NGF-dependent manner",
      "citation": {
        "db": "PubMed",
        "db_id": "11756498"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 136,
      "key": "c120b5dee4e10576b66597f1f5ed863b"
    },
    {
      "line": 392,
      "relation": "directlyIncreases",
      "evidence": "Rac1 can also activate JNK, resulting in the NFAT pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "20150991"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 177,
      "target": 138,
      "key": "74203c718167aebcbf9592443b01dcad"
    },
    {
      "line": 275,
      "relation": "directlyDecreases",
      "evidence": "The phosphorylation of Rac1 inhibited its GTP-binding activity without any significant change in GTPase activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "10617634"
      },
      "annotations": {
        "doid": {
          "1909": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 178,
      "target": 177,
      "key": "983f544bbdbd4880e27f982b346fd292"
    },
    {
      "relation": "hasVariant",
      "source": 179,
      "target": 180,
      "key": "881f9f229e3d3202f77cb57ead29e07a"
    },
    {
      "line": 357,
      "relation": "increases",
      "evidence": "In Swiss 3T3 and REF52 fibroblasts, activated MEKK induces cell death involving cytoplasmic shrinkage, nuclear condensation, and DNA fragmentation characteristic of apoptosis. Expression of activated MEKK enhanced the apoptotic response to ultraviolet irradiation, indicating that MEKK-regulated pathways sensitize cells to apoptotic stimuli. Inducible expression of activated MEKK stimulated the transactivation of c-Myc and Elk-1. Activated Raf, the serine-threonine protein kinase that activates the ERK members of the MAPK family, stimulated Elk-1 transactivation but not c-Myc",
      "citation": {
        "db": "PubMed",
        "db_id": "8621725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 179,
      "target": 88,
      "key": "2bb3c956f1f273371118365c77860817"
    },
    {
      "line": 317,
      "relation": "directlyDecreases",
      "evidence": "Phosphorylation. Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.",
      "citation": {
        "db": "PubMed",
        "db_id": "16170185"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 180,
      "target": 179,
      "key": "bc3acca274d6fafe3a253d28fdd35807"
    },
    {
      "line": 317,
      "relation": "directlyDecreases",
      "evidence": "This inhibitory phosphorylation on Raf reduces the activity of MAPK pathway (Zimmermann and Moelling, 1999).",
      "citation": {
        "db": "PubMed",
        "db_id": "18794886"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 180,
      "target": 179,
      "key": "cf5fd1c56f66158815cd67c268c655ed"
    },
    {
      "line": 317,
      "relation": "directlyDecreases",
      "evidence": "The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation.  We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo.",
      "citation": {
        "db": "PubMed",
        "db_id": "11971957"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 180,
      "target": 179,
      "key": "8f0fdbe2af1e5a5138cefa3f43ea5dcb"
    },
    {
      "line": 317,
      "relation": "directlyDecreases",
      "evidence": "This zinc-induced protein kinase A activation inhibited Raf-1 activity by phosphorylation at serine 259, preventing activation of Raf-1 by phosphorylation of serine 338.",
      "citation": {
        "db": "PubMed",
        "db_id": "17785857"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 180,
      "target": 179,
      "key": "3fd566e01cc611230c85be841c43ddf5"
    },
    {
      "line": 317,
      "relation": "directlyDecreases",
      "evidence": "Raf itself is negatively regulated by phosphorylation at Ser259 through Akt, an important effector of phosphoinositide 3-kinase (PI3K) signaling (30, 44).",
      "citation": {
        "db": "PubMed",
        "db_id": "19223555"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 180,
      "target": 179,
      "key": "366301b15b5a3170394ecff95dde50a8"
    },
    {
      "line": 317,
      "relation": "directlyDecreases",
      "evidence": "the phosphorylation of Raf-1 on Ser-259 induced by paclitaxel he region surrounding Ser-259 in Raf-1 conforms to a consensus sequence for phosphorylation by Akt",
      "citation": {
        "db": "PubMed",
        "db_id": "12087097"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 180,
      "target": 179,
      "key": "559c0e42c659544af37442e5ae6f3996"
    },
    {
      "relation": "hasVariant",
      "source": 188,
      "target": 189,
      "key": "4d921128a724a2bdf81d8c30fd1b04a6"
    },
    {
      "line": 99,
      "relation": "increases",
      "evidence": "Similarly, ROCK-1-null mice (Rock-1(-/-)) showed a marked reduction in myocyte apoptosis associated with pressure overload.",
      "citation": {
        "db": "PubMed",
        "db_id": "16983089"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 26,
      "target": 4,
      "key": "fed228f72008d519189c9a494f0a3242"
    },
    {
      "line": 99,
      "relation": "increases",
      "evidence": "In contrast, inhibition of ROCK activity using the small-molecule inhibitor Y-27632 (ref. 19) resulted in a marked reduction in formation of membrane blebs (Fig. 1a)",
      "citation": {
        "db": "PubMed",
        "db_id": "11283606"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 26,
      "target": 4,
      "key": "31b80433deb23004b4f11323947b0bb8"
    },
    {
      "line": 285,
      "relation": "directlyIncreases",
      "evidence": "We found that the p90 ribosomal S6 kinase 2 (RSK2)-cAMP response element-binding protein (CREB) pathway is commonly activated in diverse metastatic human cancer cells, leading to up-regulation of a CREB transcription target Fascin-1",
      "citation": {
        "db": "Other",
        "db_id": "24085294"
      },
      "annotations": {
        "doid": {
          "162": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 27,
      "target": 80,
      "key": "d31f6c4b591af0c725ddff7ebeeddea1"
    },
    {
      "line": 285,
      "relation": "directlyIncreases",
      "evidence": "The expression of RSK1, RSK2, or RSK3 in COS cells substantially increased the level of EGF-induced Gal4CREB Ser- 133 phosphorylation (Fig. 2B). Thus, all three RSK family members appear to be activated and able to phosphorylate CREB Ser-133 in cells upon growth factor stimulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9528766"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 27,
      "target": 80,
      "key": "f7b7e9bd427be999487723d7d60bed61"
    },
    {
      "line": 285,
      "relation": "directlyIncreases",
      "evidence": "As shown in Fig. 1, all three RSKs were induced by NGF and phosphorylated CREBtide in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "9528766"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 27,
      "target": 80,
      "key": "e8811d1d70252103d8028c07680f207a"
    },
    {
      "line": 286,
      "relation": "decreases",
      "evidence": "Thus, AR and IGF1 cooperate to prevent apoptosis by activating a specific PKC-p90(rsk)-dependent pathway, which leads to Bad and Bax inactivation",
      "citation": {
        "db": "PubMed",
        "db_id": "15767261"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 27,
      "target": 156,
      "key": "fea70fcbf1d31a2bcb13264868ca33b8"
    },
    {
      "line": 287,
      "relation": "directlyIncreases",
      "evidence": "10837486;15037618;15972258;15226424",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 27,
      "target": 157,
      "key": "462074b6f98ca486914dbbb4bd2ce4b7"
    },
    {
      "line": 436,
      "relation": "decreases",
      "evidence": "CC16-/- mice had greater CS-induced emphysema, airway remodelling, pulmonary inflammation, alveolar cell apoptosis, airway MUC5AC expression, and more compliant lungs than WT mice.",
      "citation": {
        "db": "Other",
        "db_id": "25700379"
      },
      "annotations": {},
      "source": 48,
      "target": 4,
      "key": "0b5e396821d81ca7e90adbc133f741cf"
    },
    {
      "line": 9,
      "relation": "increases",
      "evidence": "Our findings could suggest the presence of a physical interaction between PARP-1 and SIRT1. (p. 875)",
      "citation": {
        "db": "PubMed",
        "db_id": "18174544"
      },
      "annotations": {},
      "source": 56,
      "target": 189,
      "key": "7764f766a4a448cdcd36432a04c6bac7"
    },
    {
      "line": 10,
      "relation": "association",
      "evidence": "\"Our findings could suggest the presence of a physical interaction between PARP-1 and SIRT1.\" (p. 875)",
      "citation": {
        "db": "Other",
        "db_id": "16628003"
      },
      "annotations": {},
      "source": 56,
      "target": 81,
      "key": "24ca9c2bd85a53c4a782bd831fe92b70"
    },
    {
      "line": 10,
      "relation": "association",
      "evidence": "Our findings could suggest the presence of a physical interaction between PARP-1 and SIRT1. (p. 875)",
      "citation": {
        "db": "PubMed",
        "db_id": "20060806"
      },
      "annotations": {},
      "source": 56,
      "target": 81,
      "key": "de5fad9a86da8a5d258815cd57eb997b"
    },
    {
      "line": 12,
      "relation": "decreases",
      "evidence": "We measured caspase 3/7 activity, an important marker of apoptosis (Albee et al., 2007), in the lungs of room air and 8-day smoke-exposed STAT3+/+ and STAT3âˆ’/âˆ’ mice. Cigarette smoke induced a ~20 fold increase in caspase 3/7 activity in the smoke-exposed STAT3+/+ mice (p < 0.001) (Figure â€‹(Figure8).8). Compared to the STAT3+/+ mice, the STAT3âˆ’/âˆ’ had a ~10 fold increase in caspase 3/7 activity at baseline (p < 0.01).",
      "citation": {
        "db": "Other",
        "db_id": "24101903"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 62,
      "key": "2e61506afca2e5c071b013875cce25c1"
    },
    {
      "line": 13,
      "relation": "decreases",
      "evidence": "We measured caspase 3/7 activity, an important marker of apoptosis (Albee et al., 2007), in the lungs of room air and 8-day smoke-exposed STAT3+/+ and STAT3âˆ’/âˆ’ mice. Cigarette smoke induced a ~20 fold increase in caspase 3/7 activity in the smoke-exposed STAT3+/+ mice (p < 0.001) (Figure â€‹(Figure8).8). Compared to the STAT3+/+ mice, the STAT3âˆ’/âˆ’ had a ~10 fold increase in caspase 3/7 activity at baseline (p < 0.01).",
      "citation": {
        "db": "Other",
        "db_id": "24101903"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 33,
      "target": 59,
      "key": "c774d4ad289c2015ed07b0d85230ece7"
    },
    {
      "line": 292,
      "relation": "decreases",
      "evidence": "The basal and CSE-inducible expression of LC3B and cleaved caspase-3 were elevated in pulmonary alveolar type II (ATII) cells from Tlr4-deficient mice...These findings suggest that TLR exerts an inhibitory effect on the expression of the autophagic protein LC3B, and also on the apoptotic response to CSE",
      "citation": {
        "db": "PubMed",
        "db_id": "22983353"
      },
      "annotations": {},
      "source": 34,
      "target": 59,
      "key": "d964b3aa69457d828a1ebdc8b4c01191"
    },
    {
      "line": 292,
      "relation": "decreases",
      "evidence": "The Tlr4-mutated or Tlr4-deficient mice showed higher levels of LC3B under basal conditions and after CS exposure. The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS. We describe a protective regulatory function of TLR4 against emphysematous changes of the lung in response to CS",
      "citation": {
        "db": "PubMed",
        "db_id": "22983353"
      },
      "annotations": {},
      "source": 34,
      "target": 59,
      "key": "e387091e218ab86daa748e7e465cabb8"
    },
    {
      "line": 292,
      "relation": "decreases",
      "evidence": "The expression of cleaved caspase-3 was markedly increased in Tlr4-deficient mice exposed to CS.",
      "citation": {
        "db": "Other",
        "db_id": "22983353"
      },
      "annotations": {},
      "source": 34,
      "target": 59,
      "key": "95bbe3394612a3be23a05787ee11251c"
    },
    {
      "line": 424,
      "relation": "positiveCorrelation",
      "evidence": "Toll-like receptors 4 (TLR4) is induced in patients with an advanced stage of chronic obstructive lung disease (COPD) in parallel with increases in apoptosis",
      "citation": {
        "db": "Other",
        "db_id": "22983353"
      },
      "annotations": {},
      "source": 34,
      "target": 4,
      "key": "7a05c8cd51fb762bea883e4a955a018d"
    },
    {
      "line": 424,
      "relation": "positiveCorrelation",
      "evidence": "Toll-like receptors 4 (TLR4) is induced in patients with an advanced stage of chronic obstructive lung disease (COPD) in parallel with increases in apoptosis.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "source": 34,
      "target": 4,
      "key": "9e7c49da5096366e0ca4437da3ec3329"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "To confirm that TNFalpha protein synthesized in the brain of the transgenic animal is biologically active, we quantified expression of TRADD protein. Homogenates of brain sampled from TNFalpha-Tg and non-Tg rats were incubated with a primary antibody that recognizes rat TRADD only after it has been activated through binding of TNFalpha to p55/TNFR1, thereby implying biological activity of the cytokine. Regional expression of TRADD protein was uniformly higher in TNFalpha-Tg rat brain than in non-Tg controls by statistically significant margins.",
      "citation": {
        "db": "PubMed",
        "db_id": "18947406"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "90272cfedce314b5021eff8d43998eeb"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "The results support the following pathway, whereby TNF-alpha enhances expression of ICAM-1 in NHBE cells: TNF-alpha --> TNF-RI --> PC-PLC --> DAG --> PKC --> (NF-kappaB?) --> ICAM-1 mRNA --> ICAM-1 surface expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "10837365"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "f8cd2ceb0508eae706be9612e35574fe"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "he binding of TNF to the cell surface receptor TNF-R1 causes the recruitment of the adapter protein TRADD to the cytoplasmic domain of the receptor. TRADD then serves to recruit additional signaling molecules, including FADD, TRAF2, and RIP1 (Chen and Goeddel 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "15545623"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "bda72f45135df64362437d1a066695eb"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.",
      "citation": {
        "db": "PubMed",
        "db_id": "18697935"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "2f5a31b2412364f643024ee112cfec63"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "To determine the cytotoxic effects and the type of cell death facilitated by TNF in A549 cells, we treated cells with TNF and analyzed cell death based on morphological and biochemical assays. The death rate of A549 cells increased with increasing concentration of TNF (Fig. 1b), and cell death was characterized by cytoplasmic condensation and pyknotic nuclei without apoptotic body formation (Fig. 1c). Dose-dependent release of LDH into the culture medium was also noted (Fig. 1d); this is frequently encountered after necrotic cell death due to rupture of the cell membrane....Thus, TNF triggers necrotic rather than apoptotic cell death in A549 cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "20963496"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "7e2827273f4b97a5dc6dc2283a5cdbe0"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "Consistent with the in vivo findings, p75 blockade resulted in significant reduction of TNF-induced VCAM-1 and E-selectin expression by 28 and 23%, respectively (P < 0.05), but had no significant effect on ICAM-1 (Fig. 4A). On the other hand, as with in vivo experiments, p55 blockade significantly decreased the expression of all adhesion molecules",
      "citation": {
        "db": "PubMed",
        "db_id": "21378027"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "dcb807780bd989d3ecacaf194e09573b"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "After being processed by such metalloproteinases as TNF-a-converting enzyme (TACE) between residues alanine76 and valine77, the soluble form of TNF-a of 157 amino acid residues (17 kDa) is released and mediates its biological activities through Type 1 and 2 TNF receptors (TNF-R1 also known as TNFRSF1A, CD120a and TNF-R2 also known as",
      "citation": {
        "db": "PubMed",
        "db_id": "20194223"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "9b14fad25a91997355b503b1ba2e54d6"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "TABLE 1. Cytokine/chemokines, their receptors, and functions.",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "50473e97d6828b500a3e3de8f5aa8537"
    },
    {
      "line": 318,
      "relation": "directlyIncreases",
      "evidence": "Because RIP1 and TRAF2 are downstream effectors of the TNF receptor, it is possible that MNNG induces TNF through RIP1 and TRAF2 to trigger cell death. To investigate this possibility, we examined the sensitivity of TNFR1-/- MEF cells to MNNG treatment and found that it is comparable with that of WT MEF cells (Fig. 6c). As expected, TNFR1-/- MEF cells are resistant to TNF-induced cell death (Fig. 6c). These results exclude the possibility that RIP1 and TRAF2 function in the TNF signaling pathway in MNNG-treated cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16446354"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 40,
      "key": "20b0cfd0cd8952d825c368dc72a42bae"
    },
    {
      "line": 319,
      "relation": "increases",
      "evidence": "TNF increased the expression of TRAIL-R1 and TRAILR2 proteins in A549 cells (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "18511705"
      },
      "annotations": {},
      "source": 35,
      "target": 36,
      "key": "a470a87c0f96033dfb5e25060815bc8c"
    },
    {
      "line": 319,
      "relation": "increases",
      "evidence": "A549 cells (lung adenocarcinoma cell line) exposed in vitro to oxidative stress (H2O2) and TNF had higher expression of TRAIL-R1, 2, and 3 but also higher levels of p53,74 suggesting that the modulation of the TRAIL system observed in the emphysematous lung may be attributable to oxidative stress and/or infl ammatory cytokines. As TRAIL is released by activated infl ammatory cells, oxidative stress and infl ammation present in the emphysematous lung may sensitize alveolar cells to its apoptotic effects (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19436685"
      },
      "annotations": {},
      "source": 35,
      "target": 36,
      "key": "67ebd4c1d6b45046f104d8d77b5c09b8"
    },
    {
      "line": 320,
      "relation": "increases",
      "evidence": "A549 cells (lung adenocarcinoma cell line) exposed in vitro to oxidative stress (H2O2) and TNF had higher expression of TRAIL-R1, 2, and 3 but also higher levels of p53,74 suggesting that the modulation of the TRAIL system observed in the emphysematous lung may be attributable to oxidative stress and/or infl ammatory cytokines. As TRAIL is released by activated infl ammatory cells, oxidative stress and infl ammation present in the emphysematous lung may sensitize alveolar cells to its apoptotic effects (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19436685"
      },
      "annotations": {},
      "source": 35,
      "target": 37,
      "key": "1916a16442f1d6222af6fef969960eb2"
    },
    {
      "line": 320,
      "relation": "increases",
      "evidence": "TNF increased the expression of TRAIL-R1 and TRAILR2 proteins in A549 cells (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "18511705"
      },
      "annotations": {},
      "source": 35,
      "target": 37,
      "key": "908ed7c60e99ed4bdd02c82da33b37e6"
    },
    {
      "line": 321,
      "relation": "directlyIncreases",
      "evidence": "TABLE 1. Cytokine/chemokines, their receptors, and functions.",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 41,
      "key": "c7a02869f3b629342d7a43f754f746f0"
    },
    {
      "line": 321,
      "relation": "directlyIncreases",
      "evidence": "Consistent with the in vivo findings, p75 blockade resulted in significant reduction of TNF-induced VCAM-1 and E-selectin expression by 28 and 23%, respectively (P < 0.05), but had no significant effect on ICAM-1 (Fig. 4A). On the other hand, as with in vivo experiments, p55 blockade significantly decreased the expression of all adhesion molecules",
      "citation": {
        "db": "PubMed",
        "db_id": "21378027"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 35,
      "target": 41,
      "key": "b487e22e37d28f42ff47e7454cb1beff"
    },
    {
      "line": 322,
      "relation": "increases",
      "evidence": "A549 cells (lung adenocarcinoma cell line) exposed in vitro to oxidative stress (H2O2) and TNF had higher expression of TRAIL-R1, 2, and 3 but also higher levels of p53,74 suggesting that the modulation of the TRAIL system observed in the emphysematous lung may be attributable to oxidative stress and/or infl ammatory cytokines. As TRAIL is released by activated infl ammatory cells, oxidative stress and infl ammation present in the emphysematous lung may sensitize alveolar cells to its apoptotic effects (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "19436685"
      },
      "annotations": {},
      "source": 35,
      "target": 38,
      "key": "3e8316f38ad6aa9a4bbb60d1d4b20d08"
    },
    {
      "line": 59,
      "relation": "increases",
      "evidence": "Here we show that TRAIL-R1-, TRAIL-R2-, and TRAIL-R4-induced NF-kappaB activation are mediated by a TRAF2-NIK-IkappaB kinase alpha/beta signaling cascade but is MEKK1 independent.",
      "citation": {
        "db": "PubMed",
        "db_id": "10521444"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 37,
      "target": 47,
      "key": "930c731bc5335b5310c47db0fe9899b4"
    },
    {
      "line": 176,
      "relation": "increases",
      "evidence": "TRADD was essential for TNFR1 signaling in mouse embryonic fibroblasts (MEFs) but partially dispensable in macrophages; abundant expression of the adaptor RIP in macrophages  may allow some transmission of TNFR1 signals in the absence of TRADD.",
      "citation": {
        "db": "PubMed",
        "db_id": "18641653"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 40,
      "target": 46,
      "key": "418a14e23f518183bc47c20b7fd79725"
    },
    {
      "line": 176,
      "relation": "increases",
      "evidence": "We found that TRADD is required for TNFR1 to induce NF-kappaB activation and caspase-8-dependent apoptosis but is dispensable for TNFR1-initiated, RIP1-dependent necrosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16611992"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 40,
      "target": 46,
      "key": "39b68a2ee303ae548ea6b5219db3ddb8"
    },
    {
      "line": 177,
      "relation": "increases",
      "evidence": "Although both DR3 and TNFRI activated TRAF2 and NF-kappaB to induce IL-8 gene transcription, the kinase cascades that transduce signals for DR3- and TNFRI-induced IL-8 gene transcription are different.",
      "citation": {
        "db": "PubMed",
        "db_id": "16324699"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 40,
      "target": 47,
      "key": "26d040e6f0b36344dbd7319bb353fb59"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Overexpression of TRAF2, but not TRAF1 or TRAF3, was sufficient to induce NF-kappa B activation. A truncated derivative of TRAF2 lacking an amino-terminal RING finger domain was a dominant-negative inhibitor of NF-kappa B activation mediated by TNF-R2 and CD40",
      "citation": {
        "db": "PubMed",
        "db_id": "7544915"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 41,
      "target": 47,
      "key": "1d6d35b5419c524c27df1bbfde2715f2"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "TNFR2 also induces TRAF2 degradation. We show that in addition to the well characterized TRAF2 binding motif 402-SKEE-405, the human receptor contains another sequence located at the C-terminal end (aminoacids 425-439) which also recruits TRAF2 and activates NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "21558270"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 41,
      "target": 47,
      "key": "df2b0a85e0f4a3bed3ebcc6f0ab9632c"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "The endogenous RIP protein was detected by immunoprecipitation in the TRAIL-R1 complex after TRAIL treatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "10958661"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 36,
      "key": "2d8b64d9487712acdb7782a59229d553"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "IAP, inhibitor of apoptosis; SMAC, second mitochondria-derived activator of caspase. In the death receptor pathway, ligands such as tumour-necrosis factor (TNF), FAS ligand (also known as CD95L), or TNF-related apoptosis-inducing ligand (TRAIL, also known as APO2 ligand (APO2L) or TNF ligand superfamily member 10 (TNFSF10)) interact with their respective death receptors (TNF receptor 1 (TNFR1), FAS (also known as CD95) and death receptor 4 (DR4, also known as TRAIL receptor 1 (TRAILR1)) or DR5 (also known as TRAILR2), respectively). These interactions ultimately lead to the recruitment of the FAS-associated death domain (FADD) and the activation of the protease caspase 8. Caspase 8 cleaves and activates caspase 3 and other downstream caspases, which results in a proteolytic cascade that gives rise to the cell death phenotype characterized by DNA fragmentation, chromatin condensation, cell shrinkage and membrane blebbing.",
      "citation": {
        "db": "PubMed",
        "db_id": "16239906"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 36,
      "key": "63133b007377ef0ad50b69fbc7ff4c12"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "TRAIL binds to five cognate cell surface receptors, but only two of these receptors TRAIL-R1 and TRAIL-R2",
      "citation": {
        "db": "PubMed",
        "db_id": "18437894"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 36,
      "key": "cf2997057c6fedde096b9558d043aab0"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "The chemotherapeutic drugs (paclitaxel, vincristine, vinblastine, etoposide, camptothecin, and Adriamycin) induced death receptors (DRs) TRAIL receptor 1/DR4 and TRAIL receptor 2/DR5, and successive treatment with TRAIL resulted in apoptosis of both TRAIL-sensitive and -resistant cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "14500373"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 36,
      "key": "64a3dbd9da5e6d014dc50a9622424221"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "Recombinant human TRAIL (hrTRAIL) is a ligand of TRAIL receptor and TRAIL treatment is known to induce apoptosis and inhibit cell growth in lung cancer cell line [75].",
      "citation": {
        "db": "PubMed",
        "db_id": "19663788"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 36,
      "key": "db612ec3b876ad7421309b4c866a4f1d"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Elimination of endogenous Omi by RNA interference abolishes c-IAP1 cleavage and desensitizes cells to apoptosis induced by TRAIL.",
      "citation": {
        "db": "PubMed",
        "db_id": "12815069"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 37,
      "key": "48d5d2eb5433a3bb7e1944a2db8dd032"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "The chemotherapeutic drugs (paclitaxel, vincristine, vinblastine, etoposide, camptothecin, and Adriamycin) induced death receptors (DRs) TRAIL receptor 1/DR4 and TRAIL receptor 2/DR5, and successive treatment with TRAIL resulted in apoptosis of both TRAIL-sensitive and -resistant cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "14500373"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 37,
      "key": "92825b8e4b1ba994e9ecb812e477a29b"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IAP, inhibitor of apoptosis; SMAC, second mitochondria-derived activator of caspase. In the death receptor pathway, ligands such as tumour-necrosis factor (TNF), FAS ligand (also known as CD95L), or TNF-related apoptosis-inducing ligand (TRAIL, also known as APO2 ligand (APO2L) or TNF ligand superfamily member 10 (TNFSF10)) interact with their respective death receptors (TNF receptor 1 (TNFR1), FAS (also known as CD95) and death receptor 4 (DR4, also known as TRAIL receptor 1 (TRAILR1)) or DR5 (also known as TRAILR2), respectively). These interactions ultimately lead to the recruitment of the FAS-associated death domain (FADD) and the activation of the protease caspase 8. Caspase 8 cleaves and activates caspase 3 and other downstream caspases, which results in a proteolytic cascade that gives rise to the cell death phenotype characterized by DNA fragmentation, chromatin condensation, cell shrinkage and membrane blebbing.",
      "citation": {
        "db": "PubMed",
        "db_id": "16239906"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 37,
      "key": "c20943ef8d67672a4b14d824bbc67c00"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "TRAIL binds to five cognate cell surface receptors, but only two of these receptors TRAIL-R1 and TRAIL-R2",
      "citation": {
        "db": "PubMed",
        "db_id": "18437894"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 37,
      "key": "870ec6ffff56c4d04510af1f6190fa39"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Recombinant human TRAIL (hrTRAIL) is a ligand of TRAIL receptor and TRAIL treatment is known to induce apoptosis and inhibit cell growth in lung cancer cell line [75].",
      "citation": {
        "db": "PubMed",
        "db_id": "19663788"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 43,
      "target": 37,
      "key": "75b1c7211a035524bdf7157e4ab9cfc9"
    },
    {
      "line": 167,
      "relation": "increases",
      "evidence": "The endogenous RIP protein was detected by immunoprecipitation in the TRAIL-R1 complex after TRAIL treatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "10958661"
      },
      "annotations": {},
      "source": 43,
      "target": 11,
      "key": "e78fba342086cf008fe2987ccfa9400c"
    },
    {
      "line": 331,
      "relation": "increases",
      "evidence": "Cytoplasmic TRADD activates apoptosis through Fas-associated death domain protein (FADD) and caspase-8 activation that was blocked by caspase inhibitors or dominant-negative FADD.",
      "citation": {
        "db": "PubMed",
        "db_id": "15761471"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 46,
      "target": 63,
      "key": "a5c53e7866245d79a730560a3fe5cde3"
    },
    {
      "line": 331,
      "relation": "increases",
      "evidence": "We also showed that overexpressed NH2 termini of K18 and K8/18 were associated with endogenous TRADD in SW13 cells, resulting in the inhibition of caspase-8 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11684708"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 46,
      "target": 63,
      "key": "089d434db131dec732d4489cfff9363c"
    },
    {
      "line": 331,
      "relation": "increases",
      "evidence": "It also associates with death domain-containing adaptor proteins, such as TNF-receptor-associated death domain  (TRADD) and Fas-associated death domain (FADD), that are required for caspase-8  activation and apoptosis ([Schutze et al., 2008] and [Wilson et al., 2009])",
      "citation": {
        "db": "PubMed",
        "db_id": "19632174"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 46,
      "target": 63,
      "key": "d577abb31896ddfb5bfafba4e9bc27d1"
    },
    {
      "line": 443,
      "relation": "increases",
      "evidence": "The strong dominant-negative effect of FADD(80â€“205) on cell death induced by TNF, TNFR1, and TRADD suggests that FADD participates in the apoptotic pathway activated by TNF through TNFR1 and TRADD.",
      "citation": {
        "db": "Other",
        "db_id": "8565075"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 46,
      "target": 93,
      "key": "6d3d51b0fe781a331198ac76f68838ff"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "These results indicate that ASK1 acts as the downstream kinase of TRAF2 in the TNF-induced JNK activation pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "9774977"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 47,
      "target": 131,
      "key": "19c3967ada5dd202c30bded995bc5c9e"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "A PERIOD-like domain (amino acids 591-719) of AIP1 binds to the intact RING finger of TRAF2, and specifically enhances TRAF2-induced ASK1 activation. At the same time, the binding of AIP1 to TRAF2 inhibits TNF-induced IKK-NF-kappaB signaling.",
      "citation": {
        "db": "PubMed",
        "db_id": "15310755"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 47,
      "target": 131,
      "key": "88d94c2f63c764d12cdcd6ad8f967ccd"
    },
    {
      "line": 92,
      "relation": "directlyIncreases",
      "evidence": "Tumor necrosis factor receptor-associated factors 2 and 6 (TRAF2 and -6) act as the ubiquitin E3 ligases to mediate Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue in vivo and in vitro. Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue is required for TAK1-mediated IKK complex recruitment.....Our findings demonstrate that Lys(63)-linked polyubiquitination of TAK1 at Lys(158) is essential for its own kinase activation and its ability to mediate its downstream signal transduction pathways in response to TNFalpha and IL-1beta stimulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "20038579"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 47,
      "target": 133,
      "key": "3fe8c0d75626deb91a23bd985939678c"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "TRAF2 can activate NIK and subsequently the IKK complex, which leads to IkB phosphorylation and nuclear translocation of dissociated NF-kB.",
      "citation": {
        "db": "PubMed",
        "db_id": "16324699"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 47,
      "target": 130,
      "key": "7e2f773baf2f1429b408de1e613590f8"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "These results indicated that NIK is a common downstream kinase of TRAF2, TRAF5, and TRAF6 for NF-kB activation in HEK293 cells",
      "citation": {
        "db": "PubMed",
        "db_id": "9582383"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 47,
      "target": 130,
      "key": "93592e5685e96aa7b8cd9654bba4957d"
    },
    {
      "line": 62,
      "relation": "decreases",
      "evidence": "Using STL diagrams, we showed that observed differences in the concentrations of upstream proteins in different cell lines could not account for the observed cell type changes. This finding is consistent with the observation based on in vivo and in silico works that downstream proteins, most notably XIAP and caspase-3, play a key role [6], but is in apparent contradiction with the observation that upstream protein activities are markedly different in type I and II cell lines [5].",
      "citation": {
        "db": "Other",
        "db_id": "23675292"
      },
      "annotations": {
        "doid": {
          "4362": true
        }
      },
      "source": 112,
      "target": 4,
      "key": "b4b477c45774b05524730745395a536d"
    },
    {
      "line": 62,
      "relation": "decreases",
      "evidence": "Transfection of siRNA for XIAP or survivin individually resulted in a partial abrogation of the antiapoptotic effects of nicotine",
      "citation": {
        "db": "PubMed",
        "db_id": "16601104"
      },
      "annotations": {},
      "source": 112,
      "target": 4,
      "key": "b375f5865882a51a694d98b1ef61f64c"
    },
    {
      "line": 62,
      "relation": "decreases",
      "evidence": "from full text - XIAP, which binds the pool of survivin released from mitochondria in response to cell-death stimuli (59), resulting in increased XIAP stability against proteasomal degradation and inhibition of apoptosis in vivo (31)",
      "citation": {
        "db": "PubMed",
        "db_id": "18075512"
      },
      "annotations": {},
      "source": 112,
      "target": 4,
      "key": "30751f991b6142759abe894ffc1a5431"
    },
    {
      "line": 62,
      "relation": "decreases",
      "evidence": "Antisense-mediated reductions in IAP-family members XIAP, cIAP1, Survivin, or Apollon can induce apoptosis of tumor cell lines in culture, or sensitize cells to cytotoxic anticancer drugs, thus providing proof-of-concept evidence that the pathological elevations of IAPs found in cancers are important for maintaining tumor cell survival and resistance to chemotherapy (Table 1C).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "source": 112,
      "target": 4,
      "key": "5eaa0fbf1cea867dae718a3dc94b42eb"
    },
    {
      "line": 62,
      "relation": "decreases",
      "evidence": "As shown in Fig. 3A, MIHA, MIHB, and OpIAP significantly reduced the amount of death caused by ICE, whereas MIHC did not provide detectable protection.",
      "citation": {
        "db": "PubMed",
        "db_id": "8643514"
      },
      "annotations": {},
      "source": 112,
      "target": 4,
      "key": "2c9685ece5f01c91ec5ee4f5549bc7dc"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The inhibitor of apoptosis proteins (IAP) regulates cell death by inhibiting caspases. The region of X-linked (X) IAP containing the second baculovirus IAP repeat domain (BIR2) is sufficient for inhibiting caspase-3 and -7. In this study, we found that the modes of inhibition of these two caspases were different: caspase-3 is inhibited in a competitive manner whereas caspase-7 inhibition occurs through a mixed competitive and noncompetitive mechanism. Binding assays revealed that the inhibition of caspase-3 by XIAP was totally dependent on the interaction between the active site of caspase-3 and the linker region between the BIR1 and BIR2 domains of XIAP. In contrast, the active site and the NH2-terminal region of caspase-7 bound to the linker region and the BIR2, respectively. Moreover the BIR2 with a mutated linker region, which inhibited caspase-3 very weakly, still bound to and inhibited caspase-7. Furthermore, a chimeric caspase-7/3 comprising the NH2-terminal portion of caspase-7 and COOH-terminal portion of caspase-3 was inhibited by XIAP by a mixed competitive and noncompetitive mechanism. Our results suggest that the linker region between BIR1 and BIR2 domains is responsible for active site-directed, competitive inhibition of both caspase-3 and -7, whereas the BIR2 itself is involved in noncompetitive inhibition of caspase-7.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "18e367dc18e5fb9b4ee88868629446af"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "Ligation of death receptors or formation of the Apaf-1 apoptosome results in the activation of caspases and execution of apoptosis. We recently demonstrated that X-linked inhibitor-of-apoptosis protein (XIAP) associates with the apoptosome in vitro. By utilizing XIAP mutants, we now report that XIAP binds to the 'native' apoptosome complex via a specific interaction with the small p12 subunit of processed caspase-9. Indeed, we provide the first direct evidence that XIAP can simultaneously bind active caspases-9 and -3 within the same complex and that inhibition of caspase-3 by the Linker-BIR2 domain prevents disruption of BIR3-caspase-9 interactions. Recent studies suggest that inhibition of caspase-3 is dispensable for its anti-apoptotic effects. However, we clearly demonstrate that inhibition of caspase-3 is required to inhibit CD95 (Fas/Apo-1)-mediated apoptosis, whereas inhibition of either caspase-9 or caspase-3 prevents Bax-induced cell death. Finally, we illustrate for the first time that XIAP mutants, which are incapable of binding to caspases-9 and -3 are completely devoid of anti-apoptotic activity. Thus, XIAP's capacity to maintain inhibition of caspase-9 within the Apaf-1 apoptosome is influenced by its ability to simultaneously inhibit active caspase-3, and depending upon the apoptotic stimulus, inhibition of caspase-9 or 3 is essential for XIAP's anti-apoptotic activity.",
      "citation": {
        "db": "Other",
        "db_id": "12181739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "e5343c8d65fba87fa32953096a84fb05"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "Ligation of death receptors or formation of the Apaf-1 apoptosome results in the activation of caspases and execution of apoptosis. We recently demonstrated that X-linked inhibitor-of-apoptosis protein (XIAP) associates with the apoptosome in vitro. By utilizing XIAP mutants, we now report that XIAP binds to the 'native' apoptosome complex via a specific interaction with the small p12 subunit of processed caspase-9. Indeed, we provide the first direct evidence that XIAP can simultaneously bind active caspases-9 and -3 within the same complex and that inhibition of caspase-3 by the Linker-BIR2 domain prevents disruption of BIR3-caspase-9 interactions. Recent studies suggest that inhibition of caspase-3 is dispensable for its anti-apoptotic effects. However, we clearly demonstrate that inhibition of caspase-3 is required to inhibit CD95 (Fas/Apo-1)-mediated apoptosis, whereas inhibition of either caspase-9 or caspase-3 prevents Bax-induced cell death. Finally, we illustrate for the first time that XIAP mutants, which are incapable of binding to caspases-9 and -3 are completely devoid of anti-apoptotic activity. Thus, XIAP's capacity to maintain inhibition of caspase-9 within the Apaf-1 apoptosome is influenced by its ability to simultaneously inhibit active caspase-3, and depending upon the apoptotic stimulus, inhibition of caspase-9 or 3 is essential for XIAP's anti-apoptotic activity.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "ef05cc1d2f0ca2aff72565ac2c7d7c66"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The inhibitor of apoptosis (IAP) family of anti-apoptotic proteins\nregulate programmed cell death and/or apoptosis. One such pro-\ntein, X-linked IAP (XIAP), inhibits the activity of the cell death\nproteases, caspase-3, -7, and -9. In this study, using constitutively\nactive mutants of caspase-3, we found that XIAP promotes the\ndegradation of active-form caspase-3, but not procaspase-3, in\nliving cells. The XIAP mutants, which cannot interact with\ncaspase-3, had little or no activity of promoting the degradation of\ncaspase-3. RING finger mutants of XIAP also could not promote the\ndegradation of caspase-3. A proteasome inhibitor suppressed the\ndegradation of caspase-3 by XIAP, suggesting the involvement of\na ubiquitin-proteasome pathway in the degradation. An\nin vitro\nubiquitination assay revealed that XIAP acts as a ubiquitin-protein\nligase for caspase-3. Caspase-3 was ubiquitinated in the presence\nof XIAP in living cells. Both the association of XIAP with caspase-3\nand the RING finger domain of XIAP were essential for ubiquiti-\nnation. Finally, the RING finger mutants of XIAP were less effective\nthan wild-type XIAP at preventing apoptosis induced by overex-\npression of either active-form caspase-3 or Fas. These results\ndemonstrate that the ubiquitin-protein ligase activity of XIAP\npromotes the degradation of caspase-3, which enhances its anti-\napoptotic effect.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "b08d972860368f53ce1e1ed0dcd11a63"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "Caspase-3 downregulation (CASP3/DR) in tumors frequently confers resistance to cancer therapy and is significantly correlated with a poor prognosis in cancer patients. Because CASP3/DR cancer cells rely heavily on the activity of caspase-7 (CASP7) to initiate apoptosis, inhibition of activated CASP7 (p19/p12-CASP7) by X-linked inhibitor of apoptosis protein (XIAP) is a potential mechanism by which apoptosis is prevented in those cancer cells. Here, we identify the pocket surrounding the Cys246 residue of p19/p12-CASP7 as a target for the development of a protein-protein interaction (PPI) inhibitor of the XIAP:p19/p12-CASP7 complex. Interrupting this PPI directly triggered CASP7-dependent apoptotic signaling that bypassed the activation of the apical caspases and selectively killed CASP3/DR malignancies in vitro and in vivo without adverse side effects in nontumor cells. Importantly, CASP3/DR combined with p19/p12-CASP7 accumulation correlated with the aggressive evolution of clinical malignancies and a poor prognosis in cancer patients. Moreover, targeting of this PPI effectively killed cancer cells with multidrug resistance due to microRNA let-7a-1â€“mediated CASP3/DR and resensitized cancer cells to chemotherapy-induced apoptosis. These findings not only provide an opportunity to treat CASP3/DR malignancies by targeting the XIAP:p19/p12-CASP7 complex, but also elucidate the molecular mechanism underlying CASP3/DR in cancers.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "339d105769cbc6668acb3763c67f348b"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "Caspases are essential mediators of cytokine release and apoptosis. Additionally, caspase\nactivity is required for the proliferation of naive T lymphocytes. It remained unclear how\nproliferating cells are able to cope with the pro-apoptotic activity especially of effector\ncaspases-3 and -7. Possible reasons might include limited subcellular localization of active\ncaspases or inhibition byendogenous caspase inhibitors. Here, we compared the activation\nof various caspases inproliferating human Tcellswiththatin apoptotic cells. We showthat\ncleaved caspases-3/-7 appear to be widely distributed in apoptotic cells while they are\nlargely confined to the cytoplasm in proliferating cells. Additionally, in proliferating T cells\ncaspase-3 remains incompletely cleaved, while in apoptotic cells fully mature caspase-3 is\ngenerated. We provide evidence that during T cell proliferation the intracellular caspase\ninhibitor X-linked inhibitor-of-apoptosis protein (XIAP) interacts with caspases-3/-7,\nthereby blocking their full activation, substrate cleavage, and cell death. The lack of\nsubstrate cleavage might also lead to the observed limited subcellular distribution of\ncaspases-3/-7. After induction of apoptosis, second mitochondria-derived activator of\ncaspases/direct inhibitor of apoptosis-binding protein with low isoelectric point (Smac/\nDIABLO)isreleasedfrommitochondria,resultingintheabrogationoftheinhibitoryeffectof\nXIAP, full activation of caspases-3/-7, and apoptosis",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "9b097ac8fbd59d9ad80ac9ee05cdbe32"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The molecular mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood. The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7. We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resolution of 2.7 Ã…, revealing the structural basis for inhibition. The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension. This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding. The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.",
      "citation": {
        "db": "Other",
        "db_id": "11257232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "0911450e411a627e177f2b9918766003"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The inhibitor of apoptosis proteins (IAP) regulates\ncell death by inhibiting caspases. The region of X-linked\n(X) IAP containing the second baculovirus IAP repeat\ndomain (BIR2) is sufficient for inhibiting caspase-3 and\n-7. In this study, we found that the modes of inhibition of\nthese two caspases were different: caspase-3 is inhibited\nin a competitive manner whereas caspase-7 inhibition\noccurs through a mixed competitive and noncompeti-\ntive mechanism. Binding assays revealed that the inhi-\nbition of caspase-3 by XIAP was totally dependent on the\ninteraction between the active site of caspase-3 and the\nlinker region between the BIR1 and BIR2 domains of\nXIAP. In contrast, the active site and the NH\n2\n-terminal\nregion of caspase-7 bound to the linker region and the\nBIR2, respectively. Moreover the BIR2 with a mutated\nlinker region, which inhibited caspase-3 very weakly,\nstill bound to and inhibited caspase-7. Furthermore, a\nchimeric caspase-7/3 comprising the NH\n2\n-terminal por\n-\ntion of caspase-7 and COOH-terminal portion of\ncaspase-3 was inhibited by XIAP by a mixed competitive\nand noncompetitive mechanism. Our results suggest\nthat the linker region between BIR1 and BIR2 domains\nis responsible for active site-directed, competitive inhi-\nbition of both caspase-3 and -7, whereas the BIR2 itself is\ninvolved in noncompetitive inhibition of caspase-7",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "3c8ec1d76351d42bb9d2c3fbeed7e9a7"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "Smac/DIABLO and HtrA2 are needed to release the X-linked inhibitor-of-apoptosis protein (XIAP)-mediated block of full caspase 3 maturation. XIAP can effectively block caspase 3 maturation and, intriguingly, is highly expressed in primary but not in transformed keratinocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "12529384"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "90f8e6cdaf6b43261c74235ff9cae22e"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The inhibitor of apoptosis proteins (IAP) regulates cell death by inhibiting caspases. The region of X-linked (X) IAP containing the second baculovirus IAP repeat domain (BIR2) is sufficient for inhibiting caspase-3 and -7. In this study, we found that the modes of inhibition of these two caspases were different: caspase-3 is inhibited in a competitive manner whereas caspase-7 inhibition occurs through a mixed competitive and noncompetitive mechanism. Binding assays revealed that the inhibition of caspase-3 by XIAP was totally dependent on the interaction between the active site of caspase-3 and the linker region between the BIR1 and BIR2 domains of XIAP. In contrast, the active site and the NH(2)-terminal region of caspase-7 bound to the linker region and the BIR2, respectively. Moreover the BIR2 with a mutated linker region, which inhibited caspase-3 very weakly, still bound to and inhibited caspase-7. Furthermore, a chimeric caspase-7/3 comprising the NH(2)-terminal portion of caspase-7 and COOH-terminal portion of caspase-3 was inhibited by XIAP by a mixed competitive and noncompetitive mechanism. Our results suggest that the linker region between BIR1 and BIR2 domains is responsible for active site-directed, competitive inhibition of both caspase-3 and -7, whereas the BIR2 itself is involved in noncompetitive inhibition of caspase-7.",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "afffa1cf587c7febc9a9e659afe15387"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The X-linked inhibitor of apoptosis protein (XIAP) uses its second baculovirus IAP repeat domain (BIR2) to inhibit the apoptotic executioner caspase-3 and -7. Structural studies have demonstrated that it is not the BIR2 domain itself but a segment N-terminal to it that directly targets the activity of these caspases. These studies failed to demonstrate a role of the BIR2 domain in inhibition. We used site-directed mutagenesis of BIR2 and its linker to determine the mechanism of executioner caspase inhibition by XIAP. We show that the BIR2 domain contributes substantially to inhibition of executioner caspases. A surface groove on BIR2, which also binds to Smac/DIABLO, interacts with a neoepitope generated at the N-terminus of the caspase small subunit following activation. Therefore, BIR2 uses a two-site interaction mechanism to achieve high specificity and potency for inhibition. Moreover, for caspase-7, the precise location of the activating cleavage is critical for subsequent inhibition. Since apical caspases utilize this cleavage site differently, we predict that the origin of the death stimulus should dictate the efficiency of inhibition by XIAP.",
      "citation": {
        "db": "Other",
        "db_id": "15650747"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "224efbe615975041db6c9973796ae39a"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "In this issue of\nCancer Cell\n, Schimmer et al. report the identification of small molecule antagonists of XIAP that overcome\nits inhibition of caspase-3. It was remarkable that the compounds directly induced cell death in tumor cells while having lit-\ntle toxicity on normal cells.This suggests that caspases are already activated in tumor cells, which is different from the cas-\npase activation status in normal mammalian cells. In comparison with Smac peptides targeting XIAP-mediated caspase-9\ninhibition, which do not directly induce cell death, it appears that liberating downstream caspases rather than upstream\ncaspases may be a preferred strategy for cancer drug discover",
      "citation": {
        "db": "Other",
        "db_id": ""
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "7ec9dab003ecf15fffd86b477a19f06c"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "The X-linked inhibitor of apoptosis protein (XIAP) uses its second baculovirus IAP repeat domain (BIR2) to inhibit the apoptotic executioner caspase-3 and -7.",
      "citation": {
        "db": "PubMed",
        "db_id": "15650747"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 59,
      "key": "574818ba8a431eae0ebf9fa14b76e6da"
    },
    {
      "line": 388,
      "relation": "decreases",
      "evidence": "Thus, XIAP sequesters caspase-9 in a monomeric state, which serves to prevent catalytic activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12620238"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 64,
      "key": "423ec354047fb0991cafbcf985a1880b"
    },
    {
      "line": 388,
      "relation": "decreases",
      "evidence": "Here we show that the Bir3 domain is the minimal region of XIAP that is needed for potent caspase-9 inhibition.",
      "citation": {
        "db": "PubMed",
        "db_id": "10934209"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 64,
      "key": "070e9186fdfc62dddadc3d8b2dafad80"
    },
    {
      "line": 388,
      "relation": "decreases",
      "evidence": "Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.",
      "citation": {
        "db": "PubMed",
        "db_id": "14512414"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 64,
      "key": "6c9e79e1da96b215b0a202d1bc637d30"
    },
    {
      "line": 389,
      "relation": "decreases",
      "evidence": "Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.",
      "citation": {
        "db": "PubMed",
        "db_id": "14512414"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 62,
      "key": "b079ed40b2ea9e66bd122d5fa5599fbb"
    },
    {
      "line": 389,
      "relation": "decreases",
      "evidence": "The X-linked inhibitor of apoptosis protein (XIAP) uses its second baculovirus IAP repeat domain (BIR2) to inhibit the apoptotic executioner caspase-3 and -7.",
      "citation": {
        "db": "PubMed",
        "db_id": "15650747"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 112,
      "target": 62,
      "key": "1de990ec83e9ef5bcdfc1ef9c2b6f4e6"
    },
    {
      "line": 11,
      "relation": "decreases",
      "evidence": "quotation",
      "citation": {
        "db": "PubMed",
        "db_id": "15205477"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 104,
      "target": 174,
      "key": "5ca7e09d9adcdacb12bcd93e11479cfb"
    },
    {
      "line": 333,
      "relation": "directlyIncreases",
      "evidence": "Results show that active AKT directly phosphorylates Bax in vitro (Fig. 3C). Furthermore, active AKT can also directly phosphorylate recombinant Bax protein (Fig. 3D).",
      "citation": {
        "db": "PubMed",
        "db_id": "15642728"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 175,
      "key": "d11e349069f070cc6ad05b62ec1071ba"
    },
    {
      "line": 333,
      "relation": "directlyIncreases",
      "evidence": "Fig. 7. Akt is activated by IL-6, and active Akt directly phosphorylates Bax in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "19376889"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 175,
      "key": "3ef55d41d44bcb3cadfdeb206d6a8897"
    },
    {
      "line": 333,
      "relation": "directlyIncreases",
      "evidence": "Fig. 5C demonstrates that Akt could directly phosphorylate Bax in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "14766748"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 175,
      "key": "6e6fb91abbda63f8c01d8614a8d969e4"
    },
    {
      "line": 335,
      "relation": "directlyIncreases",
      "evidence": "126 S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.",
      "citation": {
        "db": "PubMed",
        "db_id": "16170185"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 180,
      "key": "1b5385ca9a501af68091e202f7b2fa5a"
    },
    {
      "line": 336,
      "relation": "directlyIncreases",
      "evidence": "AKT phosphorylates the proapoptotic Bcl-2 family member Bad at Ser-136 phosphorylated Bad is sequestered in the cytoplasm to 14-3-3",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 158,
      "key": "1436a3c2b09545036e8066d6ee3c373e"
    },
    {
      "line": 336,
      "relation": "directlyIncreases",
      "evidence": "Akt-dependent phosphorylation of Bad on Ser112 and Ser136 allows it to associate with 14-3-3 proteins and thereby suppresses its pro-apoptotic activity. Apoptotic kinases including JNK directly activate the cell death machinery by phosphorylating Bad at Serine 128 (Donovan et al., 2002Go). The phosphorylation of Bad at this residue disrupts the interaction of Bad with 14-3-3 proteins, thus allowing Bad to induce apoptosis (Konishi et al., 2002Go).",
      "citation": {
        "db": "PubMed",
        "db_id": "14673001"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 158,
      "key": "715008c54d9622f4040033b01890520b"
    },
    {
      "line": 336,
      "relation": "directlyIncreases",
      "evidence": "11020382;11577096;15037618;16044149",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 158,
      "key": "cf4ad79ea0dc13188bd09017b6943474"
    },
    {
      "line": 338,
      "relation": "directlyIncreases",
      "evidence": "PhosphoElm data from PMID 15212693",
      "citation": {
        "db": "PubMed",
        "db_id": "10617634"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 178,
      "key": "100fbfe854af48735fe4bf7e42c8b1dd"
    },
    {
      "line": 339,
      "relation": "directlyIncreases",
      "evidence": "11154276;14500571",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 132,
      "key": "5bd08c71d5e13cc70c3733a0a66d3ca2"
    },
    {
      "line": 340,
      "relation": "directlyDecreases",
      "evidence": "The Ras effector Akt is known to regulate p27 mRNA abundance by phosphorylating and inactivating the FOXO transcription factors. Phosphorylated Akt and FOXO proteins were both increased in lung tumors, correlating with a reduction in p27 mRNA transcript.",
      "citation": {
        "db": "PubMed",
        "db_id": "19648963"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 18,
      "target": 19,
      "key": "f675e9177c5ecf59eca8c01fd91096fd"
    },
    {
      "line": 341,
      "relation": "directlyIncreases",
      "evidence": "10358014;11410590",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 96,
      "key": "6f0c02e5ca9a5a759b57ff53cb4f41b9"
    },
    {
      "line": 343,
      "relation": "directlyIncreases",
      "evidence": "Akt-dependent phosphorylation of Bad on Ser112 and Ser136 allows it to associate with 14-3-3 proteins and thereby suppresses its pro-apoptotic activity. Apoptotic kinases including JNK directly activate the cell death machinery by phosphorylating Bad at Serine 128 (Donovan et al., 2002Go). The phosphorylation of Bad at this residue disrupts the interaction of Bad with 14-3-3 proteins, thus allowing Bad to induce apoptosis (Konishi et al., 2002Go).",
      "citation": {
        "db": "PubMed",
        "db_id": "14673001"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 157,
      "key": "91d84c46625a0e31002a72d6d5029786"
    },
    {
      "line": 359,
      "relation": "directlyIncreases",
      "evidence": "These data demonstrate that BimL is phosphorylated in vivo on Thr-56 and that JNK also phosphorylates BimL on at least one serine residue (Ser-44 and/or Ser-58)...JNK Phosphorylation of Bim on Thr-56 Increases Apoptotic Activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12591950"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 20,
      "target": 186,
      "key": "6815ee2bb70d2cf4f633ff914cde5c9f"
    },
    {
      "line": 361,
      "relation": "increases",
      "evidence": "Immunofluorescence analysis using a conformation specific anti-Bax antibody [19] showed the presence of active Bax at the mitochondria in wt but not in jnk-/- MEFs stimulated with Cd (Fig. 5C).",
      "citation": {
        "db": "PubMed",
        "db_id": "16458303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 20,
      "target": 174,
      "key": "26c6c313df46e8dca8110eea9a6f0c0c"
    },
    {
      "line": 440,
      "relation": "increases",
      "evidence": "PlGF-induced LE cell apoptosis and NE-induced mice pulmonary apoptosis and emphysema were mediated by the downstream c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)Â¿ signaling pathways.",
      "citation": {
        "db": "Other",
        "db_id": "25186164"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 20,
      "target": 4,
      "key": "97e421caa4d975e24f925720e8243075"
    },
    {
      "line": 191,
      "relation": "decreases",
      "evidence": "AKAP121 induction stimulates PKA-dependent phosphorylation of the proapoptotic protein BAD at Ser(155), inhibits release of cytochrome c from mitochondria, and protects cells from apoptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12427737"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 24,
      "target": 156,
      "key": "aa29a209c9620d4251ccd360aef79e35"
    },
    {
      "line": 191,
      "relation": "decreases",
      "evidence": "The antiapoptotic mechanism of epinephrine primarily involves phosphorylation and inactivation of the proapoptotic protein BAD by cAMP-dependent protein kinase.",
      "citation": {
        "db": "PubMed",
        "db_id": "17353197"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 24,
      "target": 156,
      "key": "43c573d2ca0ff8a584b2fcf65be174cd"
    },
    {
      "line": 191,
      "relation": "decreases",
      "evidence": "The PKA inhibitor H-89 (2.5, 5, and 10 umol/L) reduced the phosphorylation level of BAD at Ser112 ( Fig. 4B). To confirm that PKA mediated BAD phosphorylation in BaF3/FLT3/ITD cells, we showed that immunoprecipitated PKA from BaF3/FLT3/ITD cells had the ability to phosphorylate BAD at Ser112 with a BAD absent control, indicating that the phosphorylated BAD was not from immunoprecipitation ( Fig. 4C).",
      "citation": {
        "db": "PubMed",
        "db_id": "16103085"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 24,
      "target": 156,
      "key": "db599977d4c7bf0333298815041230d3"
    },
    {
      "line": 192,
      "relation": "directlyIncreases",
      "evidence": "aken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "10067851"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 24,
      "target": 79,
      "key": "b7530f3b03f337f1a38c47ed34f6ebec"
    },
    {
      "relation": "hasVariant",
      "source": 22,
      "target": 23,
      "key": "6d48407219593386142270f88c9c97ad"
    },
    {
      "line": 106,
      "relation": "directlyIncreases",
      "evidence": "91317794;16116087;17081983",
      "citation": {
        "db": "PubMed",
        "db_id": "15212693"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 22,
      "target": 125,
      "key": "e4bddecfcb659a1b4e6bca5b411d7aac"
    },
    {
      "line": 106,
      "relation": "directlyIncreases",
      "evidence": "Conventional (c)PKC beta 1, novel (n)PKC delta and nPKC epsilon efficiently phosphorylated the MARCKS protein in vitro. ... Site analysis revealed that only serine residues S152, S156 and S163 were phosphorylated, with S163 phosphorylated highest, followed by S156 and S152; in contrast, S160 and S167 were not phosphorylated. No further PKC phosphorylation sites could be detected in MARCKS. The phosphorylation pattern was independent of the type of PKC isotype used.",
      "citation": {
        "db": "PubMed",
        "db_id": "7588787"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 22,
      "target": 125,
      "key": "7b39a36193ddbc38ddac51fa1e3a0534"
    },
    {
      "line": 106,
      "relation": "directlyIncreases",
      "evidence": "PRK1 phosphorylates MARCKS at the PKC sites: serine 152, serine 156 and serine 163.",
      "citation": {
        "db": "PubMed",
        "db_id": "8557118"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 22,
      "target": 125,
      "key": "a130013f78b0c5a0be6c8d8cbdc984ae"
    },
    {
      "line": 441,
      "relation": "increases",
      "evidence": "PlGF-induced LE cell apoptosis and NE-induced mice pulmonary apoptosis and emphysema were mediated by the downstream c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)Â¿ signaling pathways.",
      "citation": {
        "db": "Other",
        "db_id": "25186164"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 22,
      "target": 4,
      "key": "7dbb06a0b04a8bf0b557773364de7a36"
    },
    {
      "line": 429,
      "relation": "association",
      "evidence": "Besides to inflammation, DNA methylation also\nparticipates in apoptosis in COPD. Recent studies have highlighted the role of apoptosis in\nthe development of COPD (PMID:     22913201,     22073568)",
      "citation": {
        "db": "Other",
        "db_id": "25807439"
      },
      "annotations": {},
      "source": 192,
      "target": 5,
      "key": "ff5c48b537e5dad247b815737598fe29"
    },
    {
      "line": 431,
      "relation": "increases",
      "evidence": "An increase apoptosis in airway epithelial, alveolar and endothelial cells is found in the lung of COPD patients",
      "citation": {
        "db": "Other",
        "db_id": "25807439"
      },
      "annotations": {},
      "source": 192,
      "target": 4,
      "key": "f80ed5d433aff2a1e212c79971f8bbf3"
    }
  ]
}